text,labels
case 28yearold previously healthy man present 6week history palpitation symptom occur rest 23 time week last 30 minute time associate dyspnea grade 26 holosystolic tricuspid regurgitation murmur well hear left sternal border inspiratory accentuation physical examination yield unremarkable finding electrocardiogram ecg reveal normal sinus rhythm wolff parkinson white preexcitation pattern fig1 produce rightside accessory pathway transthoracic echocardiography demonstrate presence ebstein anomaly tricuspid valve apical displacement valve formation atrialized right ventricle functional unit right atrium inlet inflow portion right ventricle fig2 anterior tricuspid valve leaflet elongate fig2c arrow septal leaflet rudimentary fig2c arrowhead contrast echocardiography saline reveal patent foraman ovale righttoleft shunting bubble left atrium fig2d patient undergo electrophysiologic study mapping accessory pathway follow radiofrequency ablation interruption pathway heat generate electromagnetic wave tip ablation catheter postablation ecg show prolong pr interval odd second qrs complex lead iii avf v2v4 fig1bottom consequence abnormal impulse conduction atrialized right ventricle patient report recurrence palpitation followup 6 month ablation,"['O', 'O', 'O', 'B-SYMPTOMS', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 34yrold man present complaint fever chronic cough smoker history pulmonary tuberculosis treat cure compute tomographic ct scan reveal multiple tiny nodule lung thoracoscopic lung biopsy take right upper lobe microscopic examination reveal typical lch tumor cell vesicular groove nucleus form small aggregation bronchiole fig1 tumor cell strongly positive s100 protein vimentin cd68 cd1a infiltration lymphocyte eosinophil tumor cell perform additional radiologic examination organ think involve quit smoking receive specific treatment follow year followup ct scan perform show 4 cmsize mass left low lobe addition multiple tiny nodule lung fig2 needle biopsy speciman reveal possibility sarcoma lobectomy perform grossly 4 cmsize poorlycircumscribed lobulate graywhite mass find fig3 small satellite nodule main mass microscopically tumor cell aggregate large sheet show infiltrative growth cytologic feature tumor cell similar see typical lch tumor cell show overtly malignant cytologic feature pleomorphichyperchromatic nucleus prominent nucleolus fig4 multinucleate tumor giant cell find numerous mitotic figure range 30 60 10 high power field abnormal foci typical lch remain main tumor mass immunohistochemically tumor cell strongly positive s100 protein fig5 vimentin positive cd68 dako n1577 clone kpi focally positive cd1a fig6 negative cytokeratin epithelial membrane antigen cd3 cd20 hmb45 ultrastructural analysis fail demonstrate birbeck granule cytoplasm tumor cell month lobectomy patient significant change radiologic finding,"['O', 'O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
23 year old white male 4 year history crohns disease present acute day history malaise fever abdominal pain vomiting stomal diarrhoea complain joint pain affect shoulder elbow wrist metacarpophalangeal knee ankle rash elbow ankle foot begin erythematous macule evolve vesicopustular lesion follow crust history sexual exposure intercurrent infection regular medication discontinue pentasa 4 month early month early undergo laparotomy excise complex ileocutaneous fistula blind tract week early defunctione ileostomy create view persistent abdominal pain cutaneous fistula present year associate terminal ileal stricture ileorectal fistula 2 year duration bowel disease resistant immunosuppressive drug include azathioprine corticosteroiod infusion infliximab year early extraintestinal manifestation admission hospital thin afebrile rest tachycardia 125minute rest cardiorespiratory examination normal abdoman minimally tender ileostomy guard rebound tenderness examination skin reveal pustule crust elbow ankle foot fig 1 2 buttock spare clinical sign synovitis wrist proximal interphalangeal metacarpophalangeal joint ankle result laboratory test show haemoglobin 131 gmdl white blood count 158    109l platelet 585    109l c reactive protein 377 mgl erythrocyte sedimentation rate 69 mmhr urea electrolyte complement urine analysis microscopy normal rheumatoid factor antinuclear antineutrophil cytoplasmic antibodie cryoglobulin hepatitis b c serology negative transthoracic echocardiogram show sign endocarditis multiple blood culture sterile skin biopsy ankle reveal perivascular lymphohistiocytic infiltrate prominent neutrophil associate fibrinoid necrosis vessel consistent leukocytoclastic vasculitis commence 60 mg prednisolone day lead prompt complete resolution feature dose prednisolone rapidly taper course month patient fast advise recurrence follow 3 year,"['B-AGE', 'I-AGE', 'I-AGE', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
30yearold female 65 kg undergo rhinoplasty general anaesthesia induce combination bolus remifentanyl 05 gkg propofol 2 mgkg muscle paralysis obtain cisatracurium 015 gkg transoral intubation perform macintosh blade no3 size 7 mm diameter reinforce tracheal tube easily gently place trachea attempt fix right corner mouth problem encounter laryngoscopy intubation cuff tube inflate pressure    20 cm h2o adjustment cuff volume intraoperatively n2o inhalation anaesthesia throat pack place pharynx avoid passage blood aerodigestive tract general anaesthesia maintain sevofluorane oxygenair remifentanyl continuous infusion 025 gkgmin moderate arterial hypotension maintain cuff systolic artery pressure approximately 90 mmhg operation carry semisupine position head slightly incline forward laterally trunk slightly elevated duration operation 100 minute patient extubate removal throat pack problem follow day patient complain difficulty swallow dysphonia hoarseness examination reveal deviation tongue right vocal cord paralysis expression hypoglossal recurrent laryngeal nerve injury local oedema haematoma movement pharynx soft palate normal meticulous neurological examination include magnetic resonance imaging mrn reveal evidence central cranial nerve involvement conservative management include steroid vitamin speech swallow therapy recovery lingual laryngeal function obtain month surgery,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
describe case 60yearold man san francisco consume raw pork travel philippine june 2003 man ill fever diaphoresis headache nausea anorexia return 7month vacation philippine day symptom onset physician prescribe doxycycline symptom continue admit local hospital 5 day later fever 389c nuchal rigidity headache general malaise patient describe recent contact sick person past medical history unremarkable physical examination somnolent fully orient focal finding neurologic examination slight nuchal rigidity leukocyte count 21000mm3 include 16400mm3 neutrophil cerebrospinal fluid csf show leukocyte count 487l 80 polymorphonuclear cell 18 lymphocyte glucose protein level 20 mgdl 167 mgdl respectively gram stain csf show grampositive cocci pair figure empiric therapy ceftriaxone vancomycin ampicillin bacterial meningitis begin compute tomographic scan head show sinusitis finding chest radiograph transesophageal echocardiogram negative hospital day 2 blood culture grow grampositive cocci pair chain organism catalasenegative bile esculinnegative pyrrolidonyl aminopeptidasenegative consistent streptococcus spp latex agglutination test detect streptococcus pneumoniae antigen antimicrobial susceptibility testing show isolate sensitive penicillin mic    003 ceftriaxone vancomycin resistant tetracycline clindamycin antimicrobial therapy change penicillin g 24 million unit intravenously day hospital day 5 patient complain hear loss left ear result nasopharyngeal endoscopy negative hospital day 7 organism identify api 20 strep system biomerieux marcy letoile france s suis serotype 2 patient subsequently state butcher culinary preference partially cook pork eat philippine week prior onset symptom hospital day 9 formal audiology evaluation show severe bilateral sensorineural highfrequency hearing loss 70 db patient complete 10day course parenteral antimicrobial drug discharge continue oral therapy close followup month discharge patient report improved hearing sequelae,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS']"
74yearold man refer hospital november 2000 liver dysfunction detect medical checkup patient diagnose nephrotic syndrome 1995 laboratory examination show elevate serum hepatobiliary enzyme igm presence antimitochondrial antibodie serologic marker hepatitis b c virus negative histopathologic examination liver biopsy speciman obtain laparoscopy reveal nonsuppurative destructive cholangitis portal area figure 1 diagnosis pbc scheuer stage 3 confirm ursodeoxycholic acid 900 mg daily start january june 2002 patient undergo endoscopic variceal ligation plus endoscopic injection sclerotherapy argon plasma coagulation worsen esophageal varix september 2007 patient admit treatment recurrent esophageal varix platelet count range 52    109l 69    109l year note decrease 61    109l june 2007 8    109l admission deterioration thrombocytopenia patient infectious disease receive medication admission patient purpura bleed episode table 1 show laboratory datum admission plateletassociate igg level markedly high bone marrow biopsy reveal normocellular marrow cellular atypia ultrasonography magnetic resonance imaging reveal cirrhotic liver splenomegaly ascite gallstone spleen size remain unchanged previous imaging examination base finding association pbc decompensate liver cirrhosis itp diagnose human leukocyte antigen hla genotype determine polymerase chain reactionsequencingbase typing polymerase chain reactionsequence specific primer srl inc tokyo japan detect a02010101 b400201 c030401 c07020101 dpb10501 dqa10103 dqa1030101 dqb1030201 dqb1060101 drb1080201 drb1080302 13c urea breath test h pylori infection negative figure 2 show clinical course oral prednisolone 30 mg daily itp start day 11 diuretic therapy combine albumin infusion ascite perform platelet count increase notably pulse therapy intravenous methylprednisolone 1 g daily add d 22 24 response weak temporary d 31 mild melena identify patient give trial intravenous immune gamma globulin therapy 25 g daily d 32 36 combine second round intravenous methylprednisolone pulse therapy d 32 34 moderate response observe prednisolone continue platelet count increase slowly ascite relatively control diuretic discharge consider decompensate liver cirrhosis platelet count determine patient require careful followup esophageal varix prophylactic endoscopic therapy,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
18yearold male diagnose attentiondeficit hyperactivity disorder adhd 2005 overweight body mass index bmi 40 start quetiapine fumarate seroquel 900 mg daily april 2005 methylphenidate concerta 54 mg daily september 2005 beginning august 2006 admit local hospital severe dyspnoea tachypnea tachycardia cyanosis admission blood pressure 12080 mmhg arterial blood gas reveal ph 745 pco2 355 kpa pao2 776 kpa 51 mmoll creactive protein elevate chest xray show enlarged heart develop hemoptysis treat unfractionated heparin suspicion pulmonary embolism subsequently develop cardiogenic shock treat vasoactive drug spite treatment oliguric liver enzyme rise refer hospital treatment admission blood pressure 9060 mmhg despite infusion noradrenaline heart rate 130minute temperature 384 c thoracic compute tomography scan pulmonary embolism echocardiography reveal biventricular failure leave ventricular end diastolic diameter 7 cm left ventricle severely hypokinetic ejection fraction ef 2025 left ventricular end diastolic pressure markedly elevate moderate mitral regurgitation intermittent hemodialysis initiate liver function improve slightly despite dialysis renal function deteriorate increase creatinine value day worsening left ventricular systolic function ejection fraction 1012 mark pulmonary hypertension systolic pulmonary pressure estimate 30 mmhg clinical picture resemble dilate cardiomyopathy low output failure cause renal liver failure suspect druginduce cardiomyopathy methylphenidate quetiapine fumarate discontinue screen infectious pathogen immunological marker iron amyloid deposition negative day transfer national hospital rikshospitalet oslo ongoing noradrenaline dobutamine infusion shortly admission intraaortic balloon pump iabp insert noradrenaline replace nitroprusside coronary angiography normal endomyocardial biopsy right ventricle reveal distinct myocardial pathology treatment iabp nitroprusside dialysis clinical situation gradually improve liver function return normal renal function improve increase diuresis creatinine fall 798 98 moll ef markedly reduce 15 behavioral problem adipose stature deny heart transplant treat iabp 26 day 28 day transfer hospital time liver renal function normal treat angiotensinconverte enzyme aceinhibitor betablocker diuretic follow week clinical status improve subsequently discharge home echocardiography show markedly dilate left ventricle ef 20 march 2007 clinical status improve function class ii new york heart association ef estimate echocardiography 3035,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
19yearold man present emergency department 12 h insertion high pressure container tanning spray rectum plain abdominal radiograph figure 1 show container rectosigmoid region sign perforation flexible sigmoidoscopy perform conscious sedation object locate rectosigmoid junction container extract bimanual manipulation attempt remove object conventional endoscopic instrument polypectomy snare unsuccessful sigmoidoscope pass alongside foreign body proximal end guide wire leave sigmoidoscope remove subsequently 40 mm pneumatic dilatation balloon rigiflex boston scientific normally achalasia patient insert guide wire inflate container figure 2 safety purpose sigmoidoscope reintroduce alongside catheter balloon allow endoscopic visual control distal end container rectum gentle traction exert balloon catheter container successfully remove fluoroscopic endoscopic control figure 3,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
63yearold woman know cardiac history present sudden onset dyspnea require intubation ventilatory support hospital deny precede symptom chest discomfort palpitation syncope infection patient afebrile normotensive sinus tachycardia 140 beatsmin cardiorespiratory examination remarkable elevated jugular venous pressure angle jaw leftsided heart sound bibasilar crackle lung field complete blood cell count electrolyte cardiac biomarker normal limit initial electrocardiogram reveal st depression lead v2 v6 suggestive anterolateral ischemia figure 1 chest radiograph demonstrate pulmonary vascular congestion consistent diagnosis pulmonary edema figure 2 echocardiographic examination reveal normal cardiac dimension normal wall motion mild diastolic dysfunction early diastolic late diastolic transmitral ratio 1 prolong deceleration time 250 ms reduce early diastolic annular velocity lateral mitral valve annulus follow aggressive diuresis require minimal ventilatory support patient extubate day follow initial presentation 1 h extubation patient develop recurrent pulmonary edema clinically radiographically require mechanical ventilation cardiac catheterization perform reveal normal coronary artery day 4 coronary care unit admission patient fail repeat attempt extubation compute tomographic scan reveal 4 cm    9 cm multinodular goiter extend mediastinum suspect associated tracheal stenosis figure 3 diagnosis nppe secondary enlarged goiter patient undergo surgical intervention thyroidectomy intraoperative bronchoscopy reveal tracheal stenosis great 50 postoperative course uncomplicated month follow discharge patient return previous activity level subjective dyspnea,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
28yearold woman refer 4week history continuous moderate right upper quadrant pain associate jaundice weight loss 10 kg 3 month liver mass identify ultrasonography pain sensation different previous colicky attack patient experience undergo laparoscopic cholecystectomy 7 year previously physical examination obese body mass index 378 icterus note conjunctivae oral mucosa skin imaging modality include compute tomography ct positron emission tomography pet endoscopic cholangiopancreatography ercp fig1 patient underwent exploratory laparotomy intraoperative ultrasonography reveal cystic lesion measure 35 25 cm central portion liver anterior porta hepatis intraoperative cholangiography demonstrate extensive stricture obliterate left hepatic duct partial occlusion right hepatic duct extended left lobectomy en bloc biliary confluence frozensection examination margin excise speciman free malignant cell reconstruction perform rouxeny cholangiojejunostomy 3 second bile duct radical right intraoperatively radiotherapy apply surgical margin patient undergo 6 week imageguide external beam radiation centre resection field label surgery final pathology describe tumour infiltrate moderately differentiate squamous cell carcinoma associate severe dysplasia bileduct epithelium fig2 patient recover complication 18 month initial surgical procedure unremarkable ct scan,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
49yearold woman admit department radiology second affiliated hospital zhejiang university october 2004 right upper quadrant pain weight loss hepatitis b virus carrier fetoprotein level 11853 ngml ultrasonography compute tomography ct reveal 10 cm mass posterior segment right liver lobe 15 cm mass find left lateral segment clinical sign indicate patient inoperable hcc childpugh class cirrhosis tace offer patient angiogram demonstrate obvious hepatic arteriovenous shunt multiple small masse lobe liver emulsion oxaliplatin pirarubicin hydroxycamptothecin lipiodol prepare 35 ml 3 ml mixture administer intraarterially right leave hepatic artery respectively patient experience right upper quadrant pain tace uneventful recovery month later second tace procedure perform right hepatic artery 40 ml mixture administer day experience sudden acute dyspnoea peripheral oxygen saturation decrease 90 chest xray show increase reticular shadow left lung especially low zone chest ct scan reveal multiple iodize oillike highdensity material parenchyma lung figure 1 10 mg dexamethasone iv supportive therapy administer respiratory symptom attenuate day later patient suffer headache transient consciousness loss accompany nausea vomiting follow confusion low extremity weakness noncontrast enhance ct scanning show multiple disseminate hyperintense lesion brain consistent deposition iodized oil figure 2 week later respiratory neurologic symptom disappear completely discharge patient consequently complete tace procedure similar symptom occur,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
71yearold woman know diastolic congestive heart failure chf present er exacerbation chf decrease level consciousness brachial blood pressure bp measure 5540 mmhg patient recent admission exacerbation chf medical history significant autoimmune hepatitis preserve liver function esophageal varix bleed episode longterm corticosteroid therapy complicate adrenal insufficiency type 2 diabetes mellitus osteoporosis recent echocardiography reveal moderate concentric leave ventricular hypertrophy diastolic dysfunction mild moderate mitral regurgitation cardiac catheterization recent admission demonstrate 50 stenosis second diagonal artery mild diffuse disease coronary artery right ventricular endomyocardial biopsy rule myocarditis infiltrative cardiomyopathy heal ischemic microinfarct atheroemboli observe previous bp value low systolic bp 60 mmhg 65 mmhg diastolic bp 40 mmhg 45 mmhg follow intubation dopamine start hypotension management later replace noradrenaline patient develop atrial flutter successfully convert sinus rhythm direct current electric shock cardiology consultation result admission coronary care unit ccu admission ccu bp measure 5636 mmhg left arm detectable right arm arterial line insert femoral artery bp measure 19192 mmhg bp value consistently high femoral arterial line cuff arm high left arm right arm instance day postccu admission bp point measure 17080 mmhg arterial line cuff reading arm 8374 mmhg left 6039 mmhg right arm investigate inconsistency brachial femoral bp value compute tomography ct scan thorax obtain 125 mm slice intravenous contrast injection sagittal coronal planar reformatte maximumintensity projection image analysis initial unenhance ct image show densely calcify plaque thrombus origin subclavian artery right common carotid artery ct angiogram show absence flow right subclavian artery tight stenosis origin left subclavian artery tight stenosis origin right common carotid artery vertebral artery show normal calibre flow figure 1 management follow insertion femoral arterial line base femoral bp reading diuretic bplowere agent patient eventually discharge stable condition remain stable month discharge time present report write exacerbation chf related er visit,"['O', 'B-SEX', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
newborn boy healthy nonconsanguineous parent deliver 37 week gestation cesarean section mother primipara 32 year old admit hospital 2 week previously reduce fetal intrauterine movement polyhydramnio child birthweight 2330 g 10th percentile length 47 cm head circumference 332 cm 25th percentile lowset ear bilateral clubfoot apgar score 2 6 7 1 5 10 minute child present severe hypotonia generalized muscle weakness require ventilatory assistance total parenteral nutrition weaning fail inadequate pulmonary ventilation respiratory acidosis hearing loss detect auditory evoke potential cranial mri show mildly enlarge ventricle liquor space day birth infant present severe abdominal distension hypoactive bowel mri reveal mark intestinal dilation mechanical obstruction laboratory investigation show hypoglycemia 27 mgdl hypomagnesemia 058 mmoll hypokalemia 24 mmoll blood lactate normal 13 mmoll normal range 0522 mmoll liver enzyme unremarkable skeletal muscle biopsy perform show scatter hypertrophic cytochrome c oxidase coxdeficient succinate dehydrogenasepositive muscle fiber figure suggest mitochondrial disorder molecular genetic study reveal marked mtdna depletion muscle 93 decrease compare agematched control screen mtdna rearrangement individual coxpositive coxdeficient fibers4 negative sequence entire code region intronexon boundary polg1 gene identify report heterozygous missense mutation compound c679ct predict pr227w c2542ga predict pg848s sequencing parental sample confirm recessive inheritance infant die 20 day respiratory failure autopsy brain remarkable change gross examination histology informative poor preservation tissue evidence neuronal damage spinal cord liver show diffuse cholestasis consistent total parenteral nutrition hepatocyte steatosis necrosis liver fibrosis observe testicle undescended remain visceral organ normal marked dilation thinning bowel wall despite normal histology analysis stomach ileum colon homogenate reveal severe mtdna depletion 94 decrease table e1 neurology web site wwwneurologyorg laser capture microdissection analysis5 reveal mtdna depletion confine muscularis propria prominent external layer figure ganglion cell myenteric plexus show milder mtdna depletion restrict small intestine figure mtdna depletion liver show,"['B-AGE', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
46yearold woman present severe acute pain right iliac fossa periumbilical region ultrasound compute tomography scan reveal mucocele vermiform appendix define lesion locate mid zone appendix patient underwent right hemicolectomy postoperative clinical course uneventful gross examination surgical speciman show enlarged appendix fill thick mucinous material distinct lesion involve appendiceal wall measure 15 cm maximally identify midportion appendix evidence perforation extravasation mucin periappendiceal tissue pseudomyxoma peritonei surgery histopathological examination show combined gcc mca vermiform appendix figure 1a appendiceal luman dilate line mucincontaine columnar epithelial cell figure 1b significant cytologic atypia mitotic figure identify focal papillary configuration lining epithelium mild epithelial pseudostratification present addition appendiceal wall infiltrate glandular structure size arrange nest tubule glandular structure comprise 2 distinct type cell 1 small intermediate sized monotonous neuroendocrine cell small finely granular eosinophilic cytoplasm mild cytonuclear atypia figure figure1c1c 2 mucinfille intermediate sized cell goblet cell peripherally locate small crescentlike hyperchromatic nucleus indistinct nucleolus figure figure1d1d scatter infiltrate single goblet neoplastic cell focally present previously described1 tumor nest appear arise basiglandular region intestinal crypt close proximity mca figure figure1e1e lymphovascular invasion perineural intraneural invasion present tumor infiltrate thickness appendiceal wall extend mesoappendix lymph node histologically identify negative malignancy immunohistochemically table 1 tumor cell gcc positive chromogranin synaptophysin serotonin neuroendocrine marker diffuse stain cytokeratin ck 20 figure 2 ck19 cd99 present ki67 proliferate index reveal nuclear staining approximately 15 tumor cell staining ck7,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O']"
60yearold man undergo colonoscopy find 2 cm sessile polyp locate 10 cm anal verge successfully remove polyp tubulovillous adenoma focal highgrade dysplasia flexible sigmoidoscopy perform month later repeat colonoscopy year initial colonoscopy negative recurrence colonoscopy perform year initial colonoscopy reveal sessile polyp 3 cm size 10 cm anal verge biopsy take report fragment villous adenoma lowgrade dysplasia previous highgrade dysplasia relatively rapid recurrence concern cancer miss sample error pelvic magnetic resonance imaging mri scan endoscopic ultrasound eus perform definitive excision mri reveal invasive rectal mass involve muscularis propria breach adventitia consistent t2 rectal carcinoma figure 1 pelvic lymphadenopathy detect eus reveal rectal mass involve mucosa submucosa involvement muscularis propria figure 2 result mri eus surgical versus endoscopic resection treatment option discuss patient opt surgical resection patient undergo low anterior resection endtoend anastomosis loop ileostomy pathology review resect rectosigmoid reveal villous adenoma lowgrade dyplasia evidence muscularis propria invasion total pericolic mesorectal lymph node excise deem benign patient underwent ileostomy reversal month later remain asymptomatic recurrence tumour,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O']"
72yearold woman undergo rf ablation treatment metachronous solitary liver metastasis rectal adenocarcinoma treat 18 mo preoperative chemoradiotherapy anterior resection lesion locate segment viii procedure go patient initially haemodynamically stable hour later condition suddenly worsen clinically dizzy fatigue pallor detect hypotension tachycardia emergency blood test show haemoglobin level    7 gdl markedly elevate transaminase level compute tomography examination reveal accumulation intraperitoneal fluid pelvis liver haematoma image show liver laceration follow path needle figure figure1a1acc unexplained laceration lead away figure figure22 patient coughing hiccup rf treatment complication cause increase abdominal pressure tumour rupture subsequently patient receive blood transfusion close monitoring haemodynamically stable second blood transfusion completely recover 24 h later patient remain bed 1 wk surgical intervention require,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
70yearold man refer hospital gastric cancer detect screen esophagogastroduodenoscopy egd significant medical history identify dysuria cause bladder contraction initial laboratory datum show serum level afp 323 ngml normal range 015 ngml abnormality include tumor marker carcinoembryonic antigen cea carbohydrate antigen 199 ca199 egd reveal 5 cm ulcerofungate mass comprise septate ulcer great curvature gastric antrum pathological examination endoscopic biopsy tissue confirm presence moderately differentiate tubular adenocarcinoma subsequent abdominopelvic compute tomography visualize gastric mass deep ulceration gastric antrum perigastric lymph node enlargement metastatic lesion observe liver lung peritoneum chest radiography show significant finding radical subtotal gastrectomy d2 lymph node dissection billroth ii gastrojejunostomy perform grossly resect speciman contain double lesion 58 cm    32 cm ulcerofungate mass antrum extensive hemorrhage light gray fibrosis second nearby 25 cm    20 cm ulcerative lesion figure 1 microscopically massive number pleomorphic bizarre tumor cell hemorrhage syncytiotrophoblast cytotrophoblast observe lesion hematoxylin eosin hestaine tissue reveal bubbly purple cytoplasm giant nucleus magnification 40    figure 2a 100    figure 2b tumor involve proper muscle layer t2a metastasis find 56 regional lymph node n1 immunohistochemical staining show positive immunoreactivity human chorionic gonadotropin hcg figure 3a focal positivity afp figure 3b finding confirm presence gastric choriocarcinoma contain small foci afpproducing adenocarcinoma second lesion moderately differentiate tubular adenocarcinoma extend submucosal layer t1b close distinct lesion negative immunohistochemical staining hcg afp patient uneventful postoperative course discharge postoperative day 9 week later hcg level 176 miuml normal range 010 miuml afp level 100 ngml cycle adjuvant chemotherapy capecitabine xeloda hoffmannla roche inc nutley nj usa start 2500 mgm2 day 14 dcycle cycle hcg level decline    3 miuml remain level recurrence distant metastasis occur 4year postoperative followup,"['O', 'B-SEX', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O']"
24yearold nonsmoking male patient present repeat hemoptysis 2008 4 day concomitant right thoracic pain intensify breathing holiday home country cuban patient suffer cold fever strong cough strong dry cough persist recovery cold patient report loss weight initial ct scan thorax show 12    4 cm solid mass paravertebral right low thorax sign metastasis figure 1 bronchoscopy figure 2 nonbleede biopsy reveal mass low right bronchus histologically immunohistologically provide evidence granular cell abrikossoff tumor 1 bronchial lavage follow negative malignant cell patient discharge surgical intervention plan day discharge spontaneous hemothorax develop patient need readmitte hemothorax drain malignant cell detect cytological examination drain liquid uneventful course decrease hematoma tumor excise perform low right lobectomy 6 month initial admission final histological examination confirm peribronchial infiltrate s100 positive tumor support schwann cell origin theory low growth rate 2 size 15 mm figure 3,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
54yearold woman stage iv nsclc treat carboplatin paclitaxel disease response molecular analysis tumor tissue unavailable time demographic profile asian minimal smoking history nonsmall cell histology predict disease harbor egfr tki sensitive cell 2 initiate standard daily dosing erlotinib 150 mg disease respond twentyeight month later acquire resistance erlotinib progression disease systemically follow progression experimental angiogenesis inhibitor initiate pemetrexed resume standard dose erlotinib initial response 11 month later disease progress dna extract biopsy progressing lung lesion examine establish technique analysis egfr mutation 5 direct sequencing exon 1821 encode kinase domain egfr reveal l858r mutation associate egfr tki sensitivity fig1 2 demonstrate t790 m mutation associate acquire egfr tki resistance fig1 2 develop headache high clinical suspicion cns metastasis despite negative imaging show refuse lumbar puncture initiate empiric temozolomide plus standard dose erlotinib 150 mg daily presume cns disease cycle headache worsen develop nausea vomiting concern cns metastasis associated raise intracranial pressure magnetic resonance imaging mri brain demonstrate lm fig2 confirm csf cytology show direct sequence dna csf cell harbor l858r predict egfr tki sensitivity fig3 leave panel t790 m resistance mutation datum show result t790 m negative sample perform sensitive fluorescence detection pcrbase assay take advantage pcr restriction fragment length polymorphism generate specific missense mutation fig3 right panel arrow positive control 6 result negative wild type peak detect fig3 right panel hypothesize lm remain sensitive egfr tki sufficiently high concentration drug achieve csf erlotinib concentration require inhibit growth cell line harbor l858r 50 ic50 100 nm nm 2 standard dose erlotinib 150 mg daily achieve 3000 nm plasma 7 csf concentration egfr tkis low 1 plasma level ic50 3 8 increase daily dose gefitinib enhance csf penetration effective strategy 3 gefitinib long available united states follow failure phase iii nsclc trial analogous increase daily erlotinib dose 150200 mg daily induce unacceptable toxicity weekly highdose erlotinib 2000 mg tolerable 4 pharmacokinetic analysis csf patient nsclc lm show treat 1500 mg erlotinib weekly demonstrate peak plasma concentration 11300 nm concurrent csf concentration 130 nm high dose weekly administration erlotinib achieve csf concentration exceed ic50 increase csf penetrance standard daily erlotinib dose patient initiate highdose weekly erlotinib 1000 mg 1200 mg persistent nausea preclude high dose pharmacokinetic analysis undertake patient 1 month partial radiographic response lm brain mri fig2b 2 month cauda equina show hydrocephalus persistent symptom referable increase intracranial pressure lead vp shunt wholebrain radiation therapy resume treatment 1500 mg weekly erlotinib month later progressive intrathoracic disease lead initiation cetixumab erlotinib continue change low dose 100 mg daily survive 14 month follow diagnosis cns disease,"['O', 'B-SEX', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
21yearold male present 2year history progressive shortness breath exertion dry cough physical examination auscultation lung reveal random wheeze coarse crackle cardiac auscultation normal cyanosis peripheral edema observe history smoking previous know pulmonary disease routine blood examination blood count serum chemistry find normal arterial blood gas analysis echocardiography show important abnormality pulmonary function test pft show mild restrictive ventilatory defect reduce total lung capacity 79 594 l force vital capacity 80 418 l force expiratory volume second 83 372 l sputum negative acidalcohol resistant bacillus human immunodeficiency virus testing negative chest plain film reveal diffuse symmetric dense bilateral micronodular pattern figure 1 base finding hrct scan obtain reveal diffuse ground glass attenuation septal thickening pronounced low pulmonary region calcification interlobar septum subpleural region subpleural cyst notice figure 2 patient undergo fiberoptic bronchoscopy bronchoalveolar lavage transbronchial lung biopsy lavage fluid negative tuberculosis fungus microlith find histology reveal round concentrically laminate microlith alveoli associate slightly thicken interstitial septum consistent diagnosis pam,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE']"
48yearold man present hospital complaining intracranial bruit cranial nerve laboratory examination normal dvaf consider conventional digital subtraction angiography perform show cognard ii dvaf location right hypoglossal canal hc dvaf feed meningeal branch bilateral ascending pharyngeal artery right anterior condylar vein hypoglossal canal fistulous point mainly drain jugular vein endovascular treatment insist patient associated intolerable intracranial bruit treatment perform transarterial approach general anesthesia biplane angiographic unit standard coaxial technique guide catheter navigate left ascendingtrawt pharyngeal artery marathon flow direct catheter ev3 subsequently navigate mirage008 microwire ev3 reach near possible fistula microcatheter flush 10 ml normal saline dead space microcatheter subsequently fill dimethyl sulfoxide dmso onyx18 inject minute fill microcatheter replace dmso dead space injection stop unwanted flow branch right ascend pharyngeal artery observe followup angiogram show residual shunt figure 1 intracranial bruit disappear immediately operation toxicity dmso 10 mg dexamethasone intravenously inject day second day endovascular treatment patient complainte difficulty move tongue left cranial nerve examination significant right hypoglossal nerve palsy patient discharge hospital day treatment continuative pharmacotherapy month followup patient main complaint difficulty swallow dysphagia slur speech dysarthria addition tongue deviate right tongue protrusion mark rightside hemiatrophy observe figure 2 cranial nerve examation show right hypoglossal nerve palsy persist telephone patient month followup request vocal cord evaluation ent specialist local hospital vocal cord paralysis find evidence vagus nerve dysfunction oral vitamin b12 prognosis long followup,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O']"
41yearold man weight loss nausea vomiting abdominal pain refer abdominal ct scan rule intraabdominal pathology dedicated ct abdoman perform institution accord standard venous phase protocol follow ingestion positive oral contrast material barium sulfate suspension 21 wv mallinckrodt injection 125 ml iopromide 300 mg iml ultravist bayer healthcare helical ct obtain 65 delay 64slice ge lightspee vct scanner ge medical systems milwaukee wi axial section abdoman show large 182222 cm heterogeneous retroperitoneal mass probably arise left adrenal gland contain multiple area macroscopic fat fig1 patient document clinical laboratory evidence adrenal hormonal excess basis clinical history ct finding patient undergo surgical resection left adrenal mass find pathologic examination represent lowgrade adrenocortical carcinoma,"['O', 'B-SEX', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE']"
48 yearold female present vaginal bleeding abnormal pap smear diagnosis invasive nonkeratinizing scc cervix undergo radical hysterectomy salpingooophorectomy demonstrate positive spread pelvic lymph node parametrium pathological examination reveal tumour extensively involve low uterine segment 5 month surgery woman undergo external beam radiotherapy intracavitary brachytherapy year later patient present threemonth history productive cough shortness breath 23 week history progressive exertional dyspnea xray chest demonstrate reticular nodular pattern ct scan reveal multiple bilateral patchy area ground glass opacity scar focal area subsegmental atelectasis lung differential diagnosis include interstitial pneumonia versus noncardiogenic edema woman undergo bronchoscopy leave thoracoscopy open wedge leave lung biopsy pathological examination left lung biopsy confirm presence neoplastic sheet cell classically distribute septal vessel perivascular peribronchial subpleural lymphatic subpleural nodule identify presence neoplastic cell distend subpleural lymphatic confirm lc figure 1a 1b 1c immunohistochemical analysis lesional cell strongly positive p16 figure 1d high low molecular weight keratin figure 1e cytokeratin7 ck7 figure 1f ck19 pan keratin negative ck20 p63 egfr base finding diagnose lymphangitic carcinomatosis lung metastatic scc cervix start chemotherapy carbotaxol corticosteroid hospital discharge day later posttreatment improvement clinical symptom parallel radiographic imaging show marked interval improvement nodular opacification interstitial thickening previously note despite improvement subsequently die 13 month initial diagnosis,"['O', 'O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
27 year old male right handed admit 2 year history frequent gelastic seizure patient describe auralike symptom especially warmth face dizziness precede seizure deny affective connotation seizure consist brief period laughter motor involvement typical seizure consist sudden laughter accompany simple motor partial seizure arm involve left arm impairment consciousness state last 1 minute previous past medical social history smoker 1015 cigarette day frequency seizure initially low increase progressively time 810 seizuresday despite antiepileptic treatment    time admission take keppra    levetiracetam 3 x 250 mgday phenytoin 3 x 100 mgday neurology electrophysiology department assistance able record couple seizure videoeeg neurological examination normal diagnosis native ct scan minimal hypodense frontal right paramedian lesion figure 1a cerebral mri figure 1 bf show small right parenchymal homogeneous lesion 162215 mm delimit involve gyrus cinguli perilesional edema mass effect hyperintense t1 t2 mr sequences nonenhance gadolinium cerebral lesion document eeg videoeeg recording 3 seizure mediofrontal origin rare interictal epileptiform element record figure 1i interhemispheric microsurgical approach corpus callosum right pericallosal artery level gyrus cinguli yellowgray infiltrative tumour have moderate vascularisation identify totally remove anatomopathological analysis reveal grade    astrocytoma patient recover deficit gelastic seizure epileptic manifestation month operation free seizure control postop ct reveal tumor 1 g h,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O']"
patient 3yearold girl follow feature vacterl association absent c1 vertebra supernumerary lumbar vertebrae hypoplastic sacrumcoccyx fatty filum terminale tethered spinal cord fused rib anorectal malformation include cloaca consist common urogenital sinus duplex vagina midline septum type c te fistula right renal agenesis moderate left hydronephrosis vesicoureteral reflux cardiac limb malformation major organ anomaly father additionally clinically diagnose hypermobile type ehlersdanlos syndrome family history noncontributory diagnosis hypermobile type ehlersdanlos base patient hypermobility 99 beighton hypermobility scale soft fragile skin unusual scarring poor skin heal skin biopsy perform test peripheral blood reveal mutation associate form ehlersdanlos syndrome microarray analysis initially show maternallyinherited deletion 4q351 detect clone confirm fish rp11173m11 subsequent performance 180k custom oligonucleotide microarray baylor college medicine medical genetic laboratory refine delete region deletion maximum size 137 mb karyotype revise 46xxarr cgh 4q351q352 187321768188694589 3 1 gene delete region contain number small copy number variation cnvs identify normal control include cyp4v2 klkb2 f11 mtrnr1a fat1 clearly relate phenotype especially mother deletion inherit unaffected evidence mitochondrial dysfunction begin 13 month age progressive muscle weakness autonomic dysregulation hypoglycemic episode exocrine pancreatic dysfunction decline gastrointestinal function eventually lead total parenteral nutrition dependency visceral hyperalgesia dysmotility malabsorption muscle biopsy show mild increase fiber size variability finding consistent mitochondrial disease include electron microscopy analysis electron transport chain etc activity show normal activity complex ii iii complex iv cytochrome c oxidase activity 454 lmolme weight control range 1489    672 lmolming weight repeat etc analysis isolated mitochondria confirm profound reproducible complex iv deficiency citrate synthase activity content etc analysis normal confirm good sample quality normal mitochondrial content mitochondrial genome sequence sequence dna polymerase gamma 1 2 polg1 polg2 thymidine phosphorylase reveal abnormality,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
52yearold man body surface area 13 m2 know dilate cardiomyopathy dcm admit worsen heart failure nyha class iv present 5month history cough progressive dyspnoea orthopnea recurrent upper abdominal pain start 2 month ago examination vital sign body temperature 37c blood pressure 8040 mmhg respiratory rate 24 breath minute electrocardiogram show atrial fibrillation heart rate 50 beat minute physical examination reveal jugular venous distension significant tender hepatomegaly bilateral pitting edema low limb laboratory test show elevate pront brain natriuretic peptide 22145 pgml normal 0 227 pgml unremarkable ddimer xray compute tomography chest demonstrate consolidation bilateral low lobe pleural effusion venous doppler low extremity normal base clinical condition echocardiography immediately insert severe dilate cardiac chamber especially enlargement left ventricle lv 58 mmm2 spherical shape decrease wall thickness impair ejection fraction 22 severe mitral regurgitation twodimensional transthoracic echocardiography 2dtte parasternal short axis subxyphoid view figure 1 show mobile right atrial mass highly suspicious thrombus traverse right atrial cavity cardiac cycle accompany freefloate small part thrombi realtime dimensional transthoracic echocardiography rt3dtte perform confirm nature mass show highly mobile thrombus irregular contour measure 26    10 cm float orifice inferior vena cava protruding right atrial cavity figure 2 addition rt3dtte evaluate right ventricle rv systolic dysfunction ejection fraction 157 figure 3 maintain digoxin spironolactone furosemide sotalol dopamine time therapeutic anticoagulation start lowmolecularweight heparin warfarin patient uneventful hospital course week followup echocardiography confirm adequate removal thrombus figure 4a 4b,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
75yearold female present emergency department ilfov clinical hospital bucharest romania dyspnea orthopnea low extremity swell palpitation 3 year history atrial fibrillation diagnose family doctor oneyear history cardiac failure nyha new york heart association class    physical examination reveal irregular pulse 80 beatsmin blood pressure 10060 mmhg bibasal crackle chest auscultation low extremity swell heart sound examination reveal ivth degree pansystolic murmur left border stern jugular vein dilate patient complain pain upper right abdominal region enhance palpation liver margin tender round 6 cm costal rib smooth liver surface spleen feel ekg atrial fibrillation 80min right bundle branch block inferolateral ischemia transabdominal ultrasound show homogenous enlarged liver suprahepatic vein dilate inferior vena cava 30 mm respiratory variation transthoracic echocardiography reveal dilate right atrium 742 mm figure 1 dilate left atrium 552 mm dilate left ventricle 64723 mm dilate right ventricle 444 mm atrial septal defect ostium secundum type 6 cm figure 2 lefttoright shunt severe tricuspid insufficiency maximum gradient 554 mm hg 4th degree mitral insufficiency severe pulmonary hypertension 75 mm hg ejection fraction 29 atrial fibrillation interventricular sept paradoxical motion flattening interventricular septum figure 3 diagnosis ivth degree chronic heart failure nyha atrial septal defect ostium secundum type lefttoright shunt severe tricuspid insufficiency 4th degree mitral insufficiency severe pulmonary hypertension 75 mm hg chronic atrial fibrillation right bundle branch block,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
81yearold female hypertension gout admit taichung veterans general hospital abdominal pain hematemesis begin suffer intermittent epigastralgia 10 year ago 4 cm gastric tumor find abdominal pain get bad 2 year admission go local hospital abdominal ct scan reveal gastric tumor 6 cm length wellcircumscribe calcificationfigure 1 surgical intervention suggest decline 10 day admission tarry stool passage note bloody vomitus find 1 day later ugi scope reveal submucosal gastric tumor central ulceration transfer hospital physical examination show upper abdominal tenderness mild muscle guard plain radiography show irregular shape calcification upper abdomen ugi scope reveal deep gastric ulcer foreign body ct scan show irregularly shape spaceoccupye lesion stomach plate calcification localize free air figure 2 3 impression perforate gastric tumor emergent laparotomy perform infiltrative mass stomach transverse colon note operation sharp bonelike thick calcify plate penetrate gastric mucosa pericolic soft tissue observe submucosal tumor 23 cm size adherent calcify plate note figure 4 5 distal subtotal gastrectomy partial colectomy perform patient discharge 13 day operation uneventfully microscopically spindleshape tumor cell low mitotic frequency 450 hpf find immunohistochemical staining tumor demonstrate diffusely strong positive reactivity cd 117 positive reactivity cd34 negative reactivity s100 protein desmin diagnosis tumor establish gist small size paucity mitotic figure tumor locate stomach classify low risk4 sporadic gist impressed family history gist gist present patient,"['O', 'B-SEX', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
33    year old woman present cardiology service sign symptom congestive heart failure medical history unremarkable year ago soon child delivery admit hospital acute pulmonary oedema labor cor triatriatum obstructive behavior cause pulmonary hypertension bee diagnose left ventricle structurally functionally intact patient time deny surgey discharge medical therapy present admission patient present nyha functional class iii symptom heart failure palpittion result persistent atrial flutter physical examination loud pulmonary component 2nd heart sound diastolic murmur hear mitral area sign rightside heart failure absent transthoracic echocardiography reveal moderately dilate left ventricle lv globally hypokinetic severely impair systolic function ef estimate 30 leave atrium la dilate mobile membranelike echogenic structure transesophageal echocardiogram tee document fibromuscular membrane la divide compartment proximal receive pulmonary venous flow distal contain left atrial appendage laa chamber communicate nonrestrictive orifice membrane prolapse mitral valve inflow cause severe obstruction mitral valve appear normal mild regurgitation patent foraman ovale pfo atrial septal defect asd anomalous venous connection rule diagnosis cor triatriatum reconfirm magnetic resonance image    mri heart reveal fibromuscular septum left atrium low left ventricular ejection fraction lvef 30 cardiac index 16 lminm2 cardiac output 27 lmin figure 1 coronary angiography show normal coronary artery finding patient schedule surgery anesthetic induction achieve standard technique include administration sodium pentothal sevofluorane fentanyl muscle relaxant invasive monitoring include use right radial arterial line pulmonary artery catheter foley catheter temperature probe measure bladder temperature indicator core body temperature transesophageal echocardiography tee institute surgery perform median sternotomy connection cardiopulmonary bypass cpb achieve standard ascending aorta bicaval cannulation mildly hypothermic 32c cpb establish cold blood cardioplegia administer antegrade fashion aortic root clamp aorta interatrial groove develop common pulmonary venous chamber left atrium open vertical incision anterior right pulmonary vein exactly mitral valve surgery insertion selfretaine retractor facilitate exposure diaphragm expose central hole identify preliminary incision hole improve exposure definitive excision orifice pulmonary vein side locate position atrial septum identify small opening right atrium insert curve clamp displace septum common pulmonary venous chamber left atrium atrial septal defect patent foraman ovale diaphragm easily completely excise expose mitral valve figure 2 left atrial appendage close inside left atrium run 30 polypropylene suture prevent future thrombus formation atriotomy incision close heart having fill blood suture place patient rewarme aortic crossclamp remove additional deairing carry usual manner cpb terminate minimal inotropic support involve milrinone levophe good hemodynamic postoperative course uneventful patient extubate 12 hour discharge hospital fifth postoperative day 3 month followup patient asymptomatic nyha class sinus rhythm tte mri reveal mildly dilate lv great improvement systolic function estimate lvef 50,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
february 2010 77yearold man history stroke peripheral vascular disease present emergency department florid pulmonary edema 6month history worsen dyspnea exertion paroxysmal nocturnal dyspnea leg edema physical examination diffuse rale murmur aortic stenosis 2dimensional doppler transthoracic echocardiogram reveal severe aortic valve stenosis peak gradient 70 mmhg mean gradient 45 mmhg calculate aortic valve area 07 cm2 severe mitral regurgitation severely dilate left ventricle lv ejection fraction 020 pulmonary edema resolve cardiac catheterization confirm echocardiographic finding show nonobstructive coronary artery disease give finding patient comorbiditie decide minimally invasive surgical approach patient place supine position underwent anesthetic induction intubation singleluman endotracheal tube bronchial blocker intraoperative transesophageal echocardiography tee confirm previous finding show mitral valve leaflet free significant disease mitral regurgitation originate a2p2 portion mitral valve fig1 mitral regurgitation think functional cause mitral annular dilation tethering papillary muscle severely dilate lv decide perform edgetoedge repair mitral valve transaortic approach femoral platform establish cardiopulmonary bypass 2 3 cm incision left inguinal crease 50 prolene pursestre suture ethicon inc johnson    johnson company somerville nj place femoral artery vein left femoral artery cannulate 16f18f arterial cannula left femoral vein cannulate 25f biomedicus femoral venous cannula medtronic inc minneapolis minn place superior vena cava aid tee 4 5 cm transverse parasternal incision 3rd intercostal space transect 4th costochondral cartilage enable adequate exposure aorta interspace choose event left atrium need enter pericardium open phrenic nerve aorta facilitate exposure retrograde coronary sinus catheter insert directly incision pursestre suture place right atrium lv vent insert pursestre suture right superior pulmonary vein transverse aortotomy perform expose aortic valve remove direct vision a2 p2 segment mitral valve identify edgetoedge repair carry 50 prolene mattress suture reinforce pericardial pledget ventricular mitral valve fig2 27 mm hancock ii bioprosthetic aortic valve medtronic implant use standard technique aortotomy close 2layer fashion patient wean cardiopulmonary bypass transect rib reattache sternum 1 cm metal plate synthe inc west chester pa fiber wire place figure8 fashion single chest tube leave pleural space thoracotomy close routine fashion postoperative tee show mitral regurgitation fig3 elbowing anterior leaflet middiastole tethering anterior leaflet posterior leaflet fig4 doubleorifice mitral valve result edgetoedge repair fig5 surgery patient shortness breath resolve discharge hospital postoperative day 6 followup evaluation march 2011 asymptomatic echocardiography show grade 1 mitral regurgitation,"['O', 'O', 'O', 'B-SEX', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O']"
59yearold man refer general surgery department hospital onemonth history progressive dysphagia solid associate malnutrition significant weight loss patient recently undergo esophagogastroduodenoscopy hospital reveal bleed ulcerative lesion middle esophagus biopsy collect medical past history include copd diagnose 1999 myocardial infarction 2002 patient smoke approximately 25 cigarette day year physical examination unremarkable computed tomography ct chest abdomen reveal stenosis involve 5 cm segment middle esophagus lesion thoracic abdominal organ barium study disclose swelling esophageal wall 7 cm cardia ulcerative pattern reduce diameter luman 5 mm endoscopic biopsy oesophageal mass demonstrate poorly differentiate g3 squamous cell carcinoma middistal esophagectomy perform oesophagogastric anastomosis gastric tube reconstruction pathological examination surgical speciman confirm biopsy diagnosis poorly differentiate g3 scc tumor measure 3 cm length infiltrate oesophageal wall surround paraesophageal fat surgical margin tumorfree seven perigastric limphnode dissect pt3 n0 postoperative period unremarkable contrast enhance xray obtain 9th pod show normal esophageal gastric transit 14th pod patient discharge oncology referral routine medical followup month operation ct esophagogastroduodenoscopy repeat imaging study reveal mild splenomegaly multiple nonspecific nodule organ figure 1 patient virtually asymptomatic exception vague sensation mild discomfort left upper quadrant abdomen fnac spleen reveal pattern numerous inflammatory cell admix large cell display immunohistochemical positivity cytokeratin figure 2 speciman gram stainnegative bonemarrow biopsy negative metastatic involvement diagnosis isolate metastasis spleen inflammatory necrotic alteration patient refer centre splenectomy perform routine procedure role spontaneous rupture spleen 12th december 2007 patient transabdominal total splenectomy splenic celiac artery lymph node dissection postoperative course uneventful 7th postoperative day doppler ultrasonography reveal portaltree patency sign thrombosis day later patient discharge stable platelet count 780000mm3 hb 109 gdl wbc count 16500mm3 pathological examination spleen describe multiple nodule contain medium largesize cell keratinize nodule solid area central necrosis figure 3 finding consistent metastasis scc patient refer oncology department hospital receive 3day cycle separate 3week interval systemic chemotherapy base 5fluorouracil 800 mgday iv cisplatin 20 mgday month splenectomy multiple liver metastasis see ct scan cutaneous metastasis present patient die 9 month later,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
26yearold man portuguese descent significant past medical history present subacute onset rightside hemiparesis aphasia marked expressive aphasia wordfinding difficulty rare paraphrasic error examination demonstrate right central facial weakness 235 strength right arm leg dysmetria right upper low extremity reflex hyperactive right rightside babinski response mri brain show multiple bilateral concentric ringlike structure centrum semiovale corona radiata t2 imaging figurea consistent pattern balo concentric sclerosis associate restricted diffusion 3 lesion incomplete ring enhancement 1 lesion csf analysis show 30 leukocyte 79 lymphocyte 4 monocyte erythrocyte count 850 oligoclonal band absent treat 1 g iv methylprednisolone daily 5 day little improvement undergo 5 plasmapheresis exchange significant improvement motor sensory speech deficit gait fortyfive day discharge examination show 45 strength right intrinsic muscle hand rightside positional tremor gait tandem gait normal place interferon1a 44 g subcutaneously 3 time week treatment presume clinically isolate syndrome good response year later neurologic examination essentially normal family history demyelinate autoimmune disorder mother significant history headache earlyonset stroke find carrier notch3 mutation consistent cerebral autosomal dominant arteriopathy subcortical infarct leukoencephalopathy cadasil sister stroke 30 history migraine headache undergo medical evaluation testing cadasil patient show notch3 mutation associate cadasil transition ct nucleotide position 1750 codon 558 skin biopsy show electrondense extracellular material close apposition smooth muscle vascular media1 figure b,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
70yearold female present emergency department palpitation dyspnea anterior epistaxis 3 year history atrial fibrillation chronic heart failure nyha class iii treat aspirin 100 mgday physical examination reveal irregular pulse 148 beatsmin blood pressure 130100 mmhg pansystolic mitral murmur 26 grade murmur tricuspid regurgitation 36 grade low extremity swell otorhinolaryngology exam conclusion anterior epistaxis 12lead electrocardiogram reveal atrial fibrillation inferior ischemia international normalize ratio inr 124 twodimensional transthoracic echocardiography show thickening mitral valve moderate mitral insufficiency mobile round mass left atrium heterogeneous inhomogeneous 18 mm size attach narrow stalk interatrial septum show tumorlike movement cardiac cycle reach mitral annular plane figure 1figure 2 echocardiography show tricuspid insufficiency maximum gradient 30 mmhg intact interatrial septum akinesia third basal inferior wall ejection fraction 42 mass left atrial appendage twodimensional transesophageal echocardiography confirm presence intraatrial mass epistaxis consider heart failure increase venous pressure patient refer cardiovascular surgery clinic refuse surgery anticoagulation fraxiparine 06 mlday start continue 3 week cessation epistaxis nasal tamponament 3 week echocardiography repeat remnant mass left atrium conclusion mass thrombus melt away particular case left intraatrial thrombus presence atrial fibrillation,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
53 year old female significant past medical history develop severe viral pneumonia rapid progressive deterioration respiratory status develop ard mechanical ventilatory management ard protocol unable maintain adequate oxygenation result bedside vvecmo plan transesophageal echocardiography tee perform visualize proper positioning guidewire cannula seldinger technique right internal jugular vein access guide wire place placement guidewire ivc prove difficult repeat migration guidewire right ventricle multiple attempt guidewire visualize course properly svc ivc bolus dose 5000 unit intravenous heparin give right internal jugular venous access site dilate final dilatation complete dilator exchange simultaneous advancement 23 french avalon cannula tee lose visualization guidewire multiple premature ventricular beat note immediately new rapidly enlarging pericardial effusion detect figure figure22 emergent preparation bedside surgical decompression pericardial space quickly patient lose blood pressure acute cardiac tamponade avalon cannula immediately clamp end remove emergent subxiphoid pericardial window perform result drainage venous blood restoration blood pressure transfusion initiate patient emergently transport operating room surgical exploration avalon cannula find perforate apex right ventricle injury repair primarily avalon cannula reposition ivc tee additional direct manipulation vvecmo initiate oxygenation improve excessive coagulopathie sternum leave open close postoperative day 2 point remain free cardiac infectious complication pulmonary condition slowly improve successfully wean vvecmo postoperative day 9 discharge home postoperative day 24 need home oxygen regain physical function home recover normal pulmonary function 3 month follow discharge hospital,"['B-AGE', 'I-AGE', 'I-AGE', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
60yearold male patient previously undergo radical resection t2bn0m0g3 stage iii retroperitoneal sarcoma include right nephrectomy cholecystectomy 2002 pathologic evaluation demonstrate 25 cm highgrade liposarcoma different histologic component include myxoid round cell welldifferentiate sclerose pleomorphic pattern surgical margin negative tumor invade kidney renal vein ureter free tumor patient undergo additional therapy surveillance magnetic resonance image 2007 reveal isolated tumor recurrence retroperitoneum exploratory celiotomy reveal tumor involvement duodenum head pancreas superior mesenteric vein vena cava leave renal vein severe adhesive change lead intraoperative assessment unresectable disease subsequently patient undergo stereotactic body radiation retroperitoneal tumor fraction total dose 30 gy complication postradiation imaging reveal near complete resolution retroperitoneal mass year later patient present weight loss postprandial abdominal pain nausea vomit crosssectional imaging reveal 7 cm mass involvement portion duodenum figure 1 obvious involvement pancreatic head structure note involve previous laparotomy elect perform resection attempt include possible pancreatoduodenectomy retroperitoneal vascular resection necessary exploration residual tumor entirely intraduodenal pedunculate mass posterior duodenal wall distal ampulla fill entire duodenal luman patient undergo duodenotomy stalk transection polypoid mass follow partial duodenal resection handsewn duodenojejunal anastomosis figure 2 surgical pathology examination reveal 95 cm recurrent highgrade liposarcoma polypoid intraluminal growth contain myxoid round cell welldifferentiate sclerose focally pleomorphic area surgical margin negative tumor come 01 cm stalk margin evidence additional neoplastic component remain resect duodenum postoperative course uncomplicated patient demonstrate recurrence 30 month resection,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
5yearold caucasian male present children emergency department epistaxis bleeding dental extraction site widespread purpuric rash secondary acute idiopathic thrombocytopenia day prior develop generalised chickenpox rash department note heart rate range 50 60 beat min haemodynamically stable normal blood pressure oxygen saturation air short systolic murmur grade 26 left sternal border clinical evidence myocarditis heart failure extensive generalised petechia purpuric rash figure 1 secondary acute thrombocytopenia presume varicella infection apparently healthy prior admission history maternal lupus ecg perform show complete heart block figure 2 admit high dependency unit close overnight monitor presume diagnosis complete heart block secondary varicella infection1 2 initial investigation show normal electrolyte calcium phosphate glucose magnesium level blood count show normal haemoglobin white cell count platelet count low 13109l platelet count normalise 10 day intervention antinuclear antibody titre autoimmune screen negative maternal autoimmune screen negative echocardiogram show structurally normal heart followup 24 h tape show persistence complete heart block follow investigation diagnosis congenital complete heart block followup 6 month heart rate remain 50 60 beat min remain asymptomatic intervention need pacemaker consider followup incidental finding complete heart block congenital aetiology association varicella infection acute thrombocytopenia case highlight asymptomatic latepresente congenital complete heart block consider differential diagnosis child present asymptomatic bradycardia emergency department,"['O', 'O', 'B-AGE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
january 2009 57yearold woman emergently present acute shortness breath 1month history progressive shortness breath gradual decrease exercise capacity secondary mild dyspnea report additional symptom age 40 diagnose stage iia t1bn1 leftside breast cancer initial treatment include lumpectomy axillary node dissection subsequently undergo 4 cycle dox therapy 75 mgm2 follow 8 cycle cyclophosphamide methotrexate 5fluorouracil multigated acquisition scan chemotherapy show normal cardiac function chemotherapy undergo leave wholebreast radiation axillary boost tumor estrogen receptorpositive subsequent medical regimen consist antiestrogen therapy take tamoxifen 5 year aromatase inhibitor letrozole 17 year chemotherapy active relatively good health addition symptom present tachycardia tachypnea hypertension mark jugular venous distention s3 pulmonary rale trace peripheral edema initial laboratory value normal limit elevated level nterminal probrain natriuretic peptide 2000 pgml result investigation newonset cardiomyopathy include normal cardiac enzyme level electrocardiogram ecg reveal ischemic change coronary angiogram normal appearance ecg show sinus tachycardia frequent premature ventricular complex leftaxis deviation leave atrial enlargement lowvoltage qrs complex nonspecific st change fig1 2dimensional echocardiogram reveal left ventricular ejection fraction lvef 020 severe diffuse leave ventricular lv hypokinesis mildly dilate left atrium well define cause lv systolic dysfunction cardiovascular magnetic resonance cmr perform confirm lvef 020 t2weighte sequence show slow flow secondary lv dysfunction myocardial edema fig2a late gadolinium enhancement disclose diffuse myocardial thinning scar fig2b patient treat medically symptom progressively improve therapy consist blocker angiotensinconverte enzyme inhibitor digoxin diuretic therapy slowly taper lvef increase 020 055 8month period medication lowdose metoprolol discontinue 1 year remain asymptomatic,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS']"
16yearold boy child nonconsanguineous parent parent young sibling healthy start school 7 year age find short height slightly myopic astigmatic subnormal visual acuity endocrinological investigation perform initially reveal borderline value growth hormone gh deficiency treat period gh beneficiary effect growth age 16 year height weight 3 sd mean compare standardized swedish growth chart ophthalmological investigation 10 year age show pigmentary retinopathy optic atrophy electroretinogram perform show severe rod cone dystrophy decrease visual acuity visual field color vision dark adaption nystagmus note 14 year age year later photophobia bilateral cataract develop cataract operate 16 year age blind 14 year age refer neurological investigation clinical examination show mild ataxia tremor dysmetria gait instability mild moderate muscle weakness weak absent tendon reflexe low extremity exercise intolerance audiometric investigation reveal mild bilateral sensorineural hearing impairment 15 year age unprovoked epileptic seizure treat levetiracetam decrease renal function identify 15 year age increase serum creatinine 145 moll reference interval 3090 moll proteinuria urine albumine 244538 mgl reference interval20 mgl urine albuminecreatinine ratio 4459 gmol reference interval 3 gmol renal scintigraphy demonstrate reduce kidney size cr51edta clearance show decrease glomerular filtration rate 42 normal filtration rate decrease time 29 normal 16 year age 14 year age cardiac investigation demonstrate hypertrophy wall left ventricle 3 sd compare normal normal systolic diastolic function obstruction outflow mitochondrial investigation perform 14 year age blood level lactate pyruvate 16 0096 mmoll respectively lead ratio 33 reference interval 20 cerebrospinal fluid csf level lactate pyruvate 36 0137 mmoll respectively lead lactate pyruvate ratio 26 urinary lactate excretion normal csf albumin increase 258 mgl reference level 225 mgl increase csfplasma albumin ratio 74 reference level 5 serum acyl carnitine profile muscle carnitine level normal serum creatine kinase activity mildly increase 54 katl reference interval 35 katl,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
51yearold man refer hospital severe congestive heart failure ventricular arrhythmia march 2008 suffer heart failure ventricular tachycardia year despite receive conventional treatment ie furosemide lisinopril hydrate pimobendan warfarin potassium carvedilol metildigoxin amiodarone hydrochloride height 161 cm body weight 83 kg blood pressure 11060 mm hg fast blood glucose 107 mgdl hba1c 63 chest xray show cardiomegaly cardiothoracic ratio 067 figure 1a ecg show video 1 reveal diffused hypokinetic left ventricle markedly dilate left ventricle dimension enddiastole 95 mm reduce ef 011 coronary angiogram normal myocardial biopsy reveal 50 cardiomyocyte replace fibrosis figure 2 implantable cardioverterdefibrillator implant typical facial appearance thickening hand refer endocrinology department plasma level gh 82 ngml igf1 504 ngml mri demonstrate macroadenoma pituitary diagnose acromegaly treat octreotide longactingrelease lar 8 month undergo transsphenoidal surgery january 2009 figure 3 plasma level gh igf1 decrease octreotide lar basal plasma level gh 4 ngml plasma igf1 level appropriate age range figure 3 surgery plasma level gh igf1 decrease basal plasma level gh 05 ngml igf1 level normal range figure 3 treatment lar cardiac function improve partially cardiothoracic ratio058 ef020 september 2008 surgery cardiac function improve drastically cardiothoracic ratio047 ef055 april 2009 figure 1b and2b2b frequency ventricular arrhythmias decrease pimobendan taper,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O']"
26yearold woman see emergency department ed chest pain hypertension find urinary tract infection send home antibiotic thiazide diuretic day later return epigastric pain nausea emesis myalgia patient significant medical history deny cardiorespiratory symptom complain low exercise tolerance year family history cardiac pulmonary disease sudden cardiac death bear usa travel recently sick contact examination hypertensive 170105 mm hg tachycardic 125 bpm dry mucous membrane appear ill look find elevated serum creatinine 160 moll normal 60110 moll receive 15 l intravenous fluid presume volume depletion prerenal azotaemia short breath crackle note auscultation chest portable chest film demonstrate hazy infiltrate likely represent pulmonary oedema develop hypotension systolic pressure 90 noninvasive positive pressure ventilation initiate ecg demonstrate sinus tachycardia rate 130 bpm minimal st depression precordial lead consultation cardiologist patient receive 40 mg intravenous furosemide echocardiogram demonstrate global hypokinesis leftventricular ejection fraction 10 figure 1 patient transfer intensive care unit anxious tachycardic 170 bpm intubate sedate despite placement foley catheter administration intravenous loop diuretic remain anuric 12 h hospitalisation develop sign acute kidney injury creatinine increase 350 moll 24 h hospitalisation receive norepinephrine milrinone improve cardiac output second day hospitalisation evaluate cardiologist cardiothoracic surgeon emergent circulatory support develop sign poor tissue perfusion lactic acidosis 84 mmoll normal 22 mmoll transaminitis aspartate aminotransferasealanine transaminase 150 iul normal 40 ul take cardiac catheterisation laboratory emergent right heart catheterisation biopsy exclude acute myocarditis day gently fluid resuscitated guide bioreactance noninvasive cardiac output pressor gradually wean nonoliguric slowly regain renal function organ perfusion improve resolution lactic acidosis decrease liver transaminase hospital day 5 transfer medical ward eventually discharge home nonselective    blockade ace inhibitor nitrate plan followup heartfailure clinic patient return ed 4 day later elevated blood pressure nausea abdominal pain contrast scan abdomen reveal pancreatitis adrenal mass treatment pancreatitis begin paroxysm headache nausea emesis abdominal pain corresponding hypertension 220s systolic tachycardia 120s baseline systolic pressure 90110 mm hg figure 2 urinary plasma catecholamine elevate confirm repeat testing give aggressive fluid rehydration      blockade plan adrenalectomy prior surgery leftventricular ejection fraction improve 55 medical management figure 1 pathology adrenal gland consistent nonmalignant pheochromocytoma figure 3,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O']"
31yearold white primipara twin pregnancy admit hospital 38th week gestation elevated blood pressure 150100 mmhg receive antihypertensive treatment blood pressure 12080 laboratory variable include plasma protein respective reference interval hour admission hospital contraction start caesarean section perform vertextransverse presentation twin liveborn female male deliver postoperative course initially inconspicuous hour postpartum experience sudden epigastric pain blood pressure rise 190130 laboratory finding show haemolysis thrombocytopenia increase serum creatinine aminotransferase table intravenous magnesium sulphate administer abdominal ultrasound disclose uterine cavity placenta residue hour postpartum patient transfer intensive care unit poor urine output drowsiness suspicion dic examination sleepy disorient combination haemolysis thrombocytopenia elevated liver enzyme suggest postpartum hellp syndrome complicate dic patient rehydrate treatment institute fresh frozen plasma red cell transfusion fresh platelet kybernin p antithrombin iii high serum urea creatinine persistent anuria compatible acute renal failure high dose furosemide fail increase diuresis sixteen hour postpartum blood pressure 6040 oxygen saturation 70 minute later patient acute cardiac arrest resuscitation start resuscitation successful normal heart action reestablish blood pressure rise 150110 oxygen saturation 90 laboratory finding deteriorate development acute renal failure indicate necessity urgent dialysis follow dialysis patient stable oxygen saturation 98 hour postpartum patient develop cardiopulmonary arrest despite resuscitation attempt outcome lethal fact death occur hospital short time surgical intervention medicolegal autopsy order autopsy reveal oedema brain lung dilatation right leave ventricle hydrothorax 900 ml hydroperitoneum 2500 ml hydropericardium 200 ml present field operation caesarean section unremarkable petechial suffusional haemorrhage observe pleura endocardium mucosa renal pelvis peritoneum small large bowel histology reveal periportal hepatocellular necrosis bloodless glomerulus swollen vacuolated intracapillary cell confluent haemorrhage kidney liver spleen death attribute multiple organ failure dic consequence hellp syndrome,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O']"
37yearold caucasian man refer department external hospital severe abdominal pain unclear aetiology patient suffer friedreichs ataxia1 2 recent transthoracic echocardiography perform day admission show dilated cardiomyopathy impair leave ventricular function ejection fraction 30 pulmonary artery pressure 55 mm hg finding unchanged previous examination time live residential home mobile wheelchair arrival emergency department patient somnolent disorient axillary body temperature 357 c arterial blood pressure 12589 mm hg pulse rate 84 rhythmic beatsmin complain increase diffuse abdominal pain day combine absence appetite vomit single occasion daily medication perindopril 25 mg torasemide 75 mg esomeprazole 40 mg physical examination find tender abdomen painful epigastric palpation normal bowel sound auscultate upper right low left quadrant renal bed free pain palpation cardiac auscultation 26 systolic murmur audible lung auscultation show normal respiration laboratory finding slightly elevate c reactive protein crp 16 mgl normal 5 mgl elevated troponinth 0070 gl normal 0014 gl highly elevated probtype natriuretic peptide 7382 pgml normal 63 pgml kidney function parameter upper normal range creatinine 100 moll calculate glomerular filtration rate 73 mlmin blood count reveal leucocytosis 156109litre thyroid function thyroidstimulate hormone ft3 ft4 reference range urine analysis show pathology abdominal sonography organ normal especially kidney free fluid detect figure 1 severe pain persist night despite analgesia paracetamol 1 g metamizole 1 g pethidine 75 g contrastenhance abdominal ct perform reveal infarction right kidney appear hypodense area kidney artery vein assess open figure 2 3 cardiac dysfunction frequent cause death patient affect friedreichs ataxia commonly congestive heart failure arrhythmia renal artery embolism rare event patient nonabdominal viscous cause severe diffuse abdominal pain porphyria familial mediterranean fever diabetic ketoacidosis tocopherol deficiency exclude negative cardiolipin test exclude tabetic crisis evidence preexist porphyria encounter example quantitative determination aminolevulinic acid porphobilinogen porphyrin 24h urine negative genetic diagnosis example clotting disorder conclusive hypovitaminosis present patient endocrinopathie example diabetes evidence hypothyreosis hyperthyreosis patient hospitalise delay department nephrology immediate anticoagulation heparin initiate later replace lifelong oral anticoagulation phenprocoumon 11 day hospitalisation complication occur kidney function parameter remain normal transoesophageal echocardiography fifth day show cardiac thrombus patent foraman ovale deep vein thrombosis exclude duplex sonography anticardiolipin antibody testing genetic testing clot disorder negative urine test reveal evidence porphyria hospitalisation patient remain stable cardiological function diuretic adjust accord fluid balance patient treat levofloxacin pneumonic infection prior hospitalisation antibiotic treatment continue increase inflammatory parameter course disease crp increase 200 mgl interpret inflammatory response renal infarction discharge laboratory parameter significantly decrease,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
45yearold lady seek dermatology consultation severely tender erythematous vesicle bullae chest arm sudden onset associate fever nausea malaise complain pain upper abdomen history receive drug prior onset lesion report significant weight loss loss appetite physical examination temperature 38c pulse rate 100min blood pressure 12672 mm hg multiple coalescing vesicle bullae upper chest arm distribute symmetrically show area pustulation necrosis surround multiple pseudovesicular satellite papule figure 1ab abdominal examination mild tenderness present right hypochondrium patient initial laboratory investigation show total leucocyte count 12 000 cellsmm3 75 neutrophil haemoglobin level 143 gm erythrocyte sedimentation rate 30 mmh liver function test kidney function test c reactive protein level normal limit gram stain purulent exudate show neutrophil organism culture growth 72 h incubation lesional skin biopsy take satellite papule show neutrophilic infiltration dermis papillary dermal oedema spongiosis figure 2ab abdominal ultrasonography reveal intraluminal gall bladder mass suggestive malignancy basis finding final diagnosis ss associate gall bladder malignancy start oral prednisolone dose 40 mg daily symptomatic treatment cutaneous lesion respond dramatically subside completely 1 week treatment figure 3ab dose prednisolone taper open cholecystectomy perform histopathology excise tissue confirm welldifferentiate gall bladder adenocarcinoma form gland papillae infiltrate muscularis propria superficially cystic duct cut margin free tumour figure 2cd patient postoperative period uneventful discharge taper dose prednisolone advice followup periodically,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
76year old woman present 24month history enlarge mass involve history trauma physical examination show mass 3x4 cm diameter localize right interscapular region mass ulcerative helophytic grayish colour hard consistency easily bleed manipulation remainder examination unremarkable lymphadenopathy abdominal masse feel resection histological examination specimen conclude basal cell carcinoma local recurrence observe 18 month later patient admit institution lumpectomy figure 1 histopathological examination reveal syringomatous pattern infiltrate dermis figure 2 figure 3 subcutis skeletal muscle neoplastic epithelial cell arrange interconnect cord microcystic area nest cord tubule tumour extend dermis adjacent muscle lobule show squamous differentiation sclerosis stroma cord present tumour cell connect epidermis immunohistochemical analysis show positivity antick7 figure 4 ae1ae3 negativity anti cea anti ck20 base histological immunohistochemical presentation diagnosis syringomatous eccrine carcinoma establish radiotherapy involved area perform 70 gy 35 session,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 4yearold boy diagnose have blau syndrome base manifestation typical clinical feature ankle wrist arthritistenosynovitis diffuse eczematous rash uveitis histologic evidence noncaseate granuloma heterozygous nod2 mutation pr334w ocular involvement initially control topical oral corticosteroid year visual impairment progress manifestation blau syndrome arthritis rash subside time bilateral panuveitis progress age 5 year initially treat methotrexate ocular inflammation persist despite addition local steroid injection repeat intravenous iv bolus methylprednisolone treatment patient age 10 year infliximab initially 5 mgkg increase 10 mgkg iv 4 6 week initiate initial improvement 1 year treatment start uveitis worsen age 12 year infliximab discontinue adalimumab 24 mgm2 2 week initiate dosage methotrexate 15 mgm2weekly increase ocular disease remain active mycophenolate mofetil 750 mgm2 abatacept 10 mgkgmonth iv sequentially administer significant improvement age 16 year patient granulomatous retinal lesion anterior chamber inflammation macular edema develop lead retinal detachment addition steroid therapy corticosteroid pulse therapy necessary control disease flare average 3 bolusesmonth 6 consecutive month suppose autoinflammatory nature blau syndrome initiate trial il1 antibody administration 2 mgkgmonth canakinumab 6 month follow ocular flare occur steroid pulse therapy necessary concomitant treatment oral methotrexate lowdose prednisone 02 mgkgday remain unchanged figure 1 show fluorangiogram treatment 6 injection drug tolerate effect finding laboratory test perform monthly normal,"['O', 'O', 'B-SEX', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
57yearold jewish man crohns disease cd ileum diagnose age thirteen present multiple nonmelanoma skin cancer nmsc develop past 16 year coincide initiation prolong course thiopurine 6mercaptopurine mercaptopurine 6mp diagnose total 84 nmsc 72 nmsc clinic 12 clinic await biopsy removal additional lesion cd initially treat sulfasalazine intermittent steroid diagnosis past 20 year take 6mp daily year begin 6mp develop 30 nmsc 14 squamous cell carcinoma scc 16 basal cell carcinoma bcc patient treat subsequent year past year return clinic 100 new lesion suggestive malignancy torso extremity subsequent exam 42 biopsyproven lesion nmcs 20 scc 22 bcc addition sccs moderately differentiate poorly differentiate large skin cancer necessitate mohs surgery xenografte large lesion pretibial measure 64x53 mm figure 1 await biopsy suspicious lesion patient fitzpatrick ii skin type admit excessive sun exposure 25 year hawaii early use sunscreen sail catamaran peak sun hour reveal mother skin cancer lesion remove deny having smoker past year discontinue 6mp begin mesalamine pentasa later adalimumab humira hope attenuate progression nmsc continue monthly skin exam overall hospitalize 16 time cd require intestinal resection unfortunately recent hospitalization diagnose metastatic adenocarcinoma small bowel pass away shortly,"['O', 'O', 'B-SEX', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O']"
18yearold lady present history progressive swaying walk bad night 5 year speech normal tremulousness upper limb history weakness numbness family history significant eld sister similar difficulty walk 7year duration die poorly control diabetes mellitus age 20 year member kin affect history consanguinity parent cognitive function normal mini mental status score 3030 visual acuity fundus examination normal extraocular movement include saccade pursuit normal saccadic intrusion nystagmus notice tone power normal limb generalised exaggeration myotatic reflex bilateral extensor plantar response vibration joint position sense intact rombergs positive patient sway perform tandem walk fasting postprandial blood glucose level normal haemogram renal liver thyroid function test normal serum vitamin b12 folic acid level normal limit nerve conduction study show absent sensory nerve action potential normal distal latency conduction velocity amplitude compound muscle action potential cmap nerve trunk mri show marked atrophy cervical cord compare cerebellum normal figure 1 genetic testing pcr disclose expansion gaa repeat allele 254 298 fxn gene variety cause autosomal recessive ataxia need consider differential diagnosis frda systemically exclude ataxia vitamin e deficiency ave phenotype similar frda titubation hyperkinesia common aved4 strong family history ataxia diabete mellitus eld sister favour frda ataxia oculomotor apraxia aoa type 1 2 consider owe lack apraxia ocular movement distal amyotrophy severe axonal sensorimotor polyneuropathy atrophy cerebellum involuntary movements5 ataxia telengiectesia presentation similar aoa type 1 2 mucocutaneous marker sinopulmonary infection hypogammaglobulinaemia radiosensitivity predisposition development variety neoplasm feature ataxia telengiectasia see aoas frda important cause autosomal recessive spastic ataxia apart frda autosomal recessive spastic ataxia charlevoixsaguenay marinescosjgren syndrome charcotmarietooth disease inherited polyneuropathy gait ataxia common frda case cmt improbable follow feature case lack motor weakness retain reflex bilaterally extensor plantar pure sensory neuropathy nerve conduction study idebenone start dose 450 mg twice day antioxidant property gait ataxia physiotherapyfrenkels exercisewas initiate blood glucose monitor regularly 4 month significant change gait difficulty,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
54 yearold diabetic woman complain blurred vision left eye 5 day scalp tenderness headache visual acuity va 2020 right eye 2030 leave eye intraocular pressure normal funduscopic examination reveal leave optic nerve edema small disc margin hemorrhage wbc count 12700 esr 7 normal 020 mmhr crp 24 normal 010 mgdl day later note new left eye pain vision decline count finger pain eye movement right pupil 4 mm react light left pupil 4 mm relative left afferent pupillary defect left optic nerve swollen peripapillary nerve fiber layer hemorrhage cherry red spot mild macular edema consistent central retinal artery occlusion posterior pole peripheral retinal hemorrhage trace cell see anterior chamber vitreous fluid repeat wbc esr crp normal treponemal bartonella antibodie quantiferontb test blood culture ekg carotid doppler ultrasound unremarkable brain contrast mri demonstrate optic nerve enhancement day later leave eye pain vision worsen patient complain jaw claudication scalp pain va decline light perception left eye 1 cell flare anterior chamber 2 vitreous cell haze funduscopic examination reveal extensive retinal necrosis diffuse hemorrhage multiple area focal venous beading fig1 consistent acute retinal necrosis vitreous fluid examine pcr amplifiable hsv vzv cmv toxoplasma sequence return positive vzv dna treat onetime intravitreal injection ganciclovir 2000 mcg05 ml left eye oral acyclovir 800 mg 5 time daily 14 day oral prednisone 60 mg daily 7 day follow 20 mg 7 day day start treatment recently develop jaw claudication intermittent scalp pain temporal artery biopsy perform histological examination normal fig2 immunohistochemical analysis demonstrate vzv antigen arterial adventitia evaluation adjacent section hsv1 antigen infiltrating leukocyte cd45 show negative fig3 antiviral therapy alter intravenous acyclovir 10 mgkg 8 h 14 day steroid discontinue,"['O', 'O', 'O', 'B-SEX', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
23yearold woman history carnitine deficiency present exertional dyspnea fatigue diagnose nonischemic cardiomyopathy age 10 year present symptom congestive heart failure transthoracic echocardiography tte reveal severe left ventricular lv dysfunction time total carnitine level 3 moll normal range 2569 moll free carnitine level 3 moll normal range 1660 moll cardiomyopathy attribute carnitine deficiency 5 month therapy carnitine supplement total carnitine free carnitine level increase 86 moll 48 moll respectively left ventricular systolic function normalize fractional shortening 347 current admission patient report past 10 year intermittently compliant carnitine supplement regiman approximately 6 month presentation total carnitine free carnitine level drop 18 moll 17 moll respectively undergo tte follow cardiac magnetic resonance cmr gadolinium enhancement tte show normal lv function mild concentric lv hypertrophy fig1 result cmr confirm normal lv size function show focal increase wall thickness basal mid lateral wall enddiastolic thickness 16 cm fig2 patchy delay gadolinium enhancement fig3 basis patient family history sudden cardiac death abnormal myocardial structure underlying disease process dualchamber implantable cardioverterdefibrillator place primary prevention sudden cardiac death bradyarrhythmia tachyarrhythmia,"['O', 'B-SEX', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
14monthold boy refer hospital hospital dilate hypertrophy left ventricle lv neutropenia developmental delay 27 october 2011 bear term body weight 32 kg sixteen day birth hospitalize owe persistent irritability chest radiograph show cardiomegaly echocardiogram reveal decrease lv contractility ejection fraction 24 impression myocarditis manage 1 yr presentation hospital patient show feeding difficulty developmental delay birth referral admit hospital 7 time infection episode take furosemide spironolactone enalapril carvedilol referral refer hospital 14 month old body weight 6 kg 3rd percentile height 71 cm 3rd percentile overall motor development delay sit mama papa recorded blood pressure heart rate 9430 mmhg 132 beat minute respectively physical examination definite heart murmur audible liver palpable show persistent neutropenia start stay previous hospital wbc neutrophil count 8800l 2 176l respectively bnatriuretic peptide level 1045 pgml chest radiograph show mild cardiomegaly cardiothoracic ratio 628 fig1a electrocardiogram show low qrs voltage limb lead echocardiogram reveal dilate hypertrophy globular lv hypertrophy papillary muscle hypertrabeculation meet criterion lv noncompaction echocardiographic parameter follow lv internal diameter diastole 377 mm z    102 ejection fraction 366 lv mass index 756 g z    63 fig1b rule systemic cause dilate hypertrophy lv perform thoracoabdominal compute tomographic ct angiography contrast dye ct finding show abnormality kidney organ vessel undergo ct angiography patient show abrupt highgrade spike fever fig2 develop secretory diarrhea 800 cc day associate metabolic acidosis time wbc neutrophil count decrease 3290l 1 33l respectively bnatriuretic peptide level great 4901 pgml associate respiratory symptom result respiratory gastrointestinal viral study negative blood stool culture negative pathogen creactive protein level 708 mgdl despite supportive care include intravenous fluid resuscitation empirical antibiotic patient condition worsen aggravate metabolic acidosi respiratory difficulty require transfer intensive care unit icu icu transfer serum ph 6881 bicarbonate level 78 mmoll total co2 414 mm hg patient treat intensive ventilator care inotropic agent supportive care measure eventually die aggravate metabolic acidosi acutely decompensate heart failure 7 day icu care stay icu perform genetic analysis barth syndrome evidence display cardiomyopathy neutropenia developmental delay gene sequence analysis reveal taz gene harbor novel hemizygous frameshift mutation c227delc ppro76leufsx7 inherit mother fig3,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
84yearold male patient history coronary artery disease right coronary artery rca stenting admit university hospital february 2012 progressive dyspnoea recur syncope cardiological workup reveal grade iii severe symptomatic aortic stenosis relevant comorbiditie logistic euroscore 19 point severe femoral arteriopathy schedule transsubclavian tavi successful implantation corevalve prosthesis medtronic medtronic world headquarters medtronic parkway minneapolis minnesota usa diameter 31 mm initial discharge refer hospital dyspnoea bilateral pleural effusions transoesophageal echocardiography tee show severe mitral regurgitation mr subsequently treat interventional mitral valve repair mitraclip abbott vascular abbott laboratories abbott park illinois usa procedurally dependent atrial septal defect asd closure amplatzer pfo occluder st jude medical gmbh helfmannpark 7 eschborn germany week secondary discharge patient develop progressive heart failure combination acute renal failure immediate echocardiography reveal moderatetosevere aortic regurgitation recurrent severe mr valvular defect result slight significant aortic valve prosthesis migration left ventricular outflow tract cause aortic paravalvular leakage partial posterior mitral leaflet detachment fig1 consequence finding patient transfer cardiac surgery department preoperative coronary angiography reveal progression coronary artery disease consequently patient schedule conventional aortic mitral valve replacement coronary artery bypass surgery operation perform median sternotomy initialization cardiopulmonary bypass ascending aorta open exploration aortic valve fig2a careful removal corevalve prosthesis edwards perimount aortic valve prosthesis diameter 25 mm implant veingrafte circumflex coronary artery mitral valve explore left atrium excise attached clip edwards perimount mitral valve prosthesis diameter 31 mm implant recently atrial septal occluder remove prior direct closure result septal defect singlesuture line fig2b intraoperative echocardiography reveal adequate function prosthesis operation complete usual manner postoperative phase patient recover surgery hospitalization prolong transient renal failure recur pleural effusion month postoperative care patient discharge hospital rehabilitation good condition sign heart failure followup month surgery patient cardiopulmonary stable condition undergo additional physiotherapy,"['O', 'B-SEX', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
60yearold caucasian woman significant medical history develop exercise intolerance fatigue shortness breath exertion month prior presentation outpatient clinic time presentation report dry cough orthopnea paroxysmal nocturnal dyspnoea generalise weakness intermittent numbness hand foot social history negative smoke alcohol illicit drug physical examination unremarkable jugular venous distension audible s1 s2 sound bilateral crackle lung auscultation bilateral pitting oedema chest xray show cardiomegaly pulmonary oedema smallsized bilateral pleural effusion 12lead ecg demonstrate normal sinus rhythm lowvoltage complex extreme rightaxis deviation figure 1 transthoracic echocardiogram tte demonstrate asymmetric biventricular hypertrophy preserve ejection fraction 60 elevate rightventricular systolic pressure 36 mm hg abnormal myocardial texture describe granular sparkling figure 2 coronary ct angiogram demonstrate normal coronary artery subsequently cardiac mri demonstrate early diffuse subendocardial delay enhancement concern infiltrative myocardial disease diffuse biventricular hypertrophy normal ejection fraction figure 3 patient undergo right heart catheterisation endomyocardial biopsy reveal diffuse amyloidosis amorphous proteinaceous material cardiac myocyte blood vessel positive congo red stain figure 4 subsequent laboratory evaluation register elevate free    light chain 863 mgl normal 57263 mgl positive bencejone protein 037 g24 h urine bone marrow biopsy reveal great 10 infiltration cd19 cd56 cd138 plasma cell reversal marrow    ratio 12 normal 21 consistent mm patient eventually diagnose systemic al amyloidosis advanced stage iii cardiac amyloidosis underlie mm give advanced cardiac amyloidosis patient deem poor candidate autologous stemcell transplantation patient start systemic chemotherapy melphalan dexamethasone despite receive standard therapy heart failureincluding diuretic blocker ace inhibitorsthe patient condition continue worsen succumb sudden cardiac death,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE']"
24yearold malay male patient refer respiratory clinic abnormal preemployment chest radiograph smoke 10 cigarette day 21 year age stop smoke 10 month ago notice have reduce effort tolerance past year office worker history exposure organic inorganic dust sibling asymptomatic examination patient tachypnoeic sign finger club pulmonary hypertension oxygen saturation room air rest 94 drop 92 climb flight stairs spirometry testing reveal restrictive pattern lung disease force expiratory volume 1 second fev1 force vital capacity fvc 27 l 69 predict 32 l 68 predict respectively fev1fvc ratio 85 haemoglobin 168 gl serum parathyroid hormone 29 pmoll normal 1173 calcium 234 mmoll level normal 24hour urine calcium normal 69 mmol 24hour urine volume 28 l chest radiograph fig1a reveal dense micronodular opacity distribute symmetrically predominantly middle low zone lung give classical sandstorm appearance cardiac border obscure sandlike opacitie highresolution compute tomography hrct scan lung fig1b show widespread tiny microcalcification lung preponderance microlith low lobe associate area interlobular septal thickening groundglass change subpleural cystic change see low lobe give rise black pleura sign fig1c 2 pneumothorax pleural effusion present bronchial system include small bronchiole size pulmonary vessel normal diffuse parenchymal lung disease videoassiste thoracic surgical vat lung biopsy plan procedure convert minithoracotomy difficulty manoeuver endostapler moderate pneumothorax postminithoracotomy patient fully recover 5 day ward lung biopsy speciman reveal feature consistent pam numerous calcospherite alveolar space fig1d intervene alveolar septae congest show mild fibrosis infiltrate mainly lymphoplasmacytic cell,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O']"
young boy child healthy nonconsanguineous white british parent bear term follow uneventful pregnancy weigh 3132 g 9th25th centile early development think normal approximately 6 month age develop tonic upward eye deviation associate flexion arm neck consistent infantile spasm electroencephalograph eeg time grossly abnormal hypsarrhythmia strongly support diagnosis west syndrome cranial mri report normal prednisolone prescribe treat seizure effectively steroid wean 6 week remain seizure free 6 month age 1 year apparent early developmental progress maintain function 68 month developmental stage seizure return shortly birthday prolong frequent occasion focal involve right arm leg right face clonazepam briefly improve seizure frequency subsequently epilepsy prove refractory combination anticonvulsant therapy prolong seizure 60 min associate stepwise regression neurodevelopment seizure semiology predominantly epilepsia partialis continuum involve right face right arm right leg development focal seizure progressive nature condition prompt second cranial mri age 2 year 6 month contrast previous scan mri reveal symmetrical subcortical white matter lesion fig1a thinning anterior genu corpus callosum fig1b examination patient small round anteriorly rotate ear broad nasal root demonstrate visual awareness startle loud noise tone increase 4 limb internal rotation leg hip reflex pathologically brisk brief myoclonic jerk evident examination,"['B-AGE', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
67yearold japanese female present left buttock tumor detect approximately 1 year early recently gradually enlarge physical examination reveal relatively wellcircumscribe skincolore tumor hyperkeratosis measure 43 x 38 mm diameter left buttock biopsy speciman reveal bowen disease squamous cell carcinoma situ subsequently total resection tumor perform histopathological study resect speciman reveal proliferation atypical squamous cell entire layer acanthotic epidermis accompany hyperparakeratosis figure 1a atypical squamous cell enlarge hyperchromatic nucleus figure 1b multinucleate atypical squamous cell present mitotic figure scatter present upper portion epidermis atypical mitotic figure observe figure 1b invasive neoplastic growth note figure 1a approximately 95 lesion compose abovementione bowen disease squamous cell carcinoma situ superficial sebaceous carcinoma present central area lesion component compose proliferation nest atypical cell vacuolated clear cytoplasm large nucleus contain conspicuous nucleolus figure 1c 1d1d sebaceous carcinoma invade superficial reticular dermis figure 1c atypical cell contain vacuolated cytoplasm present lesion bowen disease adjacent sebaceous carcinoma figure 1e immunohistochemical study perform autostainer ventana method previously report 912 epithelial membrane antigen ema cytokeratin 7 adipophilin express sebaceous carcinoma component bowen disease figure 2a androgen receptor express tumor cell sebaceous carcinoma bowen disease atypical vacuolated cell lesion bowen disease positive adipophilin figure 2b overexpression p53 protein observe sebaceous carcinoma bowen disease accordingly ultimate diagnosis sebaceous carcinoma associate bowen disease,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
44yearold chinese man 7 packyear smoking history refer shanghai pulmonary hospital february 2013 left upper lobe lung mass multiple bilateral intrapulmonary metastasis leave pleural effusion 2r4r10l11l lymphadenopathy pleural fluid cytology reveal adenocarcinoma scorpion amplification refractory mutation system amoydx co xiamen china show detectable epidermal growth factor receptor mutation commence chemotherapy gemcitabine cisplatin single cycle symptom worsen image confirm progressive disease second opinion request university colorado compute tomographyguided biopsy left upper lobe lesion perform permit additional molecular testing interim patient commence pemetrexed nedaplatin unfortunately cycle shortness breath worsen evidence progression scan fig1a molecular testing repeat biopsy speciman reveal mutation snapshot multiplex pcr testing life technology carlsbad technically negative alk breakapart fish test show atypical negative pattern specifically 68 cell demonstrate single copy 5 alk signal numerous cell doublet 5 alk signal combine 3 alk signal fig2a subsequently confirmatory diagnostic assay demonstrate alk protein expression ihc d5f3 antibody cell signal technology inc danver ma h score    150 fig2b presence echinoderm microtubuleassociate proteinlike 4 eml4alk transcript e13 a20 rtpcr fig2c patient receive crizotinib 250 mg twice daily thirdline therapy 2013 impressive symptomatic improvement ct response 1 month therapy fig1b remain treatment crizotinib evidence progression september 2013,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
35yearold woman present medical emergency department lowgrade fever 3 week vomit 1 week anuria 3 day report dysuria breathlessness 1 week history decrease urine output dialysis effort intolerance chest pain palpitation dyspnoea weight loss menstrual history normal limit report gradually progressive loss appetite family history include smoky urine young brother childhood die accident general survey patient conscious alert dyspnoeic febrile severe pallor present mild pedal oedema blood pressure 180100 mm hg pulse rate 116min regular evidence jaundice club cyanosis lymphadenopathy find physical examination reveal bibasilar endinspiratory crepitation lung suprapubic tenderness hepatosplenomegaly ascite cardiac examination normal find severe bilateral hearing loss gradually progressive 5 year fundus bilaterally pale patient refer department ophthalmology comprehensive eye examination visual acuity document 618 eye obvious lenticular opacity slitlamp examination show bilateral anterior lentiglobus figure 1 posterior lenticonus figure 2 distant direct ophthalmoscopy reveal oil droplet sign suggestive confirmation presence lenticonus peripheral retina reveal multiple yellowish white lesionlike fleck midperiphery blot haemorrhage indicative hypertensive change figure 3 4,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
30yearold woman history hiv hcv present emergency department 4month history gradual progressive swelling low limb abdoman deny chest pain dyspnoea paroxysmal nocturnal dyspnoea orthopnoea vital stable cardiovascular examination remarkable elevated jugular venous pressure jvp 12 cm pronounced y descent prominent pericardial knock sound hear praecordium pericardial rub murmur lung clear auscultation patient markedly oedematous abdoman low limb admit diagnostic workup management diagnose hiv 2010 antiretroviral therapy illicit drug approximately 56 year renal hepatic disease rule blood test image peritoneal fluid negative malignancy echocardiogram show thicken bright pericardium adjacent right heart border figure 1 parallel separation epicardial pericardial echo railroad track sign septal bounce lack pericardial slide annulus paradoxus demonstrate tissue doppler figure 2 leave ventricular ejection fraction 64 right ventricle normal size function moderate tricuspid regurgitation pericardial effusion pericardial space remarkable debris constrictive physiology demonstrate doppler study tricuspid mitral inflow figure 3 inspiration expiration diastolic flow reversal demonstrate hepatic vein expiration mark dilatation inferior vena cava change inspiration expiration ct chest reveal thickening pericardium evidence calcification lung nodule bilateral pleural effusion interstitial thickening present lung basis cardiac mri confirm presence diffusely thicken pericardium 5 mm inferior vena cava hepatic vein appear plethoric rapid early diastolic filling associate diastolic septal bounce secondary hinder late diastolic filling figure 4 patient show good response diuresis undergo right leave heart catheterisation confirm constrictive physiology,"['O', 'B-SEX', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
affected individual male fourth child bear arab muslim family palestinian origin parent cousin sible girl die age 1 month sid accord parent investigation inform consent muscle skin biopsy exome sequence obtain parent study approve local institutional review board pregnancy patient suspect iugr deliver cesarian section 362 gestational week apgar score 9 10 birth weight 23 kg 10th percentile head circumference 32 cm 10th percentile physical exam birth detect systolic murmur 36 day life patient develop metabolic acidosi lactate level 27 mm normal range 0524 mm elevated ammonia level 277 m normal range 1060 m metabolic work show normal acylcarnitine elevate alanine level 1400 m normal 700 m urine organic acid show increase lactic acidosi ketone chest xray reveal cardiomegaly cardiac echo reveal symmetrical left ventricular hypertrophy tricuspid regurge pulmonary hypertension patient transport nicu treat bicarbonate acetate diuretic age 4 day quadricep muscle biopsy perform pathology show decrease cytochrome c oxidase stain brain ultrasound perform age 5 day normal subsequently head circumference grew rapidly add 13 centimeter age 35 day repeat brain reveal dilated ventricle confirm head ct show subcortical white matter cortical hemorrhage occipital region 15 week ventriculoperitoneal vp shunt insert head ct perform age 2 year show prominent dilatation ventricle figure 1 hypotonia feed difficulty recurrent aspiration percutaneous endoscopic gastrostomy peg feeding tube insert age 10 week eye examination age 15 week reveal cortical blindness hear test abr normal repeat cardiac echo continue mild tricuspid regurge mild left ventricular hypertrophy lvh pulmonary hypertension phtn month life age 4 month start develop hypertrophic obstructive cardiomyopathy start diuretic beta blocker late calcium channel blocker add followup echo age 2 year reveal improvement lvh phtn coenzyme q10 supplementation 60 mg twice daily initiate 4 month discontinue parent following month patient admit time hospital mainly chest infection shunt malfunction fever die age 30 month severe hypoxemia febrile illness chest infection pulmonary edema parent refuse mechanical ventilation refuse reanimation,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O']"
woman 60 find screen detect invasive lobular breast carcinoma right breast invasive ductal carcinoma special type left breast stage ct image prior mastectomy show 12 cm pelvic mass initial impression think fibroid uterus associate postmenopausal bleeding lead pelvic ultrasound hysteroscopy biopsy biopsy show undifferentiated sarcoma unclassifiable immunohistochemistry follow discussion multidisciplinary team meet feel uterine tumour separate primary malignancy metastasis breast hysterectomy bilateral salpingooophorectomy perform treatment purpose fully categorise malignancy guide adjuvant therapy histological examination resection speciman show partially necrotic tumour discrete outline locate extend myometrium tumour compose malignant spindle cell figure 1a intermittent component pleomorphic cell abundant eosinophilic cytoplasm plentiful osteoclastlike giant cell present figure 1b mitose numerous structurally abnormal form common neoplastic cell surround hyaline osteoid matrix foci coarse neoplastic weave bone figure 1c generous sampling tumour show admixed neoplastic epithelial element rule common carcinosarcoma malignant mixed mllerian tumour tumour cell show immunohistochemical expression vimentin smooth muscle actin sma desmin focally cd99 epithelial marker express morphological immunohistochemical appearance keep primary uterine osteoblastic variant osteosarcoma unfortunately despite treatment ct imaging show development multiple peritoneal pulmonary deposit confirm biopsy metastatic osteosarcoma patient receive palliative chemotherapy die month later,"['B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
56yearold african american man initially present diarrhea weight loss painless jaundice subsequently find adenocarcinoma head pancrea initial workup reveal localize cancer evidence distant metastasis undergo pancreaticoduodenectomy complete surgical resection 5 cm moderately differentiate pancreatic adenocarcinoma patient underwent complete surgical resection pathological examination reveal neoplastic invasion resect adjacent organ seven resect lymph node contain cancer t3n1m0 point oncology department recommend proceed adjuvant chemotherapy gemcitabine 1000mgm2 iv day 1 8 15 28day cycle cycle try reduce likelihood recurrence complete cycle total dose chemotherapy present emergency department worsen exertional dyspnea threepillow orthopnea paroxysmal nocturnal dyspnea fatigue physical examination reveal elevated jugular venous pressure jvp 10 cm sternal angle bibasilar rale 2 pitting edema low extremity cardiac auscultation reveal gallop rhythm s3 grade 3 holosystolic murmur precordium chest xray show cardiomegaly mild moderatesize rightside pleural effusion think presentation consistent fluid overload secondary congestive heart failure chf start intravenous iv furosemide partial improvement symptom day twodimensional echocardiography 2d echo perform show leave ventricular ejection fraction lvef 15 20 percent global hypokinesia moderate mitral regurgitation give finding 2d echo absence significant risk factor coronary artery disease cad ischemic cardiomyopathy cmp conclude patient cmp relate recent use gemcitabine patient start carvedilol angiotensinconverte enzyme inhibitor addition diuretics discharge hospital day later euvolemic state point cardiology department recommend stop chemotherapy gemcitabine oncology department advise testing rule ischemia cause cmp opinion chemotherapy gemcitabine option reduce risk recurrence patient week later patient underwent myocardial perfusion imaging mpi show fix small moderatesize inferior wall defect evidence active ischemia ejection fraction ef mpi calculate 17 20 percent severe global hypokinesia patient continue standard heart failure therapy admission hospital chf exacerbation month later respond iv furosemide adjustment heart failure therapy 2d echo repeat month later show improvement systolic function lvef 40 percent poor functional status underlie cmp gemcitabine chemotherapy stop later patient develop recurrence pancreatic cancer refuse chemotherapy decide proceed palliative care exact etiology patient dilate cardiomyopathy remain unclear gemcitabine remain likely culprit temporal relationship symptom initiation gemcitabine chemotherapy lack risk factor ischemic cmp prior history cad finding global hypokinesia 2d echo absence ischemia mpi improvement systolic function discontinuation gemcitabine consistent gemcitabineinduce cardiomyopathy,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
66yearold caucasian woman history hypertension admit hospital recent diagnosis burkitt lymphoma lactate dehydrogenase level high diameter mediastinal mass 10 cm physical examination normal basal electrocardiography ecg show sinus rhythm heart rate 72 beatsminute twodimensional transthoracic echocardiography tte siemens acuson sequoia c512 reveal normal biventricular function lv ejection fraction lvef 60 mild mitral tricuspid regurgitation moderate pericardial effusion risk assessment patient highrisk category undergo rituximabhyperfractionatedcyclophosphamidevincristinedoxorubicindexamethasone rhypercvad chemotherapy protocol laboratory value summarize table 1 receive highdose cyclophosphamide 300mgm2 twice daily 3 day doxorubicin 25mgm2day 2 day rituximab 375mgm2day 1 day dexamethasone 40mgday 4 day vincristine 2mgday 2 day total treatment dose cyclophosphamide doxorubicin receive 1800mgm2 50mgm2 respectively give allopurinol 300mgday perorally sodium bicarbonate 84 10 flaconday infusion 24 hour chemotherapy mesna 600mgm2day 2 day prophylaxis tumor lysis syndrome hemorrhagic cystitis respectively receive granisetron 2mgday lansoprazole 30mgday antiemetogenic gastric prophylaxis respectively patient develop dyspnea seventh day therapy physical examination reveal blood pressure 10060mmhg heart rate 110 beatsminute chest auscultation inspiratory sound hear low zone inspiratory crackle hear middle zone cardiac murmur s3 hear ecg show low voltage limb precordial lead tte show diffusely increase myocardial echogenicity mild pericardial effusion generally impair biventricular systolic function lvef 31 right ventricular midapical akinesis manifest pleural effusion detect druginduced cardiotoxicity myocarditis suspect furosemide ramipril start betablocker therapy patient take hypertension continue 12 day tte show lvef 37 normal right ventricular function dyspnea decrease discharge day 20 1 month tte show normal biventricular function lvef 60 course rhypercvad chemotherapy protocol undergo highdose methotrexate cytarabine cycle severe neutropenia pneumonia cardiac failure symptom chemotherapy course decline course chemotherapy remission despite abbreviate course chemotherapy,"['O', 'O', 'B-SEX', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O']"
29yearold primipara present complaint persistent severe right side upper abdominal pain deep inspiration physical exercise local pressure complaint develop gradually give birth year early pregnancy complicate hellp syndrome subcapsular liver hematoma size 20 cm    5 cm resolve spontaneously current presentation liver function test normal assure having experience sign suggestive sexually transmit disease pelvic inflammatory disease pid undergo intraabdominal intervention upperabdominal magnetic resonance imaging reveal density liver diaphragm site subcapsular hematoma suspect perihepatic adhesion figure 1 refer hepatobiliary surgeon perform laparoscopy confirm presence thick adhesion liver segment vviii diaphragm figure 2 adhesiolysis perform session monopolar diathermia sharp dissection follow instillation 15 l adept 4 icodextrin solution peritoneal cavity prevent formation new adhesion followup year postsurgery free symptom,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
45yearold woman present general practitioner leftsided neck shoulder pain pain mild nonspecific patient history unremarkable deny history smoke excessive alcohol use radiation exposure physical examination demonstrate mild left side cervical lymphadenopathy routine blood test reveal borderline elevate calcium 105 mgdl subsequent work exhibit markedly elevate parathyroid hormone level 286 pgml patient refer otolaryngology evaluation thyroid ultrasound show hypoechoic nodule left low lobe thyroid ct scan neck reveal 2 cm hypodense nodule posterior inferior aspect left low thyroid sestamibi scan show increase uptake low pole left thyroid lobe elevated pth aberrant parathyroid gland imaging suggest primary hyperparathyroidism historically hyperparathyroidism associate bone disease renal stone neuromuscular dysfunction current screening modalitie patient catch early asymptomatic3 primary hyperparathyroidism commonly cause parathyroid adenoma infrequent cause include parathyroid hyperplasia affect gland rarely cause parathyroid carcinoma markedly elevate serum pth calcium level lead severe renal bone manifestation helpful diagnosis cancer usually discover operatively base local invasion metastases3 primary indication parathyroidectomy historically symptomatic patient currently patient catch early new indication surgery include asymptomatic patient follow glomerular filtration rate 60 mlmin bone density tscore 25 site andor previous fracture age 50 serum calcium 10 ngdl upper limit normal3 patient present pain markedly elevated pth young 50 year old decide surgery good choice management patient bring operating room undergo parathyroidectomy surgeon find parathyroid gland firm densely adherent thyroid capsule overlying strap muscle make difficult dissect visible invasion capsule surround muscle regional lymph nod resect speciman note brownish grey colour scatter necrotic foci irregular texture postoperative pathology speciman confirm positive parathyroid carcinoma capsular invasion focal tumour necrosis reactive fibrosis local skeletal muscle invasion figure 1 2 margin resect immunohistochemical stain show increase ki67 reactivity strong bcl1 cyclin d1 reactivity support diagnosis parathyroid carcinoma figure 3 additionally p57 staining negative report parathyroid carcinomas associate marked hypercalcaemia nonfunctione cancer patient tend behave aggressively1 owe severity uncertainty lesion patient follow postoperatively repeat image determine residual tumour remain repeat sestamibi positron emission tomography pet scan reveal residual activity surgical area patient subsequently undergo second operation radical left neck dissection leave hemithyroidectomy patient recover postoperatively 3 year second surgery patient continue follow 3 month monitor serum pth calcium level long report neck shoulder pain patient blood test marginally elevated pth level remain eucalcaemic followup nuclear scan pet scan continue negative patient continue monitor 3 month indefinitely,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
20yearold male cystic fibrosis transfer houston methodist hospital january 2013 evaluate lung kidney transplant patient cystic fibrosis know develop chronic lung infection adapt time unique anatomic niche 14 15 complicated medical history include pancreatic insufficiency liver transplantation 2004 steroidinduced diabetes endstage renal disease testicular cancer long history respiratory infection multidrugresistant bacteria include mrsa treat ceftaroline outside hospital immediately prior transfer houston methodist hospital patient periodically hospitalize january july 2013 treat recurrent respiratory catheterrelate infection cause mrsa multidrugresistant pseudomonas aeruginosa antibiotic exposure include long treatment course agent include meropenem ceftazidime doxycycline vancomycin linezolid cefepime ciprofloxacin inhaled systemic colistin tobramycin shortly readmitte hospital june 2013 mrsa grow culture blood respiratory specimen isolate resistant clindamycin linezolid oxacillin trimethoprimsulfamethoxazole susceptible minocycline rifampin vancomycin blood isolate grow confluently ceftaroline et strip yield mic 32 mgliter additional s aureus respiratory tract isolate available study mrsa isolate patient smallcolonyvariant scv phenotype,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
7yearold boy goldenhar syndrome postnatal genetic diagnosis refer department radiology imaging study temporal bone patient undergo 3dct scan brilliance ct64channel philips medical system amsterdam netherlands employ protocol generate 120 kv current 150 ma slice thickness image 1 mm 05 mm increment image dicom format process pc commercial software obtain threedimensional reconstruction skeletal structure 3dimensional reconstruction skin plan show hypoplasia auricle right consist simple dysmorphic rough left auricle regular dimension morphology atresia right auditory conduit normal left auditory conduit observe upper image show partial ossification cranium typical paediatric age description profile typical ii class convex profile interposition inferior lip reduce neckchin anglefig1 skeletal study mandibular condyle ramus corpus short affected tilting oral rhyme occlusal plane mandibular plane evident number form abnormality find mixed dentition mandibular condyle temporomandibular joint asymmetric particular right condyle deform short wide mandibular condyle dimension 11    7 mm right 14    7 mm leave 3dimensional reconstruction skeleton plane show different morphology right leave hemimandibula mandibular 3dimensional reconstruction show detail shift medial axis hypoplastic right asymmetry right mandibular condyle appear dysmorphic short wide axial coronal scansion figs2 3 study temporal bone show right external auditory canal atresia hypoplasia tympanic cavity pneumatize occupy dense material soft part pneumatization present right mastoid cell leave external auditory canal dimension morphology normal left tympanic cavity normally form totally occupy dense material soft tissue right leave ear present minor hypoplasia auricle bone right agreement resolution instrument normal representation malleus head articulate dysmorphic rough deform incus observe impossible staple left malleus incus visible appear articulate abnormal manner reduce contact surface staple difficult observe regular morphology dimension morphology cochlea semicircular canal vestibulum utriculum unaltered figs47 conclusion 3dct valuation young patient observe asymmetry condyle particular right condyle dysmorphic short wide auricle right external ear hypoplastic dysmorphic rough present right middle ear hypoplastic tympanic cavity right internal ear atresic auditory conduit,"['O', 'B-SEX', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O']"
19yearold woman present lump right breast macrocephaly milimetric papule tongue give cobble stone appearance breast ultrasonography show circumscribe oval masse breast usguided core biopsy perform palpable masse confirm juvenile fibroadenoma biopsy breast followup 6 12 month 3 year surveillance period core biopsy perform time follow usguided vacuumassisted core needle excision surgical excision lesion increase size pathologic result fibroadenoma tubular adenoma atypical ductal hyperplasia adh involve fibroadenoma age 19 year patient undergo neck palpable mass left neck indeterminate nodule reveal thyroid gland followup reveal nodule increase size patient undergo total thyroidectomy pathologic result reveal invasive follicular carcinoma left thyroid follicular adenoma right thyroid fig1a age 21 year visit hospital swelling left cheek head neck ct scan reveal vascular mass left parotid gland extend left forehead external carotid angiography confirm diagnosis avm feeder vessel arise left internal maxillary artery fig1b partial embolization decrease blood flow avm alleviate patient symptom refer genetic counseling suggestion cowden syndrome pten dna sequence test blood sample reveal frameshift mutation c301dupa pi101nfsx6 age 22 year patient present mass increase size increase vascularity left breast usguided vacuumassisted core needle excision reveal ductal carcinoma situ dcis noncomedo type low grade involve fibroadenoma fig1c contrastenhanced breast mri preoperative evaluation demonstrate multiple wellcircumscribe enhance masse breast fig1d masse show high intermediate signal intensity t2weighte image fig1e masse show early rapid enhancement washout kinetic pattern timesignal intensity curve evaluation tend associate malignancy fig1f bilateral prophylactic mastectomy immediate breast reconstruction perform view multiple bilateral breast masse suspicious kinetic feature breast mri high risk breast cancer cowden syndrome surgical histopathology reveal adh involve tubular adenoma residual carcinoma left breast multiple tubular adenoma fibroadenoma intraductal papilloma breast patient family history breast cancer cowden syndrome,"['O', 'B-SEX', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient d 73387 female child bear emergency caesarean section 34 week gestation consanguineous firstcousin british pakistani parent antenatal scan show small gestation weigh 119 kg birth head circumference 267 cm considerably 04th centile induction labour attempt growth retardation fail lead emergency caesarean section apgar score 4 1 min 7 5 min 9 10 min admit neonatal intensive care unit continuous positive airway pressure ventilation hour age develop severe lactic acidosis initial lactic acid concentration 22 mmoll subsequently increase 63 mmoll normal range 0721 mmoll treat intravenous infusion sodium bicarbonate trishydroxymethyl aminomethane tham possible correct metabolic acidosis develop hypoglycaemia hour birth correct intravenous infusion 15 glucose 78 mgkgmin ammonia concentration normal urine organic acid profile show massive excretion lactic acid increase phenolic acid especially hydroxyphenyllactate plasma amino acid show raise concentration alanine glutamine 1567 1369 moll respectively consistent lactic acidosis amino acid mildly increase gross generalised aminoaciduria blood acylcarnitine analysis normal echocardiography show structurally normal heart good ventricular function cranial ultrasound show bilateral intraventricular cyst frontal horn anterior portion lateral ventricle leftsided cyst large 15 mm diameter large cyst right 8 mm diameter choroid plexus hyperechoic irregular suggest previous intraventricular haemorrhage abdominal ultrasound show distended urinary bladder unremarkable severe coagulopathy extended prothrombin time 477 s normal 123166 s low plasma albumin 7 gl normal 3550 gl normal liver function test raise creatine kinase 2700 ul normal 300 ul transfer tertiary centre worsen metabolic acidosis start have seizure 48 h age despite infusion bicarbonate tham acidosis continue worsen muscle skin biopsy perform family agree withdrawal intensive care treatment die aged 55 h document study approve perform ethical guideline issue institution clinical study write inform consent obtain family,"['O', 'O', 'O', 'B-SEX', 'B-AGE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 57yearold woman note rapidly enlarging mass left neck 2010 undergo total thyroidectomy central neck dissection reveal 38 cm anaplastic thyroid cancer arise background oncocytic variant poorly differentiate thyroid cancer fig1a figs1 supplementary appendix 1 available text article nejmorg resection margin positive 3 12 lymph node involve 3 week surgery serum thyroglobulin level 172 ng milliliter undetectable thyroglobulin antibodie patient receive concurrent radiation therapy weekly carboplatin paclitaxel chemotherapy serum thyroglobulin level 4 week completion chemotherapy radiation therapy 120 ng milliliter restage scan obtain 3 month later reveal new rightside hilar mass fig1c patient enrol phase 2 clinical trial everolimus administer dose 10 mg daily 6 month followup scan show lesion greatly diminish size 30 26 cm 11 08 cm fig1d 18 month sustain response everolimus scan reveal progressive disease fig1e patient undergo mediastinoscopy removal enlarged lymph node contain metastatic anaplastic thyroid cancer fig1b figs1 supplementary appendix 1 wholeexome sequence perform biopsy sample pretreatment resistant tumor blood sample,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
46yearold caucasian woman ashkenazi jewish descent present chief complaint severe constant throbbing pain left posterior mandible report pain aggravate chew start month initial consultation visit visual analog scale pain report 710 day visit past medical history remarkable gaucher disease leave hip replacement gall bladder removal herniorrhaphy spleen abscess drainage hepatitis c infection asthma social history significant 20 packyear cigarette smoke family history unremarkable hereditary systemic disease medication include oral antiresorptive drug alendronate early osteoporosis associate gaucher disease 70 mg weekly 2 year calcium supplement loratadine hydromorphone esomeprazole promethazine levalbuterol carisoprodol fluticasone ibuprofen report enzyme replacement therapy ert intermittently year treat gaucher disease diagnose 20 year prior receive intravenous injection twice month ert recount fatigue infusion report receive antibiotic analgesic medication pain month ago helpfulhead neck examination cranial nerve examination vital sign normal limit intraoral examination complete percussion testing vitality testing probe evaluation mandibular posterior tooth region chief complaint leave mandibular molar endodontically treat 3 year prior test nonvital remain mandibular tooth normal vitality testing evaluation opposing nonrestored noncarious tooth internal control gingival tissue jaw noninflame gross evidence plaque calculus periodontal pocket mandible range 4 6 mm significant bony defect mouth dental xray panoramic radiograph take show relatively welldefine radiolucent lesion multiple region mandible bilaterally pseudocystic multilocular appearance conebeam compute tomography confirm finding reveal large lytic lesion left posterior mandible region chief complaint figure 1our clinical radiographic differential diagnosis chief complaint include chronic apical periodontitis radicular cyst central giant cell granuloma keratocystic odontogenic tumor ameloblastoma odontogenic fibroma neuralgianeuropathy mandibular involvement gaucher disease give medical history finding discuss patient write consent obtain surgical biopsy left mandible local anesthesia definitive diagnosis fourcorner gingival flap buccally reflect posterior leave mandible extend canine second molar cortical bone remove surgical bur create window access lesion pathologic soft tissue evident access window entire pathologic soft tissue bone access window submit pathology laboratory histological evaluation histopathological finding reveal infiltration jawbone marrow fibrous connective tissue contain abundant gaucher cell figure 2 evidence abscess neutrophil granuloma malignancy postoperative healing uneventful patient report resolution chief complaint symptomatology 1month followup refer physician consultation evaluation relate gaucher disease status follow finding treat ert 1year reevaluation symptom free oral cavity,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O']"
21yearold man present emergency department rash arm neck figure 1 develop course 36 h discrete pin prick area erythema maculopapular rash vesicle figure 2 cover forearm dorsal aspect hand flexor surface elbow begin develop neck figure 3 describe rash itchy painful feel weather patient previous dermatological medical history note take medication work supermarket handle food item history occupational chemical exposure recently change washing powder personal hygiene product physiological observation entirely normal systemic examination unremarkable close examination rash reveal present skin expose sun wear shortsleeve shirt striking feature v shape patient chest keep neck line polo shirt question patient describe period time 48 h prior presentation 12 h prior development rash spend strimme grass hedge garden blood test include blood count urea electrolyte liver function test creactive protein normal reference range list potential differential diagnosis maculopapular rash long give distribution rash history plant material exposure diagnosis phytophotodermatitis patient discharge chlorphenamine simple analgesia advice wear longsleeve tshirt sunscreen garden future rash resolve period 3 week remain pruritic healing associated pain settle day residual scarring begin fade 2 month presentation,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O']"
77yearold woman dysphagia present twoweek history rash characterize brown plaque erythematous border overlie thick scale involve face prior percutaneous endoscopic gastrostomy peg tube site fig1a c oral conjunctival involvement present receive parenteral nutrition month follow removal peg tube infection differential diagnosis include drug hypersensitivity autoimmune disorder nutritional deficiency rash appearance consistent acrodermatitis enteropathicalike eruption secondary zinc deficiency serum zinc level 12 mcgdl normal 55150 mcgdl rash resolve week parenteral zinc supplementation fig1b d zinc essential protein synthesis wound heal acrodermatitis enteropathica present infancy periorificial desquamative dermatitis result autosomal recessive mutation impair zinc absorption similar syndrome occur nutritional zinc deficiency report setting parenteral nutrition fail include zinc supplementation prompt response supplementation help confirm diagnosis recent national shortage parenteral zinc united states likely contribute patient presentation,"['O', 'B-SEX', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
42 yearold man chronic lymphocytic leukemia underwent allogeneic bone marrow transplant september 2013 graft mismatch single human leukocyte antigen allele dqb1 tcell deplete vivo alemtuzumab engraft day 12 transplant aside persistent lymphopenia diarrhea noroviru infection posttransplant course unremarkable midoctober develop tinnitus rapidly progressive sensorineural deafness result subtotal hearing loss bilaterally 95 db 23 week brain magnetic resonance imaging mri unremarkable cerebrospinal fluid csf analysis 4 leukocytesl 50 neutrophil 50 lymphocyte 6 red blood cellsl glucose 24 mmoll normal range 2247 mmoll protein 61 mgdl normal range 1545 mgl absence oligoclonal band viral polymerase chain reaction pcr testing csf negative enterovirus herpesvirus infection patient treat empirically highdose valacyclovir broadspectrum antibiotic 2 gkg intravenous immunoglobulin ivig despite intervention develop new symptom central dyspnea postural hypotension nausea gradually worsen balance repeat neurological assessment confirm persistent vestibulocochlear dysfunction 6 week symptom onset middecember patient increasingly withdraw irritable intermittently agitate remain lymphopenic lymphocyte 054    106l normal range 1236    106l mri scan brain unremarkable serum testing antineuronal antibody electroencephalogram reveal diffuse encephalopathy give continue suspicion viral etiology patient treat highdose glucocorticoid ivig begin refuse fluid food medication detain uk mental health act repeat mri scanning show interval development new nonenhancing signal abnormality thalami midbrain cranial nerve involvement meningeal enhancement figure 1a near end december frontal lobe biopsy perform histology reveal reactive gliosis diffuse infiltration cd38 lymphocyte figure 1b extensive microbiological testing biopsy tissue infectious etiology negative supplementary table 1 give absence diagnosis patient progressive neurological deterioration csf brain biopsy tissue analyze january 2014 metagenomic nextgeneration sequence ng 2 ng analysis brain biopsy genome assembly situ hybridization reveal finding neuroinvasive astrovirus astv infection despite lack approve therapy patient treat ribavirin ivig respond intervention remain minimally conscious state follow withdrawal sedation march 2014 eventually die end 4 month ngs diagnosis approximately 75 month onset symptom,"['O', 'O', 'B-SEX', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
68yearold man refer optometrist s suspect ltg repeatedly irregular visual field test result advanced optic disc cup normal intraocular pressure iop family history glaucoma patient subjectively feel vision good left eye le normally visual acuity 66 n5 start deteriorate 6 month early point referral well correct 675 n6 right eye know amblyopic visual acuity 618 n12 medical history include considerable risk factor systemic vasculopathy hypertension hypercholesterolaemia 50 packyear smoking type 2 diabetes diabetic retinopathy despite detailed questioning deny new systemic symptom apart experience increase lethargy clinical examination s reveal advanced bilateral cupped optic disc cuptodisc ratio right 09 90 leave 08 80 figure 1 furthermore finding refer optometrist equal reactive pupil normal eye movement iop midteen confirm computerised perimetry show constricted visual field eye albeit considerably raise falsenegative error rate excess 30 figure 2a result poor concentration attention span testing compound especially amblyopic field test repeat 4 week later similar result figure 2b visit patient experience deterioration good le visual acuity measure 624 loss snellen line n36 amblyopic 618 loss snellen line n36 le show depressed colour vision urgent scan patient head orbit request rule compressive lesion blood analysis carry screen cause optic neuropathy include vitamin b12 folate level inflammatory marker mri reveal large mass centre pituitary fossa measure approximately 45 cm51 cm 48 cm figure 3ac extend suprasellar cistern infrasellar sphenoid sinuse optic chiasm optic nerve displace superiorly compress side mass show heterogeneous t1 t2 signal multiple fluid level likely previous haemorrhage lowsignal component suggest calcification appearance probably craniopharyngioma haemorrhagic pituitary adenoma patient refer urgently neurosurgery unit find markedly raise prolactin level great 200 000 miul confirm diagnosis giant prolactinoma cooperation local endocrinology service start cabergoline 500 g dexamethasone 8 mg week lead dramatic improvement patient visual field acuity 618 69 le prolactin level show similar dramatic response level come 336 miul month later visual acuity le 618 65 respectively visual field examination show strike recovery normal result figure 2c,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
8yearold boy refer evaluation fatigue bear term weigh 4 kg nonconsanguineous parent attain normal early developmental milestone height weight 10th 50th centile respectively preliminary examination remarkable hepatomegaly extend 35 cm right costal margin initial laboratory evaluation reveal normochromic normocytic anaemia haemoglobin 78 gdl 11516 mean corpuscular volume mcv 858 fl 7587 mean corpuscular haemoglobin mch 254 pg 2535 marked anisocytosis redcell distribution width rdw 29 11145 hypochromia teardrop evident blood film leucopoenia feature white cell count 29109l 45135 neutrophil 17109l 275 lymphocyte 08109l 154 bone marrow aspirate biopsy reveal hypercellular marrow erythroid hyperplasia iron stain reveal approximately 50 erythroblast ring sideroblast marrow cytogenetic normal include fluorescence situ hybridisation study chromosome 5q 7 8 flow cytometry detect blast population serum copper lead normal blood smear proband parent sister analysis gene responsible hereditary sa alas2 abc7 fech pus1 reveal report pathogenic variant fast lactate elevate 38 mmoll neurological examination identify upper motor neuron sign low limb bilaterally cerebellar sign negative mri brain demonstrate volume loss slight prominence cerebellar folia urine organic acid reveal elevate 3methylglutaconate 3methylglutarate lactatepyruvate ratio elevate 301 muscle biopsy reveal structurally normal muscle biochemical assay respiratory chain component result diagnosis partial complex iv deficiency subsequently commence highfat diet coenzyme q resultant improvement energy analysis mtdna leucocyte muscle utilise pcr reveal deletion carnitine vitamin thiamine pyridoxine folate uridine supplement improvement anaemia haemoglobin level fall 44 gdl lead occasional regular threeweekly red cell transfusion repeat transfusion ferritin rise 1700 gl necessitating iron chelation peak growth hormone cortisol insulininduced hypoglycaemia 309 mul normal 20 447 nmoll normal 500 respectively age 13 year thyroid function normal repeat peak cortisol 384 nmoll follow adrenocorticotropic hormone acth stimulation plasma renin activity elevate 15 ngmlh adrenal androgen low limit assay detection urinary steroid profile qualitatively normal abdominal ultrasound hydrocortisone 5 mg twice daily fludrocortisone 100 g daily initiate adrenal autoantibody 21hydroxylase negative verylongchain fatty acid normal patient recently develop renal tubular fanconi syndrome include glycosuria hypokalaemia hypophosphataemia low maximal tubular reabsorption phosphate generalised aminoaciduria addition incidentally note hyperglycaemia admission percutaneous endoscopic gastrostomy insertion glycate haemoglobin elevate 62 mmolmol 78 despite rapid red cell turnover pancreatic autoantibody negative glutamic acid decarboxylase antiinsulin antiislet antigen 2 pancreatic islet cell antibodie maintain twice daily insulin detemir satisfactory glycaemic control fructosamine 161 moll 205285,"['O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
71yearold africanamerican woman present hospital worsen exertional dyspnoea associate orthopnoea low extremity oedema 3 week longstanding history hypertension document g6pd deficiency prior episode haemolysis cigarette smoker family member g6pd deficiency hypertension diabete mellitus vital sign measurement reveal blood pressure 15073 mm hg pulse rate 70 bpm respiratory rate 24 breathsmin temperature 366c 97 saturation room air comfortable rest physical examination show distend jugular vein inspiratory crackle bilateral lung basis laterally displace apical impulse bipedal oedema ecg show leave ventricular hypertrophy inferolateral twave inversion chest radiography reveal cardiomegaly mild pulmonary oedema metabolic panel troponin level normal btype natriuretic peptide increase 8265 pgml echocardiography show dilate left ventricle ejection fraction ef 30 mild right ventricular systolic dysfunction coronary artery catheterisation reveal normal coronary circulation ethacrynic acid 50 mg daily choose diuresis improve day dyspnoea add spironolactone subsequently metoprolol succinate losartan include regimen repeat chest radiography show resolution pulmonary oedema patient laboratory result hospital stay sign haemolysis worsen kidney function develop ototoxicity discharge home asymptomatic,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS']"
65yearold woman present complaint right upper quadrant pain year prior patient incidentally diagnose idiopathic bcs health checkup doppler ultrasound examination show obstruction middle leave hepatic vein investigation underlying thrombophilia unremarkable treat warfarin maintain international normalize ratio 2 3 discontinue 1 year noncompliance patient consult doctor 2 year remain asymptomatic past 3 year recently start experience steadily worsen intermittent pain right upper quadrant abdomen associated alleviate factor physical examination notable mild right upper quadrant tenderness laboratory test reveal mildly elevate bilirubin 22 mgdl albumin deficit 238 gdl childpugh cp score 8 model endstage liver disease meld score 11 rotterdam score 015 bcstips prognostic index bcstips pi score 63 contrastenhanced compute tomography ct scan show nonvisualized middle leave hepatic vein hepatomegaly hypertrophy caudate lobe splenomegaly hepatic venous collateral saccular aneurysm locate extrahepatic portal vein main branch measure 32 cm height 25 cm    24 cm diameter figure 1a aneurysm think associate bcs precede history trauma present doppler examination perform 3 year previously patient ascite variceal bleed decision create tip relieve hepatic venous outflow obstruction increase pain concern complication aneurysm size direct approach aneurysm consider risk associate complication setting portal hypertension stentgrafting consider concern patency setting hepatic venous outflow obstruction underlie thrombophilia inform consent obtain patient bring interventional radiology suite procedure perform patient conscious sedation portal vein access obtain right hepatic vein fluoroscopy portography show saccular aneurysm locate main portal vein extensive intrahepatic portal vein thrombosis small splenorenal varix figure 2a 10 mm diameter expand polytetrafluoroethylene eptfe cover stentgraft fluency plus bard peripheral vascular tempe arizona united states deploy liver parenchymal tract deploy stentgraft main portal vein trunk cover aneurysm neck consider obstruct blood flow portal vein branch completion portography show widely patent shunt markedly decrease aneurysm filling figure 2b portosystemic pressure gradient ppg decrease 19 mmhg 8 mmhg patient recover uneventfully complete resolution abdominal pain 2 d discharge longterm warfarin remain asymptomatic 1 year followup recent laboratory test reveal normal liver function doppler examination perform 1 3 6 12 mo postprocedure confirm patent shunt cp score 5 meld score 8 rotterdam score 012 tipsbc pi score 61 ct scan show aneurysm decrease size 24 cm height 20 cm    19 cm diameter 3 mo tip figure 1b decrease 19 cm height 16 cm    15 cm diameter 1 year figure 1c,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
present case 66yearold female patient significant past medical history present chest pain treat antacid primary care physician day present emergency room electrocardiogram reveal posterolateral st elevation myocardial infarction patient immediately take catheterization lab successful percutaneous intervention perform acutely occlude large ramus intermedius vessel supply large portion lateral wall figure 1 patient initially hour later suddenly go cardiogenic shock intraaortic balloon pump place echocardiogram demonstrate severe mitral regurgitation ruptured papillary muscle figure 2 patient maximal support deteriorate rapidly progressive acidosis oliguria florid pulmonary edema spite high risk decide intervene surgically operating room transesophageal echocardiography confirm severe mitral regurgitation ruptured anterolateral papillary muscle small left atrium shortly patient cardiopulmonary bypass acidosis resolve begin urine excellent visualization mitral valve obtain vertical transseptal approach right atrium valve carefully inspect necrotic rupture anterolateral papillary muscle see figure 3 large chunk muscle attach a1 chordal apparatus anterior leaflet mitral valve excise keep posterior leaflet intact 27 mm st jude epic bioprosthesis insert figure 4 place extracorporeal membrane oxygenation successfully wean 3 day later follow remarkable early recovery month later prior discharge expire develop pneumonia progress sepsis multiorgan failure,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE']"
patient 68yearold woman chronic obstructive pulmonary disease history gastroesophageal reflux disease esophageal disorder find progressive solitary pulmonary nodule 113 cm right low wedge resection perform december 2011 university iowa pathology department identify tumor lcnec approximately month operation patient start having slowly progress dysphagia solid liquid positron emission tomography pet scan perform 2012 year post surgery unremarkable recurrence metastasis repeat compute tomography ct june 2013 18 month post surgery recurrence figure 1 patient esophagogastroduodenoscopy egd barium swallow reveal stricture esophagus failure primary secondary peristaltic wave reflux july 2013 esophageal manometry find failure low esophageal sphincter relax residual pressure 32mmhg patient treat calcium channel blocker partial relief far 18 month post resection patient able maintain weight basic laboratory parameter include hemoglobin albumin cholesterol level january 2014 report worsen dysphagia weight loss 10 lb period month refer center treatment achalasia repeat esophageal manometry show elevated low esophageal sphincter pressure 50mmhg nonpropagative nonperistaltic contraction esophageal musculature figure 2 repeat egd intention perform therapeutic pneumatic dilation show nearly circumferential ulcerated fungating mass approximately 36 cm extend gastroesophageal junction 39 cm biopsy reveal lcnec similar feature primary tumor resect 2011 conclude metastasis subsequently repeat ct scan reveal progressive diffuse metastatic disease patient undergo course chemotherapy die disease month,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
woman early 70 present emergency room 30 min husband expire 810 substernal chest pain concurrent diaphoresis dyspnoea patient husband outofhospital cardiac arrest early day bring emergency room subsequently admit coronary care unit recurrent ventricular fibrillation successfully resuscitate patient medical history include hypertension hypothyroidism deny having similar episode pain regular appointment primary care physician medication include oral furosemide 20 mg levothyroxine 100 g daily deny allergy presentation patient afebrile blood pressure 10555 heart rate 93 bpm respiratory rate 20min oxygen saturation 98 room air physical examination significant distress pain skin warm moist minimal crackle bilateral basis regular rate rhythm 26 systolic murmur apex radiation rub elevate jugular vein distention 8 cm strong peripheral pulse peripheral oedema abdoman soft nontender nondistende bowel sound patient alert orient focal neurological deficit complete blood count basic metabolic panel coagulation test normal limit cardiac enzyme increase troponin 259 ngml normal range 00150045 ngml creatine phosphokinase 84 ul normal range 26192 ul ecg admission reveal normal sinus rhythm 23 mm st segment elevation lead v2v3 q wave lead v1v3 suggestive anterior wall infarct figure 2 echocardiogram reveal leave ventricular ejection fraction 3035 mild concentric leave ventricular hypertrophy akinesis apex 23 inferoseptum apical inferioranterior wall segment suggest ischaemic damage left anterior descend artery distribution versus takotsubo cardiomyopathy figure 3 4 patient receive aspirin 162 mg prasugrel 60 mg take cardiac catheterisation laboratory angiogram show nonobstructive coronary artery disease luminal irregularity figure 5 6 left ventriculography show ejection fraction 35 akinesis apical wall hyperkinesis basal segment figure 7 8 patient remain haemodynamically stable start oral heart failure medication include lisinopril 25 mg daily metoprolol tartrate 125 mg time day pain shortness breath resolve discharge home 48 h hospitalisation stable condition repeat echocardiogram 2 month later show resolution cardiomyopathy ejection fraction 6570 normal left ventricular motion,"['B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
36yrold previously healthy sri lankan male take care horse present medical casualty ward fever arthralgia myalgia day complain mild dysuria normal urine output chest pain shortness breath inquiry reveal treat leptospirosis febrile illness past examination patient afebrile anicteric blood pressure 9060 mmhg pulse rate 76 bpm rest examination unremarkable initial investigation perform day admission reveal neutrophil leukocytosis mild thrombocytopaenia microscopic haematuria table 1 renal function liver enzyme normal limit urine analysis reveal pus cell 05    06 hpf red cell 30    35 hpf crp creactive protein 75 mgdl clinical diagnosis leptospirosis start intravenous penicillin addition adequate hydration second day illness develop hypotension tachycardia dyspnoea ecg reveal sinus tachycardia st depression lead v4    v6 figure 1 cxr chest x ray show gross cardiomegaly bilateral pulmonary shadow figure 2 cvp central venous pressure 16 cmh2o 2d echocardiogram reveal dilatation chamber severe global hypokinesia ejection fraction 20 troponin 1277 ngml normal range    040 diagnose early severe myocarditis patient transfer icu intensive care unit need inotropic support intravenous antibiotic include penicillin meropenem levofloxacin continue patient electively ventilate 3rd day illness severe respiratory distress day develop rapid atrial fibrillation figure 3 unresponsive digoxin intravenous amiodarone platelet count drop 10    103 l give platelet transfusion prevent bleeding table 1 start intravenous methylprednisolone base previous study show mortality benefit severe leptospirosis complicate myocarditis 11 serum creatinine increase 362    moll 5th day illness alt alanine transaminase ast aspartate transaminase markedly elevate 2726 ul 7438 ul respectively dengue mycoplasma infection exclude blood culture negative leptospira igm antibody perform 5th day illness positive igg negative patient develop refractory shock die persistent ventricular tachycardia despite optimal treatment icu,"['O', 'O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
35yearold woman present ear nose throat outpatient department headache block leftsided nasal canal epistaxis 2 year medical history reveal secondary amenorrhoea past 19 year regression secondary sexual characteristic galactorrhoea physical ophthalmological examination normal limit nasal examination reveal leftsided choanal mass mass bleed palpation imaging advise prior perform biopsy mri head show sellar infrasellar mass extend nasopharynx figure 1 patient refer endocrinologist hormonal investigation serum prolactin high7443 gl n20 pituitary hormone normal limit final diagnosis giant prolactinoma patient prescribe cabergoline 025 mg twice week associate risk explain advance,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
38yearold woman present emergency department severe abdominal pain history drug use constipation say intermittent bloody diarrhea physical examination reveal rebound tenderness guard abdomen stool microscopy negative amoeba trophozoite parasite fecal occult blood find sedimentation 27 mms crp nephelometry 656 mgl normal range 05 antinuclear antibody 04 008 negative antid dna 10 20 negative white blood cell count 1498 normal range 410 hemoglobin level 109 neutrophil count 1314 platelet count 473 100300 urea level 17 mgdl bun level 794 mgdl creatinine level 056 mgdl ast 20 ul alt 24 ul hiv negative abdominal ultrasound scanning show free fluid right paracolic perihepatic left paracolic gutter pelvis detection airfluid level free air diaphragm erect abdominal xray emergency laparotomy perform operation multiple perforation area find sigmoid colon descend colon transverse colon wide resection transverse colon descend sigmoid colon resection undertake figure 1 pathergy test positive patient recurrent oral genital aphthous ulcer 45 time past year eye examination result normal computed tomography reveal extensive thrombus inferior vena cava extend right middle hepatic vein figure 2 patient receive corticosteroid anticoagulant immunosuppressive therapy patient alive healthy 53 week later figure 3 macroscopy transverse colon 50 cm sigmoid descend colon specimen 27 cm length specimen colon segment 4 cm diameter perforation area evident serosal surface colonic wall bowel mucosa edematous hyperemic plicae regular course 3 roundish punchedout perforation transverse colon 4 descending sigmoid colon somewhat separate colonic wall large 2 cm diameter figure 4 multiple ulcer large 1 cm diameter different location merge somewhat separate surround mucosa certain limit cover exudate surround hyperemic region macroscopic lymph node serosa numerous sample take ulcerated perforate region normal mucosa sample submit routine microscopic tissue followup hematoxylineosin tissue giemsa passtaine slide prepare examination microscopic examination neutrophil leukocyte lymphocyte reaction wall lumen arteriole venule perforated ulcerated lesion figure 5 and66 wellorganize thrombi intimal proliferation vessel figure 7 and88 mark acute peritonitis surface epithelium colonic crypt regular colonic mucosa apart ulcerated perforate lesion sample free parasite egg,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 38yearold caucasian man spanish origin height 165 cm parent cousin parent normal height show minor anomaly evc syndrome spectrum patient healthy sister morphological feature normal mouth opening miss low incisor fig1 b small chest determine cardiothoracic examination c disproportionately short extremity additional postaxial digit hand fig2 sensorymotor deficit note patient present mild mental retardation genetic analysis early infancy show previously report homozygous nonsense mutation c1195 c1 t parg399x evc2 result loss function protein5 parent heterozygous carrier mutation 1998 patient undergo successful ostium primum atrial septal defect closure midsternotomy represent embolic cerebral ictus 2007 cavotricuspid isthmus ablation common atrial flutter perform successfully aftereffect routine examination 2012 highpitche systolic murmur discover electrocardiography show sinus rhythm hemiblock right bundle branch block echocardiography reveal dilated hypertrophic left ventricle abnormality produce flow direct left atrial appendage lead severe mitral valve regurgitation patient systolic pulmonary artery pressure 50 mmhg aortic valve normal medical treatment include ramipril duloxetine alprazolam acenocumarol patient schedule mitral valve surgery operating theatre patient right femoral artery cannulate right thoracotomy perform fourth intercostal space bicaval cannulation establish vein exclude operation normothermic cardiopulmonary bypass crossclampe aorta beat heart avoid air embolisms continuous carbon dioxide co2 field flooding apply carbonaid co2 diffuser cardia innovation ab stockholm sweden attempt perform mitral valve repair unsuccessful bileaflet mechanical valve no29 implant complication associate anaesthesia occur patient postoperative recovery uneventful discharge postoperative day 10 year followup echocardiography reveal optimal function mitral valve decrease systolic pulmonary artery pressure 30 mmhg,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
march 2009 21yearold man admit institution symptom intermittent fever headache polyarthralgias skin rash trunk petechia finger palm patient previously healthy history drug abuse take regular medication pet travel recently usual state health month admission intermittent high fever develop maximum axillary temperature 39 c addition report headache bilateral symmetric arthralgia wrist hand inflammatory pattern petechia palm finger salmoncolore rash trunk nausea vomit evanescent salmoncolore rash observe chest abdoman 2 mm petechia cover palm finger sign suggest arthritis lymphadenopathy hepatosplenomegaly blood testing show elevated inflammatory marker table ii electrocardiographic ecg chest radiographic result normal ibuprofen 1200 mgd acetaminophen need begin provide symptomatic relief extensive evaluation perform include blood culture viral bacterial serologic study immunologic screen rheumatoid factor antinuclear antibody compute tomographic ct study chest abdomen pelvis cranium significant change find transthoracic echocardiogram tte show circumferential mild pericardial effusion maximal diameter 8 mm sign tamponade relevant finding day later dyspnea diffuse chest pain develop pain relieve chest anteflexion aggravate deep inspiration lie supine patient hypotensive tachycardic hyperpneic manifest jugular venous distention ecg show sinus tachycardia diffuse stsegment elevation fig1 chest radiograph reveal enlarged cardiac silhouette fig2 inflammatory marker elevate table ii repeat tte show increase pericardial effusion maximal diameter 12 mm fig3 collapse right heart chamber emergency pericardiocentesis drain 60 ml serosanguineous fluid repeat ct chest abdomen reveal mild right severe left pleural effusion mild ascite thoracocentesis perform 350 ml serosanguineous pleural fluid drain heart lung fluid exudate yield negative microbiologic examination unremarkable histologic analysis diagnosis aosd establish patient medicate prednisone 05 mgkgd major clinical laboratory improvement table ii stsegment normalization followup echocardiogram show mild pericardial effusion 23 mm hemodynamic compromise screen autoimmune infectious disorder repeat significant change find patient discharge hospital regimen prednisone recurrence pericardial pleural effusion 2 month discharge corticosteroid weaning withdrawal resolve resume prednisone therapy month discharge patient present institution followup visit asymptomatic maintain corticosteroid therapy followup ecg tte show significant change figs4 5,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
11yearold boy present history headache vomiting present month physical examination show papilledema presence neurological deficit magnetic resonance imaging mri reveal large prepontine mass dorsal displacement brainstem secondary obstructive hydrocephalus compression aqueduct lesion inhomogeneous hypointense aspect t1weighte image t1wi inhomogeneous hyperintense aspect t2weighte image t2wi administration iv gadolinium inhomogeneous enhancement fig1 compute tomography ct imaging show bone involvement operation ventriculoperitoneal shunt insert right lateral ventricle treat hydrocephalus careful study mri suggest infra supratentorially locate tumour resect single approach left frontotemporal transsylvian approach perform gain access tumour tumour welldefine margin entirely locate intradural plane attachment cranial nerve brainstem macroscopic complete resection perform postoperatively patient develop left oculomotor nerve palsy completely recover 4 week postoperative mri show complete removal tumour fig2 careful consideration multidisciplinary team decide indication postoperative radiation therapy followup half year later patient find remain asymptomatic sign tumour recurrence mri scan followup 6 year treatment sign tumour recurrence mri scan histological examination show slightly lobulate tumour consist chondromyxoid matrix tumour cell show vacuolated pale cytoplasm moderate nuclear polymorphism observe obvious mitotic activity fig3 calcification see tumour cell stain positive pankeratin s100 epithelial membrane antigen ema finding suggest histopathological diagnosis chordoma,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE']"
25yearold female patient notice leftsided visual loss amenorrhea 2 year prior see right hemiparesis develop 6 month aggravate symptom droop corner right lip bilateral temporal hemianopia finally prompt hospitalization time massive 5 cm tumor intra suprasellar location exclude mesencephalon backward see computerized tomography ct head fig1a testing reveal exceedingly highserum level prolactin prl 4408 ngml level pituitary hormone reference range growth hormone gh 050 ngml luteinize hormone lh 260 miuml folliclestimulating hormone fsh 457 miuml adrenocorticotropic hormone acth 374 pgml thyroidstimulate hormone tsh 268 iuml t1weighte magnetic resonance mr image contrast gadolinium show homogeneous tumor enhancement adjacent tissue edematous t2weighte view mass regress despite 4week course dopamine analog cabergoline 1 mgweek serum prl level 2207 ngml remain elevated relative status admission right lateral ventricle enlarge somewhat obstruction foraman monro fig1b light intransigence surgical debulking tumor elect craniotomy transsphenoidal approach harden elastic quality tumor strong attachment neighboring structure prevent complete removal related mass effect significantly reduce serum prl level decline 250 ngml step procedural stage normalization prl level achieve administration cabergoline increase 05 mgday residual tumor show evidence regrowth distant metastasis 1 year surgery histopathologically hematoxylin eosin hestaine section specimen second surgical procedure similarly compose polygonal spindle cell round oval elongate nucleus eosinophilic cytoplasm fig2ac cell form irregular nest short fascicle accompany frequent hyaline change vessel wall vacuolation fig2d nuclear pleomorphism prominent hand high mitotic rate necrosis evident fig2b c conspicuous fibrous change tumor stroma note focally fig3a chromophobic nature tumor cell confirm pearse periodic acid schiff pas stain fig3b immunostain show strong diffuse positivity prl fig3c chromogranina synaptophysin hormone gh tsh acth lh fsh express tumor cell marker include s100 protein fig3d glial fibrillary acidic protein gfap epithelial membrane antigen ema cytokeratin ae1ae3 ck ae1ae3 vimentin p53 bcl2 negative immunostaine ki67 labeling index approximately 2    final diagnosis prlproduce pituitary adenoma reach consider immunohistochemical profile suprasellar location prolactin production tumor absence metastatic foci invasion surround tissue,"['O', 'B-SEX', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
62yearold male present 15day history dyspnea exertion associate low extremity edema admission suffer abdominal bloating tasteless year noticeable body weight loss time 20 kg past 6 month develop multiple system disorder include painless paresthesia low limb erectile dysfunction chronic diarrhea average stool frequency time day obvious blood mucus abdominal pain tenesmus unfortunately previous stomach rectum biopsy examine accumulation amyloid fibril protein family history unremarkable physical examination blood pressure 8256 mmhg heart rate 52 bpm significant jugular venous distention moderate hepatomegaly low extremity edema note neurological examination reveal weakness muscular atrophy bilateral tibialis anterior gastrocnemius hyporeflexia note knee ankle sensory examination reveal diminish tactile pain sensation stocking glove pattern vibratory sensation distally reduce low limb motor sensory function upper extremity relatively spare initial laboratory datum include blood count transaminase creatinine electrolyte cardiac troponin thyroid function normal negative nterminal fragment probrain natriuretic peptide ntprobnp 3996 pgml nerve conduction study confirm bilateral sensorymotor neuropathy table 1 electromyography study demonstrate active denervation chronic reinnervation change tibialis anterior gastrocnemius electrocardiogram ecg reveal sinus rhythm low voltage limb lead qs wave precordial inferior lead firstdegree atrioventricular block prolong qtc figure 1 twodimensional echocardiography reveal mark concentrically thicken speckle appearance ventricular wall biatrial dilatation leave ventricular ejection fraction 70 figure 2 doppler reveal severe restrictive mitral filling pattern ea ratio 21 coronary angiography finding normal combine occurrence low qrs voltage ecg ventricular thickening sign diastolic dysfunction strongly suggestive cardiac amyloidosis follow serum    lightchain concentration 1763 normal range 5981329 mgdl    lightchain concentration normal rectum biopsy confirm amyloid infiltrate figure 3 diagnosis al amyloidosis establish despite chemotherapy administration melphalan dexamethasone immunomodulator lenalidomide supportive therapy include montmorillonite decrease diarrhea lowdose furosemide alleviate fluid retention patient continue deteriorate die home 3 month initial diagnosis,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O']"
56yearold man present 2year history dysphagia diagnose middle thoracic oesophageal squamous cell carcinoma gastroscopy biopsy chest compute tomography ct scan show enlarged azygos vein diameter 25 cm continuation ivc fig1a b ct scan abdoman show defect suprarenal segment inferior vena cava direct drainage hepatic vein right atrium consultation thoracic surgery department clinician anaesthesiology department decide perform mckeown oesophagectomy patient anaesthetise doubleluman tube undergo standard posterolateral thoracotomy traditional open surgery perform jugular femoral vein percutaneous puncture create venovenous bypass connect pressure sensor system monitor monitor display realtime pressure value jugular vein femoral vein macroscopically diameter azygo arch approximately 25 cm fig1c superior edge tumour adhere tightly arch azygos vein arch azygo vein pull rubber hose dissociate carcinoma monitor show femoral vein pressure increase 52 mmh2o pressure return normal value open bypass femoral vein jugular vein fig2 surgery perform smoothly injury azygo vein postoperative recovery uneventful pathology resect speciman show poorly differentiate squamous cell carcinoma evidence malignancy 15 lymph node 5 month followup patient asymptomatic evidence recurrent disease clinically ct,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O']"
55yearold woman refer hospital suspicion mediastinal tumor incidentally find medicalcheckup plain xray photography xp figure figure1a1a chest mri reveal 3 cm diameter tumor connect right lobe thyroid project mediastinum figure 1b 123iri unusual accumulation detect figure 1c fine needle aspiration biopsy view gold standard diagnosis case try reach conclusive diagnosis 18ffdgpet perform high accumulation reveal standardized uptake value suv 38 figure 1d possibility malignancy exclude right lobe excision procedure thyroid gland enforce obtain tumor continuous right lobe expect surface flat smooth exfoliation circumference organization easy figure 2a microscopically encapsulate tumor consist atypical largesize follicle malignant characteristic background thyroid tissue show remarkable change figure 2b histological diagnosis follicular thyroid adenoma ethical approval think necessary clinical course case completely usual medical care informed consent give case occasion diagnostic examination therapeutic procedure,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
65year old female admit progressive dysphagia 2 month 5 kg weight loss past medical history significant osteoporosis treat calcium lactate tablet daily 5 year upper gastrointestinal endoscopy describe 4 cm whitish firm mass middle esophagus fig1 semicircumferential deep ulcer irregular border opposite mucosa fig2 endoscopy pedicle identify handle polipectomy snare esophageal mass upper gastrointestinal series gastrografin fig3 reveal ovoid lacunar image distal esophagus esophageal inhomogeneous calcification smooth contour peristalsis image mobile pedicle identify esophageal luman enlarge diverticula development posterior wall computer tomography thorax exclude pedunculated tumor describe intraluminal calcify esophageal mass fig4 biopsy obtain esophageal ulcerated mucosa reveal inflammatory cell malignancy base endoscopic imagistic result bezoar suppose develop esophageal diverticula subsequently ulcerated mucosa esophageal mass remove endoscopic snare piece fragmentation physically possible macroscopic appearance reveal 4 cm globular mass heterogeneous dense whitish place harsh yellow foci likely dystrophic calcification macroscopic examination cross section reveal light gray aspect fibrous appearance include multiple harsh yelloworange structure difficult section fig5 mass immerse trichloracetic acid decalcification microscopic examination reveal hyaline fibrous tissue fig6a stain green tricrom mason fig6b numerous crystalline basophil deposit mineral rare fibrocyte vessel presence capillary structure rare fibroblast collagen fiber bring discussion mesenchymal originate mass likely fibrovascular polyp definitive histological diagnosis possible pedicle identify presence connective tissue suggest previous presence pedicle lesion long term calcium tablet intake explain calcification process develop vascularconnective tissue reveal histology numerous crystalline basophil deposit mineral month later patient asymptomatic endoscopy reveal enlarged esophagus appearance esophageal mucosa normal ulceration diverticula identify motility disturbance find esophageal manometry base clinical course history calcium lactate intake histological appearance diagnosis esophageal benign mesenchymal originate mass probably fibrovascular polyp autoamputate calcify formulate,"['O', 'O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
58yearold man past medical history poorly control hypertension type 2 diabete present icu cardiogenic shock complicate acute myocardial infarction physical examination reveal reduce level consciousness glasgow coma scale 1015 weak vital sign blood pressure 8050 mmhg 80 oxygen saturation capillary blood glucose 226 gl heart rate 125 bpm crackling pulmonary auscultation cardiovascular examination show cardiac murmur sign right heart failure ecg admission show normal sinus rhythm heart rate 125 bpm extended stelevation anterior territory laboratory result demonstrate troponin level 641 ngml creatinine kinase ckmb 67 uil lactate deshydrogenase 281 uil glucose level 270 gl urea 040 gl creatinine 186 mg    l patient intubate sedated inotropic agent start norepinephrine 04gkgmin dobutamine 20gkgmin chest xray show diffuse alveolar syndrome transthoracic echocardiography reveal wall motion abnormality extensive akinesis anteroseptal anterior lateral inferior wall severe left ventricular systolic dysfunction ejection fraction 29 medical management initiate anticoagulant therapy acute coronary syndrome start 500 mg acetylsalicylic acid subcutaneous lowmolecularweight heparin 06ml enoxaparin patient prepare myocardial revascularization coronary angioplasty nonimprovement neurological status occurrence seizure brain ct indicate reveal infratentorial diffuse hemorrhage fisher grade iii figure 1 cerebral angiography confirm dissecting aneurysm anastomotic branch leave pica v4 segment leave vertebral artery figure 2 successfully embolize 24 hour patient improve withdrawal vasoactive drug 24 hour leave hemicorporeal seizure persist despite anticonvulsant treatment control brain ct report rebleeding angiography show complete exclusion aneurysm eeg reveal diffuse brain damage 10 day admission patient discharge stable condition suffer amnesia,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE']"
53yearold male patient go hospital chief complaint massive gum bleed 1 day patient history chronic hepatitis c pegifn2a 180 g plus ribavirin 1200 mgday prescribe patient march 17 2014 deny autoimmune condition treatment baseline virological datum reveal high virus load hcv rna 21    106 iuml genotype 1b rapid virological response achieve fourth week hcv rna 212    106 iuml partial early virological response hcv rna 103 iuml week 12 delay virological response hcv rna 15 iuml week 24 note fatigue anemia depression syndrome progress 30th week patient request stop treatment week 36 viral load endoftreatment eot undetectable platelet count eot 92    103 cellsl elevate 159    103 cellsl 1 week later week follow eot patient develop massive gum bleed physical examination show multiple petechia extremity sign intracerebral hemorrhage gastrointestinal bleeding internal bleeding initial platelet count 4    103cellsl coagulation profile show normal prothrombin time activate partial thromboplastin time fibrinogen ddimer fibrin degradation product peripheral blood smear show fragmented red blood cell helmet cell abnormal platelet aggregation concomitant autoimmune connective tissue disease systemic lupus erythematosus cryoglobulinemia exclude negative antinuclear antibody cryoglobulin positive anticardiolipin igg 116 gpl normal range 20 gpl antiphospholipid igg 165 u normal range 15 u antiphospholipid syndrome exclude previous thromboembolic event accord 2006 sapporo criteria12 bone marrow biopsy perform reveal hypocellular marrow cellular distribution evidence lymphoid neoplasia potential drug cause platelet lysis rule blood transfusion platelet perform poor response rapid decline platelet count day transfusion diagnosis immune thrombocytopenic purpura start intravenous methylprednisolone therapy 40 mg 3 time daily november 27 combine platelet transfusion treatment show significant improvement azathioprine 100 mg oral daily add december 3 hydroxychloroquine 400 mg oral daily prescribe positive antiphospholipid antibodie platelet count gradually increase 93    103 cellsl 17 day admission methylprednisolone change oral form slowly taper december 15 patient discharge stable condition platelet count elevate 117    103 cellsl figure 1 follow laboratory datum 5 month reveal sustained virologic response platelet count 150    103 cellsl decrease anticardiolipin igg 305gpl antiphospholipid igg 7321 u level,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
66 year old patient history uc treat mesalazine 5 year consult july 2012 painful erythematous swelling right hand bacteriological sample negative lesion consider abscess patient treat antibiotic local antiseptic improvement evolution characterize appearance erythematous vesiculobullous centrifugal expansion take right hand treat time antibiotic unsuccessfully biopsy lesion initially specific october 2012 patient hospitalize fever polyarthralgia context impaired general condition quiescent uc disease skin examination find erythematous plaque 10 cm diameter raise border vesicule take right hand wrist figure 1 infiltrate erythematous plaque right leg figure 2 top large pustule left ankle figure 3 biology biological inflammatory syndrome high leukocytosis neutrophil hepatic renal function normal skin biopsy show edge closet right hand ulcerated epidermis dermis infiltrate rich neutrophil leukocytoclastic vasculitis find pg figure 4 biopsy take infiltrate erythematous plaque ankle show normal appearance skin edema superficial dermis base infiltrate rich neutrophil vasculitis confirm diagnosis ss figure 5 corticosteroid treatment start prednisolone dose 1mgkgj evolution mark day 7 treatment desinfiltration plaque figure 6 recovery general condition disappearance biological inflammatory syndrome,"['B-AGE', 'I-AGE', 'I-AGE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
35yearold woman admit 5day history increase drowsiness fatigue personality change generalised weakness deteriorate mobility medical history include 10year history schizoaffective disorder lithiuminduce diabetes insipidus hypothyroidism medication include sodium valproate 1 g twice daily carbamazepine quetiapine lithium admission patient drowsy difficult rouse sleep night afternoon glasgow coma scale gcs 1415 abbreviate minimental test score 610 note slow response neurological examination show reduce power low limb 345 pyramidal distribution brisk reflex intact sensation modality cardiovascular respiratory gastrointestinal examination unremarkable demonstrable feature hepatic disease routine biochemistry unremarkable patient alanine transaminase 7 ul 115 alkaline phosphatase 61 ul 30130 glutamyl transferase 17 ul 45 bilirubin 6 moll 21 normal serum b12 folate level normal thyroid function test serum lithium level therapeutic range serum ammonia 47 moll 112354 valproate concentration elevate 140 mgl 50100 brain imaging include ct mri haemorrhage intracranial mass lumbar puncture demonstrate clear cerebrospinal fluid white cell count 1106l protein 025 gl 0204 eeg demonstrate mild variable slowing irregularity background activity likely medication differential diagnosis include encephalitis guillainbarr syndrome acute disseminate encephalomyelitis adem exclude investigation view raise valproate ammonia level diagnosis valproate hyperammonaemic encephalopathy vhe point dose sodium valproate reduce half completely withdraw complex challenging nature manage patient schizoaffective disorder 3 day evident clinical improvement mental status patient able sit communicate team abbreviate mental test score improve 1010the serum ammonia normalise valproate level decrease therapeutic range 4 day discharge home result investigation urea cycle await week postdischarge patient clinically stable term mental functioning having episode confusion drowsiness continue fatigue walk difficulty residual leg weakness result serum amino acid reveal patient carnitine deficiency evident low acylcarnitine low free serum carnitine 142 moll normal range 2352 low total serum carnitine 199 moll normal range 2763 start oral carnitine 1 g twice daily 2 week symptom resolve completely normalisation serum carnitine level free carnitine 252 moll total carnitine 413 moll sodium valproate initially stop completely relapse patient schizoaffective disorder restart valproate 1 g daily longterm carnitine supplement,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
50yearold male patient admit department thyroid nodule right neck incidentally detect carotid doppler ultrasound scan fineneedle aspiration cytology fnac show follicular lesion time evaluation patient good health medical history reveal hypertension vitiligo celiac disease physical examination small nodule 1 cm palpable right thyroid lobe enlarged neck lymph node palpable neck ultrasound show 13 cm hypoechoic nodule irregular margin right thyroid lobe bilateral small thyroid nodule 45 mm absence enlarged cervical bilateral lymph nodes thyroid function test normal absence thyroid autoantibody serum calcium normal 97 mgdl normal range 84104 mgdl pth routinely measure serum calcium center patient undergo thyroid surgery slightly elevate 68 pgml intact pth 2nd generation assay normal range 1065 pgml rereview original slide fnac confirm follicular lesion particular cytology nodule show epithelial cell hyperchromatic nucleus organize small cohesive cluster resemble microfollicle typically observe thyroid follicular lesion evident fig1a patient undergo right lobectomy neck exploration macroscopic sign local invasion intraoperative frozensection pathological examination raise suspicion pc definitive histology show markedly irregular infiltrative growth tumor invasion thyroid tissue cervical soft tissue fig1b c immunostaine thyroglobulin negative stain chromogranin pth show strong reactivity fig1df base light microscopic finding immunohistochemical profile tumor diagnose pc postoperative serum calcium 87 mgdl phosphate 3 mgdl level normal range month surgery serum calcium plasma pth 96 mgdl 47 pgml respectively neck ultrasound total body compute tomography scan negative local metastatic disease month later serum calcium plasma pth level 9192 mgdl 3844 pgml 184 pth 3rd generation assay normal range 840 pgml respectively neck ultrasound pathological lesion order exclude familiar form phpt pc rarely occur nonfunctione tumor 11 screening serum calcium neck ultrasound firstdegree relative normal,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
60yearold male visit outpatient clinic mass left hip diabete alcoholic hepatitis physical examination large mass measure 10 cm diameter observe hip approximate 5 cm leave inguinal lymph node palpable figure 1 serum tumor marker include cea 199 normal limit serum amylase 227 iul normal range 43116 iul lipase 378 iul normal range 760 fast blood sugar 144 mgdl normal range 70100 mgdl liver function test level include aspartate aminotransferase 178 iul normal range 738 iul alanine aminotransferase 225 iul normal range 443 iul serum alkaline phosphatase 370 iul normal range 103335 iul normal range abdominal computerized tomography ct scan demonstrate left hip mass enlarged leave inguinal lymph node huge heterogeneous enhance mass body pancreas figure 2 pet scan additional metastasis find plan stage surgery perform hip inguinal mass excision december 19 2014 histopathological report reveal metastatic small cell neuroendocrine carcinoma maximal diameter 105 cm buttock mass 7 cm growth inguinal lymph node mitotic index 50 mitose 50 hpf ki67 index measure 50 january 21 2015 perform total pancreatectomy total gastrectomy finding reveal tumor body pancrea 9 cm    6 cm diameter involve left gastric artery splenic artery splenic vein histopathological report metastatic lesion additionally tumor spread 8 32 lymph node figure 3 7th postoperative day patient develop high fever leukocytosis administer abdominal ct scan reveal infected fluid collection less sac 47 cmsize recur mass detect operative bed left hip figure figure44 infection abdominal cavity treat antibiotic remove left hip recur mass february 3 2015 histopathology previous report maximum diameter 75 cm patient discharge complication february 9 2015 currently receive chemotherapy base etoposide cisplatin treatment,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
68yearold female nonsmoker nondrinker medical history hypertension present newonset painless jaundice pruritus threemonth history 99 kg weight loss chronic diarrhea loose bowel movement day medication include vitamin d amlodipine eprosartan physical examination normal jaundice muscle waste recent colonoscopy normal total direct bilirubin level 684 mgdl 11696 moll 918 mgdl 15698 moll respectively result include international normalize ratio 10 alanine aminotransferase level 247 ul normal 33 ul aspartate aminotransferase level 139 ul normal 32 ul alkaline phosphatase level 524 ul normal 35 104 ul viral hepatitis serology antimitochondrial antibody antismooth muscle antibody test negative alphafetoprotein level 24 ngml normal 5 ngml total immunoglobulin ig g 1880 mgdl normal 640 mgdl carbohydrate antigen 199 856 uml normal 33 uml igg4 890 gl normal 3 gl doppler ultrasound magnetic resonance cholangiopancreatography magnetic resonance imaging liver suspicious subtly enhance mass 28 cm 42 cm diameter region hilum porta hepatis obstruct right leave hepatic duct endoscopic retrograde cholangiopancreatography identify stricture central portion right leave hepatic duct concern cholangiocarcinoma figure 1 biliary brushing negative malignancy esophagogastroduodenoscopy normal biopsy ampulla vater reveal chronic active duodenitis figure 2 and33 ancillary test confirm diagnosis figure 4 treatment corticosteroid normalize patient biochemical radiological abnormality month,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
report case previously healthy 28yearold woman afrobrazilian pregnancy patient medical record 36th pregnancy week report allergy diclofenac present emergency department acute onset abdominal pain jaundice nausea vomit sign encephalopathy arterial blood pressure 11060mmhg heart rate 98bpm axillary temperature 35c severely dehydrate decrease peripheral perfusion laboratory examination reveal hemoglobin 123gdl leukocyte 13    109ml platelet 97    103mm3 international nationalize ratio inr 69 fibrinogen 98mgdl total bilirubin 142mgdl serum creatinine 34mgdl serum aspartate aminotransferase ast 306ul serum alanine aminotransferase alp 302ul arterial bicarbonate 11meql arterial ph 721 blood glucose 65mgdl ionic calcium 102mmoll abdominal ultrasound depict fatty infiltration liver confirm fetal viability patient receive initial fluid load crystalloid calcium glucose hypothermia reverse diagnosis aflp confirm follow swanseas criterion 9 cesarean section indicate thromboelastometry rotem pentapharm co munich germany perform beginning surgery thromboelastometry analysis show intense kinetic structural hypocoagulable state fig1 table 1 fibtem reveal impairment fibrinogen function quality extem depict coagulation factor deficiency fig1ac table 1 base respectively fibtem maximum clot firmness mcf 0 mm table 1 extem clotting time ct 228s table 1 40 g fibrinogen concentrate haemocomplettan p csl behre marburg germany 1000ui prothrombin complex concentrate beriplex pn 500ui csl behring marburg germany administer beginning cesarean section fluid input crystalloid output caesarian section respectively 2000ml 200ml cesarean section succeed major bleeding hemostatic therapy additional hemocomponent transfusion fresh frozen plasma ffp cryoprecipitate platelet blood concentrate necessary second thromboelastometry analysis perform end surgery fig1de table 1 show mild hypocoagulation state patient admit intensive care unit icu remain stable bleeding recovery phase discharge icu 3 day admission 3 day later discharge hospital,"['O', 'O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
woman age 31 year g2p2 pathological past history good prenatal care normal prenatal analysis blood pressure followup normal admit elective caesarian section 38 week amenorrhea realization spinal anesthesia patient present peak hypertensive 180100 mm hg normalize minute treatment postpartum 12 hour caesarian section lady present severe headache apyrexia develop episode generalized tonicoclonic convulsion 1st convulsion cease 1 min measure resuscitation injection diazepam iv postcritical clinical examination find afebrile patient blood pressure 14090 mmhg glasgow coma scale 14 neurological deficit neck rigidity diuresis preserve examination urine urinary strip positive      2nd 3th convulsive crisis stop spontaneously second laboratory finding hellp syndrome include raise liver enzyme asat 525 iul alat 214 iul hemolysis hemoglobinemia 7 mgdl low platelet count 44 000 plateletml investigation include renal function test inflammatory marker thyroid hormone normal viral serology negative patient transfer intensive care unit treat immediately magnesium sulfate associate calcium channel blocker nicardipine antiepileptic phenobarbital preventive dose low molecular weight heparin anemia thrombopenia correct transfusion pack red blood cell platelet respectively magnetic resonance imaging mri realize hour episode convulsion show zone hyposignal t1 hypersignal t2 flair sequence interesting cerebral cortex parietal occipital subcortical white matter intracranial venous sinus permeable diagnosis pre syndrome secondary severe preeclampsia immediate postpartum retain figure 1 electroencephalogram eeg realize second day show anomaly evolution mark normalization blood pressure normalization neurological state biological analysis patient discharge good condition day 5 betablocker sodium valproate maintain month mri controle month later show complete resolution cerebral edema figure 2,"['B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O']"
58yearold man suffer general fatigue severe anemia month hemoglobin level 66 gdl normal range 1216 gdl medical history medicine esophagogastroduodenoscopy colonoscopy reveal significant bleed abdominal computer tomography reveal 2 cm hypervascular tumor small intestine fig1 oral dbe detect 2cmdiameter reddish submucosal tumorlike lesion surface ulceration jejunum approximately 20 cm away treitz ligament fig2 perform biopsy difficult stop bleed case hypervascular lesion diagnosis small bowel tumor gastrointestinal stromal tumor gist malignant lymphoma cancer perform laparoscopicassiste segmental resection jejunum dissection lymph node examination resected tumor show measure 19    16 mm diameter fig3 histology reveal proliferation blood capillary granulation tissue consistent pg fig4 patient discharge postoperative day 9 complication anemia improve gradually need oral iron surgery,"['O', 'B-SEX', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
33yearold man present left flank dull ache abdominal compute tomography solid renal mass upper portion left kidney identify mass measure 28 cm    28 cm    25 cm size welldefine patient abnormal finding suspect distant metastasis lymph node metastasis radical nephrectomy perform 1492005 gross examination nephrectomy speciman measure 115 cm    65 cm    45 cm tumor solid grayishbrown mass measure 35 cm    25 cm    22 cm size histologic examination demonstrate trabecular ribbonlike pattern minimal fibrotic stroma cytoplasm granular eosinophilic uniform round oval nucleus finely stippled chromatin inconspicuous nucleolus mitose find 0 10 highpower field stain final pathologic examination reveal welldifferentiate neuroendocrine carcinoid tumor confine kidney fig1 immunohistochemical stain demonstrate label chromogranin neuronspecific enolase synaptophysin fig2 proliferation index 2    measure immunohistochemistry ki67 radiation chemotherapy receive year radical nephrectomy compute tomography abdoman demonstrate 2 cm    18 cm cyst mass right liver multiple high density shadow gallbladder enlarged lymph node find abdominal cavity cholecystectomy extirpation hepatic cyst perform laparoscopy surgery histologic examination demonstrate trabecular glandlike growth fig3 moderate uniform nucleus mitose not find 0 10 highpower field advanced immunohistochemistry reveal lesion positive synaptophysin fig4 cd56 negative chromogranin neuronspecific enolase feature support neuroendocrine tumor similar pathologic characteristic primary renal carcinoid tumor liver tumor final pathology report indicate carcinoid tumor left kidney liver metastasis,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 9 yearold caucasian female diagnose medulloblastoma age 3 year treatment include surgical resection tumor follow systemic chemotherapy vincristine lomustine cisplatin carboplatin cyclophosphamide etoposide craniospinal radiation 2340 cgy boost posterior fossa total dose 5900 cgy cisra subsequently administer 14day cycle 180mgm2 day 13month period cumulative dose 17360 mg 24640 mgm2 complete medulloblastoma therapy age 56 year age 6 year diagnose radiationinduce central hypothyroidism growth hormone deficiency ghd treat levothyroxine subsequent biochemical euthyroidism give tumor remission status abnormal height velocity 094 cmyear growth hormone gh therapy initiate age 7 year 03 mgkgweek subsequent increase height velocity 36 cm growthseven month seven month initiation gh increase bony prominence note wrist knee concomitant decline height velocity 16 cm growthfive month physical examination radiograph significant leg length discrepancy right low extremity measure 175 cm short left right femur 249 cm right tibia 196 cm right low extremity 445 cm leave femur 2525 cm leave tibia 21 cm leave low extremity 4625 cm prior initiation gh height 102 cm figure 1 armspan 102 cm similar upper segmentlower segment ratio seven month gh height increase minimally 1056 cm compare significant increase armspan 1092 cm upper segmentlower segment ratio remain radiograph reveal poorly visualize growth plate distal proximal femur tibia figure 2ab raise concern premature closure physe low limb growth plate closure normally observe time latestage puberty contrast bone age left hand wrist radiograph precede year display open growth plate figure 2cd,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
73yearold woman initially refer 19 month prior current presentation time fluorescein indocyanine green angiography show mediumsize subfoveal classic cnv left eye previously treat return treatment current presentation note decrease vision left eye bestcorrected visual acuity bcva 20100 slit lamp examination show small yellowish patch perifoveal region retinal edema structural oct reveal retinal elevation subretinal fluid hyperreflective elongate area rpe indicate type ii cnv antiangiogenic treatment intravitreal aflibercept injection administer treatandextend regimen oct angiograms fig1 show noticeable reduction cnv flow area 12 day post injection continue reduction 1 week 2 week cnv flow area vessel density reduce probably decrease flow temporary closure small anastomose significant reappearance cnv noticeable 4 week injection 6 week second injection vascular pattern reenlarge cnv fig1a similar initial pretreatment cnv suggest recurrence reopen original channel growth new vessel compare cnv network prior 3rd injection baseline notable few small channel large caliber channel remain quantitative measurement oct angiography fig2a show reduction cnv flow area flow index 2 week subsequent return retinal thickness fig2b show fluid resorption 4 week treatment cycle continue 2 week second treatment cycle time fluid remain fig1b fluid reaccumulate retina 6 week 2nd injection visual acuity fig2b continue improve 3 treatment cycle,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
8yearold boy s549r17171 g    genotype start ivacaftor 150 mg bid compassionate use age 9 month diagnose cf failure thrive previous history remarkable recur nasal polyposis require endoscopic surgery exocrine pancreatic insufficiency necessitating enzyme replacement therapy grow body weight height 10th percentile suffer mild respiratory symptom primarily intermittent productive cough close normal lung function parameter previous year measure body plethysmography spirometry minimal zscore fev1 12 sputum culture grew haemophilus influenzae staphylococcus aureus occasion 6 week ivacaftor treatment patient report clinical improvement cough frequency sputum production physical performance salt craving gain 14 kg body weight change dose pancreatic enzyme replacement therapy sweat chloride level macroduct decrease 115 mmoll ivacaftor 40 mmoll 6 week 52 mmoll 41 week normal    30 mmoll 11 treatment fev1 increase 125 l 12 zscore 165 l 05 zscore 41 week ivacaftor therapy lci normal    8 measure n2mbw decrease 145 83 6 week 78 41 week ivacaftor treatment table 1 fig1,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
36yearold female present emergency department aggravate right upper abdominal pain 2 hour patient diagnose hepatitis b virus hbv carrier year nonalcoholic specific personal familial medical history note initial blood pressure 10060 mmhg pulse rate 70min respiration rate 20min body temperature 375 laboratory finding white blood cell 12000mm3 poly 70 hemoglobin 128 gdl platelet 198000mm3 prothrombin time 143 second international normalize ratio 111 aspartate aminotransferase 22 iul alanine aminotransferase 12 iul total bilirubin 05 mgdl alkaline phosphatase 134 iul lactate dehydrogenase 295 iul gammaglutamyl transpeptidase 26 iul proteinalbumin 6440 gdl uric acid 50 mgdl blood urea nitrogencreatinine 16607 mgdl serum viral marker hbsag    antihbs    antihbc    hbeag    antihbe    hbvdna 20 iuml antihcv    antihiv    patient serum fetoprotein afp 6765 ngml carbohydrate antigen 199 ca199 06 uml take abdominal ct scan show 9 cm sized necrotic mass internal hemorrhage right hepatic lobe rupture peritoneum fig1a emergency hepatic central bisectionectomy fig2a initial histological diagnosis chcccc spindle cell metaplasia cholangiocarcinoma element fig2b serum afp decrease 767 ngml time discharge chcccc postoperative adjuvant chemotherapy tegafururacil uft administrate 3 month 3 month later followup abdominal ct scanning show previously unseen 55 cm sized leave subphrenic mass mild enhancement delay image fig3a b afp increase 31206 ngml undergo laparoscopic splenectomy mass excision histologic examination mesenchymal element consist proliferation primitiveappeare mesenchymal spindleshape cell intimately admixed epithelial element highly cellular pattern cytoplasm abundant mature fibroblast nucleus elongate plump cell blend progressively area intense cellular mesenchymal proliferation relatively acellular fibrous septum osteoid present primitive mesenchyme near fibrous septum pseudocapsule admix epithelial element osteoid foci contain cell morphologically identical osteoblast fig4a immunohistochemistry stain show expression hepatocyte hcg afp vimentin ck7 ck19 cd56 catenin negativity ceafig4b c d e f g metastatic hepatoblastoma confirm histologic examination immunohistochemistry stain immunohistochemistrically reexamination previous surgical specimen confirm hepatoblastoma followup abdominal ct scan perform 1 month reoperation show newly onset 17 cm sized subtle enhance soft tissue mass splenic bed positron emission tomography pet show multiple fdg uptakemax suv    380 leave upper low quadrant area abdomen paralumbar area include right subphrenic area fig5a b c followup afp 16269 ngml systemic chemotherapy start cisplatin 60 mgm2 5fluorourasil 5fu 600 mgm2 vincristine 15 mgm2 total 3 cycle chemotherapy 4 week entecavir 05 mg start chemoprophylaxis chb 3rd chemotherapy cycle followup abdominal ct pet scan show progression multiple intraperitoneal metastasis large intraperitoneal fluid fig6a b followup afp increase 254 ngml chemotherapy regiman change carboplatin 350 mgm2 doxorubicin 30 mgm2 3 week patient experience neutropenia new regimen recover shortly treatment granulocyte colonystimulating factor gcsf second carboplatin doxorubicin chemotherapy followup afp increase 151019 ngml abdominal ct scan show ascite decrease fig7 radiologic improvement fourth chemotherapy perform 4th chemotherapy followup abdominal ct reveal progression multiple intraperitoneal metastatic masse newly develop hepatic metastasis large intraperitoneal fluid fig8 diagnostic paracentesis perform show white blood cell 310mm3 poly 20 lymph 80 protein 36 gdl albumin 23 gdl ascitic fluid analysis serum albumin 31 gdl serumascite albumin gradient saag 08 gdl afb stain culture negative ascitic fluid afp 688193 ngml serum regard peritoneal carcinomatosis patient underwent conservative treatment include use repeat therapeutic paracentesis 1 month death,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
42yearold woman present right breast lump low pain loss height mark kyphosis hepatomegaly core biopsy breast lump show ductal carcinoma situ sample label p11 supplementary fig1 supplementary table 1 additional biopsy ipsilateral axillary lymph node p12 reveal metastatic ductal adenocarcinoma er 88 her2 3 compute tomography scan reveal widespread metastatic disease bone pleura liver supplementary fig2 supplementary table 2 patient start treatment trastuzumab taxanebase chemotherapy significant partial response supplementary fig3 induction chemotherapy maintain tamoxifen trastuzumab 19 month treatment present seizure head compute tomography reveal large metastasis left frontal lobe supplementary fig4 resect m21 therapy tamoxifen trastuzumab continue collection plasma sample initiate sample t1t9 month surgery enlarge liver lesion new metastatic deposit left ovary supplementary fig5 treatment switch combination lapatinib capecitabine result stable disease 12 month supplementary fig6 general deterioration occur disease progression chest new pulmonary nodule bilateral pleural effusion posterior chest wall mass supplementary fig7 eastern cooperative oncology group performance status 23 treatment stop patient die 4 month later tumour sample obtain diagnosis primary breast site p11 axillary lymph node p12 19 month brain metastasis area m21 autopsy 3 year treatment primary breast site metastatic deposit chest liver ovary vertebrae label p31 m31m34 respectively serial plasma sample obtain 500 day clinical followup t1t9 tumour plasma sample collect clinical course summarize fig1ab,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
present case 22yearold woman diagnose childhood type iib vhl know multiple retinal angiomas pancreatic cyst spinal cerebellar hemangioblastomas admit hospital complaining progressive dyspnea palpitation examination blood pressure 159119 mm hg pulse 123 bpm physical examination reveal systolic murmur mitral focus irradiation axilla pulmonary rale electrocardiography reveal remarkable finding sinus tachycardia laboratory test show elevated nterminal probrain natriuretic peptide chest xray show sign pulmonary interstitial edema patient admit department cardiology diagnosis acute decompensate heart failure transthoracic echocardiography show dilate left ventricle severely depressed ejection fraction generalized hypokinesia mild mitral regurgitation fig1a admission patient episode paroxysmal dyspnea despite treatment blocker diuretic clinical suspicion adrenal gland disease 24hour urinary catecholamine metanephrine test request cardiac mri perform order complete cardiomyopathy study confirm echocardiographic finding reveal incidental finding great left renal mass 24hour urine laboratory test show markedly elevate level norepinephrine total catecholamine normetanephrine metanephrine normal epinephrine value 24hour norepinephrine 468 g normal range 23105 24hour epinephrine 13 g normal range 420 24hour total catecholamine 658 g normal range 217575 24hour normetanephrine 2988 g normal range 105354 24hour total metanephrine 3013 g normal range 01000 abdominal mri perform show presence cystic masse fig2 locate left hypochondrium surgical resection masse perform blockade phenoxybenzamine blockade propranolol laparoscopic approach confirm diagnosis pheochromocytoma clear cell renal carcinoma histology followup blood pressure heart rate value normalize 12477 mm hg 78 bpm 24hour urinary catecholamine value return normal range norepinephrine 69 g24 h total catecholamine 221 g24 h normetanephrine 202 g24 h total metanephrine 259 g24 h patient new episode palpitation dyspnea month surgical resection echocardiography repeat show left ventricle normal diameter preserve ejection fraction fig1b genetic analysis reveal germline mutation exon 3 deletion vhl tumor suppressor gene short arm chromosome 3 patient family history vhl conclude de novo mutation,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
13 yearold boy present 1 month history intermittent episode small volume epistaxis significant past medical surgical family history physical examination reveal left palatal fleshy mass center left posterior molar nasoendoscopic examination demonstrate large swelling floor leave anterior nasal space involve left inferior meatus abut inferior turbinate compute tomography ct paranasal sinus show lobulated expansile lytic lesion left maxilla fig 1 lucent center peripheral calcification lesion associate large soft tissue component demonstrate mild heterogeneous contrast enhancement lesion center left maxillary alveolus involve left hard palate inferior anterior leave maxillary wall medial left maxillary wall lesion involve root left maxillary molar premolar abut left orbital floor gross orbital invasion patient subsequently undergo 18fdg petct study mass center left maxilla hypermetabolic index suvmax 97 fig 2 fdgavid metastatic disease transoral incisional biopsy left palatal mass perform suggestive preliminary diagnosis mesenchymal chondrosarcoma evidence biphasic pattern feature sheet small round cell hemangiopericytomalike vascular pattern mature cartilaginous island patient underwent leave subtotal maxillectomy lateral rhinotomy translabial approach final histology conclusive 5 cm highgrade grade 3 mesenchymal chondrosarcoma resection margin positive tumor involvement patient plan adjuvant chemotherapy,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O']"
case report approve review board shandong power central hospital patient parent sign informed consent publication case report accompany image 4yearold female child present outpatient department slowly enlarge painless symmetrical swelling cheek girl approximately 2 year old parent notice change facial symmetry later obvious palpation swelling bony hard consistency skin swelling smooth freely movable increase temperature fig1 history trauma pain pus discharge blood discharge fever paresthesia anorexia weight loss significant family history report panoramic radiography reveal involvement mandible maxilla show soap bubblelike multilocular radiolucency thin expand cortex unerupted tooth include 15 25 35 37 45 47 impact fig2 multislice compute tomography show presence multilocular cystic lesion fill softtissue density material dental anomaly affect body side mandible similar lesion observe maxilla fig3 biopsy obtain central area left rami histologic examination show large multinucleated giant cell loose delicate fibrillar connective tissue stroma contain large number fibroblast small blood vessel fig4 child grow old lesion static regression puberty current case surgical intervention take patient follow regular interval,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
49yearold man history cardiac disease present progressive dyspnea month duration medical history medical history include blunt chest trauma result accidental fall scaffold 15 month early fall approximately 8 foot land right right shoulder patient sustain bilateral pneumothorax right iliopsoas muscle hematoma multiple right costal fracture fracture l3 vertebral body transverse process displace fracture right clavicle hospitalization last 40 day time clinician detect murmur request cardiac evaluation patient return normal activity 4 week discharge hospital remain asymptomatic year arrival department auscultation reveal bibasilar rale pansystolic murmur chest radiography show mild lung congestion transthoracic echocardiography limit suboptimal acoustic window reveal severe eccentric mitral regurgitation valvular subvalvular apparatus appear structurally normal left atrium mildly dilate patient treat intravenous diuretic sign symptom congestion relieve coronary angiography reveal absence substantial coronary disease plan elective surgical procedure mitral valve repair surgical procedure intraoperative transesophageal echocardiography tee observe trivial central mitral regurgitant jet severe perivalvular regurgitant jet originate ventriculoatrial fistulous communication p1 scallop fig1 examination confirm absence structural disease involve mitral leaflet subvalvular apparatus surgical exposure mitral valve small tear length 67 mm see posterior leaflet lateral position involve annulus left atrial wall absence leaflet abnormality vegetation suggest posttraumatic origin perivalvular leak valvular repair successfully achieve direct suture tear 50 prolene stitch subsequent insertion 30 mm mitral annuloplasty ring patient extubate day postsurgical course uncomplicated year later asymptomatic oneyear followup transthoracic echocardiogram confirm excellent result surgical treatment,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
60yearold white brazilian man control hypertension stage 2 obesity present institution complaint progressive fatigue moderate light exertion approximately 1 year duration period undergo myocardial perfusion scintigraphy evidence obstructive ischemic disease clinical evidence systolic heart failure undergo biological mitral valve replacement 3 year previously mitral valve stenosis undergone ablation atrioventricular nodal reentry tachycardia 18 month previously time valve replacement reported evidence pulmonary arterial hypertension patient medication list include aspirin 100 mgday carvedilol 50 mgday atorvastatin 10 mgday losartan 25 mgday echocardiogram show normal function mitral prosthesis global leave ventricular systolic function normal limit leave ventricular ejection fraction 62    measure teichholz method stage diastolic dysfunction mean pulmonary arterial systolic blood pressure 50 mmhg 6minute walk test patient walk 104 meter table 1 catheterization right heart chamber pulmonary artery confirm diagnosis pulmonary hypertension table 2 followup period therapy nifedipine sildenafil tolerate secondary orthostatic hypotension patient refer radiofrequency ablation pulmonary artery trunk treatment refractory pulmonary hypertension procedure perform catheterization laboratory direct visualization fluoroscopy radiopaque contrast dye patient remain unconscious sedation catheterization right femoral artery standard seldinger technique perform 8french valve short sheath subcutaneous injection local anesthetic subsequently sheath replace steerable long sheath agilis st jude medical st paul mn usa standard overthewire technique unfractionated heparin administer intravenously target activate coagulation time 250 350 second electroanatomic reconstruction right ventricular outflow tract pulmonary artery perform ensite velocity cardiac mapping system stjude medical direct fluoroscopic visualization merger format image obtain perform cardiac compute tomography angiography fig1 agilis sheath advance right ventricular outflow tract reach pulmonary valve long sheath introduce ablation catheter open irrigate tip stjude medical parameter application accord protocol follow power 5 w maximum temperature 48 c 60second duration spot maximum impedance variation 10    baseline value irrigation flow rate 17 mlminute create circle pulmonary artery trunk patient discharge morning noteworthy change procedure discharge patient radiographic echocardiographic laboratory parameter see patient blood pressure right heart chamber pulmonary artery determine catheterization 3 6 month procedure result show table 2 patient 3month followup examination show improvement functional class fatigue major exertion demonstrate increase distance walk 6minute walk test reduction pressure right cavity pulmonary artery currently 6 month clinical followup maintain improvement functional classification pedal bicycle,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 50year old man bicuspid aortic valve insufficiency ascend aorta dilatation undergo freehand aortic homograft implantation replacement noncoronary sinus 24 mm homograft 2006 age 41 followup evaluation perform 6 month show mild aortic valve insufficiency 8 year followup patient present hospital fever echocardiography show severe aortic insufficiency rupture cusp homograft worsening cardiac contractility left ventricular ejection fraction lvef depression 4045 dilatation left ventricle telediastolictelesystolic diameter 6042 mm respectively patient present orthopnoea hypotension need infusion dopamine diuretic compute tomography scan show calcification homograft pleural effusion sign pericardial effusion fig1 duke criterion endocarditis satisfied final diagnosis early structural deterioration homograft severe calcification process operation perform median resternotomy standard aortaright atrium central cannulation extracorporeal circulation leaflet annulus homograft present severe calcification sign endocarditis find edwards intuity bioprosthesis 21 mm implant fig2 crossclampe time 41 min cardiopulmonary bypass time 64 min patient require dopamine adrenaline low dose bypass wean complication occur postoperative period echocardiography discharge show absence paravalvular leak peakmean aortic gradient 3420 mmhg lvef 33 followup echocardiography 3 month operation show leak malfunction edwards intuity prosthesis peakmean gradient 3822 mmhg initial recovery lvef value 47 patient asymptomatic,"['O', 'O', 'O', 'B-SEX', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS']"
69yearold woman history hypertension present generalized petechial rash shortness breath 3 day duration rash nonpruritic painless start thigh rapidly disseminate rest body progressive dyspnea exertion significant decrease exercise tolerance deny fever headache dizziness hemoptysis bleed history new drug use unusual food intake contact sick person recent travel medication enalapril take year patient deny use recreational drug tobacco alcohol admission afebrile normotensive mild tachypnea respiratory rate 22 breath minute physical examination reveal scatter petechial rash prominent low extremity nonpalpable nonblanche chest auscultation reveal coarse crackle bilaterally cardiovascular abdominal neurological examination normal palpable lymphadenopathy visceromegaly laboratory examination reveal thrombocytopenia platelet 7000l anemia hemoglobin 108 mgdl hematocrit 34 leukocytosis white blood cell wbc 11600l coagulation profile normal exclude disseminate intravascular coagulation arterial blood gas ambient air reveal partial pressure oxygen pao2 64 torr partial pressure carbon dioxide paco2 37 torr ph 745 increase alveolararterial gradient 44 torr diffuse airspace consolidation find chest roentgenogram fig1a compute tomography ct chest show diffuse ground glass alveolar opacity patchy infiltrate fig1b c start broadspectrum antibiotic receive intravenous steroid peripheral smear show giant platelet occasional small platelet clump schistocyte flexible fiberoptic bronchoscopy ffb show normal mucosa endobronchial lesion fig2a serial aliquot bal fluid balf turn hemorrhagic confirm bronchoscopic diagnosis dah fig2b cytology balf show substantial hemosiderinladen macrophage support diagnosis balf culture gram stain negative patient remain severe thrombocytopenia hypoxia despite steroid platelet transfusion high dose pulse steroid intravenous immunoglobulin ivig add clinicoradiological improvement bone marrow aspirate morphologically normal additional laboratory study fail reveal etiology secondary thrombocytopenia table 1 support diagnosis itp steroid gradually taper repeat chest radiograph show complete resolution bilateral infiltrate fig3 platelet count return normal week 10 admission additional therapy fig4,"['O', 'B-SEX', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
24yearold azeri male present chief complaint blurred vision eye diagnose achondroplasia early childhood bear term normal birth weight history hereditary ocular systemic disease patient characteristic feature achondroplasia ie short stature lumbar lordosis short proximal long bone large hand frontal bossing flat nasal bridge figure 1 height 108 cm well correct visual acuity 2070 right eye 075    125    60 2070 left eye os 025    050    130 pupil equal size round reactive light reverse afferent pupillary defect ocular motility normal eye slit lamp examination unremarkable intraocular pressure 12 mm hg goldmann applanation tonometry central corneal thickness value right leave eye 561 557    respectively dilate fundus examination reveal welldemarcate circular macular lesion eye right eye lesion approximately 25 disc diameter dd width 27 dd length left eye lesion approximately 25 dd width 28 dd length border lesion pigment underlie choroidal overlying retinal vasculature appear normal addition stalk tissue emanate optic disc course vitreous figure 2 fluorescein angiography posterior segment optical coherence tomography optic nerve head stratus carl zeiss gmbh jena germany perform figure figures3 4 background maculopathy patient appropriately fixate target image acquisition result slightly decentered fluorescein angiography image figure 3,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
64 year old female know hht refer clinic recurrent epistaxis nearly 50 year recurrent symptom age 16 condition diagnose sibling diagnose hht mother pass away intracranial hemorrhage year prior presentation undergo leftsided septodermoplasty lateral rhinotomy approach operation significantly reduce frequency symptom year epistaxis control use low dose thalidomide refer clinic increase epistaxis severity frequency prior 12 month necessitate frequent transfusion time consultation patient concern daily severe left side epistaxis despite month use topical bevacizumab oral tranexamic acid require intravenous iron blood transfusion month baseline hemoglobin time consultation 75 gl normal    120    160 gl hht epistaxis severity score 17 severe normalize score 949 examination multiple telangiectasia finger face lip palate endoscopic examination reveal bilateral telangiectasia nasal septum extensive crust entire left nasal cavity manipulation result immediate profuse epistaxis give severity patient epistaxis despite medical therapy offer endoscopic leftsided septodermoplasty surgical goal improve quality life reduce number severity epistaxis episode diminish need blood transfusion patient content treatment plan agree undergo surgical intervention endoscopic procedure perform general anesthesia endotracheal intubation nasal cavity prepare insert pledget soak topical adrenaline 11000 place nostril decongestion zero degree endoscope residual stsg mucosa left septum dissect supraperichondrial plane result expect significant diffuse hemorrhage immediate hemostasis attain topical gelatinthrombin matrix floseal floseal hemostatic matrix baxter healthcare corporation deerfield il usa fig1 mucosal defect fig2 measure approximately 3 cm anteriorposterior dimension 4 x 2 cm split thickness skin graft harvest right thigh piecruste 15 blade place endoscopically length septal defect see fig3 graft place overlap mucosa nasal floor residual superior septal mucosa finally 2 ml fibrin sealant tisseel fibrin sealant baxter healthcare corporation deerfield il usa apply edge central portion stsg fig4 packing postoperatively patient discharge home day surgery clinical followup week surgery fig5 show entire graft take leftsided epistaxis dramatically diminish patient content result procedure 6 month followup baseline hemoglobin improve 102 gl require transfusion 4 month hematologist intent stop transfusion hemoglobin remain great 100 gl epistaxis severity score 6 month follow mild normalize score 305,"['B-AGE', 'I-AGE', 'I-AGE', 'B-SEX', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
65yearold man admit chinajapan friendship hospital chief complaint progressive dysphagia 3 mo complain drastic weight loss 8 kg past 2 mo deny history smoke alcohol intake substance abuse chronic atrophic gastritis nearly 10 year family history genetic defect malignancy physical examination show palpable finding admission blood test show slight decrease hemoglobin 106 gl upper gastrointestinal gi examination barium contrast show large tumor block esophagogastric junction figure 1 compute tomography ct scan reveal soft mass esophagogastric junction lymph node metastasis less curvature stomach figure 2 endoscopic examination show black spot low esophagus bulky black mass block esophagogastric junction black craterlike ulcer fundus stomach figure 3 biopsy specimen take tumor identify poorly differentiate adenocarcinoma preoperative nutrition status case score 2 base nutrition risk screen 2002 nrs 20026 obstructive symptom cause tumor debulking surgery distal esophagectomy proximal gastrectomy perform esophagogastric anastomosis reconstruction complete staple device intraoperatively tumor find locate esophagogastric junction tumor infiltrate layer lymph node metastasis station ascite dissemination tumor observe peritoneal cavity tumor measure 3 cm    6 cm size black pigmentation figure 4 pigment satellite nodule main tumor lesion large 1 cm    1 cm diameter ulceration lesion find fundus stomach microscopically excise tumor tissue compose nonorganized pleomorphic cell exhibit atypical nucleus abundant melanin granule figure 5 pathological examination identify case stage iva t4an1m0 immunohistochemical staining show tumor positive s100 hmb45 mcleana vimentin negative cytokeratin 7 cytokeratin 20 figure 6 base result diagnosis primary advanced esophagogastric melanoma establish postoperative course smooth complication patient gradually recover discharge 14 d surgery patient deny postoperative adjuvant therapy abdominal recurrence hepatic metastasis find month postoperative followup ct effective treatment administer patient die diffuse metastatic disease 2 mo later,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O']"
65yearold man refer hospital evaluation stutter chest pain 10 day common worker positive finding relevant physical examination medical family psychosocial history include comorbiditie relevant genetic information electrocardiogram show twave inversion lead v1 v4 figure 1 coronary angiography show 90 stenosis midleft anterior descend coronary artery lad stente figure 2 twave inversion lead v1 v4 percutaneous coronary intervention pci figure 3 patient discharge pci 5 day recharge hospital palpation electrocardiogram demonstrate ventricular tachycardia figure 4 severe hypertension remarkable blood pressure fluctuation 22476 7050 mm hg antihypertensive drug ventricular tachycardia occur 2 time precede period blood pressure fluctuation burst concomitantly peak hypertension crisis patient feel abdominal pain abdominal ultrasound show suspicious right adrenal gland tumor enhance computed tomography adrenal gland conform tumor right adrenal gland accompany upset level aldosterone figure 5 tumor remove laparoscope pathological examination show pheochromocytoma figure 6 surgery blood pressure turn normal gradually twave inversion lead v1v4 figure 7,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
50yearold lady present complaint pain abdoman jaundice half month complain intermittent type fever 1 week physical examination reveal presence icterus palpable tender globular mass right hypochondrium measure 3    3 cm clinical diagnosis obstructive jaundice secondary periampullary carcinoma ultrasonographic examination abdomen pelvis reveal dilatation intrahepatic biliary radicle ihbr multiple freely mobile gall stone dilated common bile duct cbd measure 18 cm sudden narrowing distal end ct scan show moderate dilatation extra intrahepatic biliary radicle cholelithiasis suspicious thickening gall bladder wall fundus distal cbd stricture evidence distant metastasis fig1 preoperative diagnosis periampullary carcinoma chronic cholecystitis patient plan pancreaticoduodenectomy whipples procedure optimization patient undergo classical whipples procedure table examination resect speciman reveal multiple gall stone gall bladder area mucosal thickening fundus irregular circumferential growth involve intrapancreatic portion cbd postoperative period uneventful patient recover satisfactorily histopathological examination resect speciman figs2 3 reveal thickening gall bladder wall fundus multiple small calculi large measure 14 cm fig3 section study area thickening show feature suggestive adenocarcinoma limit mucosa microscopic section obtain distal cbd region show adenocarcinoma common bile duct invasion muscular wall duodenum section study resected lymph node free tumor cell pathological staging pt1an0m0 adenocarcinoma gall bladder pt2n0m0 adenocarcinoma distal cbd patient subject adjuvant therapy patient diseasefree 2 year surgery,"['O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
53yearold man come hospital sign symptom acute heart failure 2week history progressive breathlessness history recurrent skin abscess atopic dermatitis regularly visit dermatologist hospital arrive hospital extremity warm dry accord new york heart association criterion class iii congestive heart failure chf electrocardiogram reveal diffuse nonspecific twave change low voltage 5 mm extremity lead poor rwave progression anterior chest lead multiple sporadic ventricular premature beat see figure 1 chest xray film confirm right pleural effusion mild cardiomegaly pulmonary congestion figure 2 blood test show severely elevate btype natriuretic peptide 901 pgml markedly raise ige 12 000 iuml eosinophilia eosinophil count 162108l biochemical analysis reveal significant finding blood urea nitrogen 143 mgdl reference value rv 7002200 creatinine 090 mgdl rv 060100 creactive protein crp 02 mgdl rv 000050 serum amyloid saa 70 gml rv 080 troponin t 007 ngml rv 001 immunology testing reveal negative perinuclear antineutrophil cytoplasmic antibody elevation myeloperoxidase antibodie distribution albumin globulin serum normal serum protein immunoelectrophoresis reveal mprotein urinalysis reveal bencejone protein transthoracic echocardiography figure 3 show concentric mild left ventricular lv hypertrophy 12 mm characteristic granular sparkling appearance pericardial effusion preserve ejection fraction 60 biatrial enlargement normal ventricular chamber dopplerderive lv diastolic filling demonstrate restrictive pattern transmitral early filling wave deceleration time 160 m elevated ea ratio 28 markedly elevation ee ratio 273 indicate elevate lv fill pressure day 1 hospitalization prescribe angiotensinconverte enzyme ace inhibitor lowdose diuretic day 3 hospitalization initiate ace inhibitor diuretic therapy patient symptom resolve dermatologist perform biopsy blue macula forehead skin day 4 introduce lowdose blocker perform endomyocardial biopsy emb obtain 3 fragment right ventricular septum diagnostic confirmation cardiac amyloidosis require demonstration amyloid deposit addition perform right heart catheterization rhc coronary angiography exclude obstructive coronary artery disease datum obtain rhc indicate subset type iv accord forrester classification right ventricular pressure curve dipandplateau configuration skin biopsy reveal hyperkeratosis epidermis mild inflammatory change dermis infiltration lymphocyte speciman exhibit applegreen birefringence polarize light congo red staining figure 4 histological examination myocardial speciman show sign suggest myocarditis eosinophilic granulomas cardiomyopathy iron deposition congo red staining reveal amyloid deposit figure 5 addition strongly positive immunohistochemical reaction immunoglobulin chain myocardial interstitium lead diagnose patient systemic amyloidosis al amyloidosis patient generally tolerate lowdose blocker discharge day 10 complication patient currently followedup 6month interval outpatient exacerbation chf far,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
institutional review board chengdu military general hospital approve work waive need inform consent 2013 66yearold farmer history ventricular tachycardia vt hypertension present emergency department continuous palpitation chest tightness profuse sweating nausea obvious predisposing cause patient experience sudden drop blood pressure acute confusion immediate electrical conversion consciousness gradually restore symptom relieve patient transfer department cardiology evaluation treatment patient blood pressure 10575 mm hg admission heart rate 75 beatsmin body temperature 366c respiration rate 18 timesmin heart border extend left apical impulse locate left 5th intercostal space 10 cm lateral midclavicular line patient history hypertension 30 year regular antihypertensive medication high blood pressure 170110 mm hg family history early coronary artery disease sudden cardiac death smoke cigarette use illicit drug rarely consume alcohol report known contact sick person recent travel twelvelead surface electrocardiogram ecg vt indicate origin vt boundary right ventricular outflow tract rvot tricuspid valve vt increase 150 beatsmin high epsilon wave find precordial lead figure1a b contrast vt decrease 120 beatsmin low epsilon wave appear lead v1v2 figure1c notably epsilon wave precede qrs wave lead v1v2 endocardiac tracing confirm correspond local potential originating rvot appear prior ventricular rhythm figure figure1d1d sinus ecg year 2013 suggest slight left deviation electric axis heart rate 87 beatsmin flat t wave lead ii t wave inversion find lead iii avf v1v3 epsilon wave find follow qrs complex lead v1v3 figure figure2b2b lead avr amplify epsilon wave find qrs wave figure 2c atrial premature beat appear occasionally ventricular premature beat find originate right ventricular apex epsilon wave appear qrs wave figure figure2b2b contrast sinus ecg obtain year 1999 reveal similar left deviation electric axis flat t wave t wave inversion absence epsilon wave figure figure2a2a datum biochemical assay follow cardiac troponin level 0714 gl normal range 0006 gl serum btype natriuretic peptide level 466530 pgml normal range 0100 pgml serum ddimer level 814 mgl normal range 0055 mgl blood urea level 1169 mmoll normal range 290720 mmoll serum creatinine level 14400 moll normal range 44133 moll serum uric acid level 61140 moll normal range 100432 moll endogenous creatinine clearing value 5790 mlmin normal range 80 mlmin echo datum reveal remarkably enlarge right atrium right ventricle widen rovt uncoordinated motion left right ventricular wall detect find aortic valve degradation slight regurgitation slight mitral regurgitation moderate severe tricuspid regurgitation left ventricular diastolic function reduce 55 figure 3a b coronary angiogram reveal vascular stenosis figure 3ce base abovementione examination patient meet 2 major criterion bilateral ventricular dilation existence epsilon wave provide diagnostic support arvc diet low salt low fat suggest patient treat metoprolol succinate sustainedrelease tablet 2375 mg daily po amiodarone 200 mg daily po furosemide 20 mg daily iv compound ketoacid tablet 252 g daily po vts different morphology cycle length find radiofrequency ablation figure 4 substrate voltage mapping reveal anterior wall rvot wrap circular scar figure 5a consider association vt scar area substrate ablation choose patient residual potential scar area search linear focal ablation perform figure 5b program stimulation induce stimulation induce vt procedure complete indicate success operation ecg radiofrequency ablation show sinus rhythm heart rate 61 beatsmin t wave inversion lead iii avf epsilon wave t wave inversion lead v1v3 figure 2d patient discharge hospital day 9 regimen metoprolol succinate sustainedrelease tablet 2375 mg daily po amiodarone hydrochloride tablet 200 mg daily po spironolactone tablet 40 mg daily po fosinopril sodium tablet 10 mg daily po patient follow 3 month discharge recurrent palpitation chest tightness profuse sweating nausea arvc main diagnosis time patient initial presentation essential case perform reassessment presence structural heart disease evolve time,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
36 year old white woman 40 week gestation admit local obstetric clinic elective repeat cesarean delivery slant position fetus previous current pregnancy uncomplicated past medical history unremarkable family history cardiac disease report caesarean delivery perform follow administration standard spinal anesthesia surgery patient hypotensive ephedrine inject maintain blood pressure normal range hour delivery healthy male infant patient complain nausea increase dyspnoea palpitation physical examination tachycardia ventricular extra systole pulmonary rale detect blood pressure 8040 mmhg demand administration inotropic agent initially continuous infusion norepinephrine 05 mgh follow dobutamine 7 gkgmin owe worsening oxygen saturation 70    gradual deterioration consciousness mechanical ventilation apply patient transfer intensive care unit chest x ray indicate pulmonary congestion emergency computer tomography exclude pulmonary thromboembolism pe confirm severe pulmonary oedema fig1 patient receive loop diuretic furosemide initial daily dose 80 mg progressively reduce diuretic discontinue 12 day treatment electrocardiogram disclose sinus tachycardia st segment elevation 15 mm negative t wave avl st segment depression 1 mm ii iii avf v5v6 fig2 laboratory test show elevated troponin 908 pgml normal value 14 pgml not pro bnp 6236 pgml normal value 125 pgml bedside transthoracic echocardiography tte reveal severe left ventricular lv systolic dysfunction patient transfer intensive cardiac therapy clinic repeat tte show lv ejection fraction 30    hypokinesis mid basal segment posterior anterior lateral wall preserve contractility apical segment urgent coronary angiography present normal coronary artery diagnosis invert stress induce cardiomyopathy set overall clinical datum 3 day patient wean respirator extubate follow hemodynamic improvement inotropic agent taper gradually tte magnetic resonance image figs3 4 perform fifth day show complete recovery myocardial function patient discharge 15 day good overall condition 12 month follow remain asymptomatic echocardiographic abnormality,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O']"
66yearold man admit hospital november 2008 splenomegaly high red cell count subnormal serum erythropoietin level cytogenetic analysis show normal male karyotype molecular study negative bcrabl1 rearrangement reveal jak2v617f mutation allele burden 449 diagnosis pv basis morphological bone marrow analysis accord 2008 criterion patient start aspirin hydroxyurea phlebotomy tolerate year later abdominal ultrasound scan reveal presence dense bilateral perinephric infiltration confirm wholebody compute tomography ct scan fluotine18 fluordeoxyglucose positron emission tomography ffdgpet scan demonstrate increase glucose uptake medullary channel humeri femur morphological bone marrow analysis confirm previous diagnosis pv show evident change grading bone marrow fibrosis mf0 accord eumnet consensus13 cytogenetic analysis reveal follow complex male karyotype 47xy922047xyadd6p25922046xy1620 histological nature perinephric infiltration identify mean ctguided core biopsy lesion morphological analysis demonstrate accumulation foamy histiocyte positive cd68 negative dendritic cell marker cd1a s100 surround fibrosis scanty lymphomonocytic infiltrate figure figure11 detection brafv600e mutation lead diagnosis ecd cardiac magnetic resonance imaging mri reveal pseudotumoral infiltration atrioventricular wall14 bone scan show symmetrically irregular radiotracer uptake long bone limb consistent ecd figure figure222 finding cerebral pulmonary imaging negative accordance recent guideline treatment ecd1 patient start therapy pegylate interferon ifnalpha 3 month treatment new abdominal ultrasound scan reveal complete resolution dense bilateral perinephric infiltration normalization blood cell count achieve,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
50year old man history metastatic mucinous appendiceal adenocarcinoma present evaluation desquamate rash face spread scalp inguinal region perineum past 4 month figure 1 rash accompany diffuse alopecia face scalp axilla groin improvement rash despite multiple round oral fluconazole topical antibiotic ointment intravenous antibiotic prior development rash complete neoadjuvant chemotherapy follow surgical resection undergo colostomy fail surgical correction enterocutaneous fistula require total parenteral nutrition tpn past year notice significant change ostomy output time dermatological examination reveal widespread erythematous plaque face scalp medial aspect thigh bilaterally scatter papule scale face scalp chest diffuse nonscarre alopecia present face scalp axillae groin patient acquire ae rare dermatologic condition cause zinc deficiency patient develop acquire zinc deficiency setting inadequate zinc supplementation tpn patient receive trace element approximately year national shortage key correct diagnosis acquire ae combination desquamate rash couple alopecia setting chronic supplemental alimentation reasonable consider skin biopsy skin biopsy definitively establish diagnosis paraneoplastic panel consider delay diagnosis presentation consistent nutritional deficiency appropriate start topical steroid cream diagnosis determine patient zinc level 29 ugdl normal range 56134 ugdl receive zinc supplementation tpn month patient complete resolution rash fatigue gradual return hair growth figure 2 repeat zinc level follow supplementation 90 ugdl patient recover zinc deficiency later pass away,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
present case 16yearold girl admit clinic severe abdominal pain loss appetite nausea vomit anamnesis reveal girl come family potter participate process pottery father diagnose lead poisoning 2 year patient personal history underline approximately 1 year ago present severe abdominal pain diagnose acute appendicitis undergo appendectomy pain persist family history lead poison suspicion saturnine colic rise diagnose lead poison urinary lead 219 gl receive symptomatic treatment approximately 3 week admission clinic admit regional hospital episode saturnine colic blood lead 1132 gdl chelation therapy edta 4 day admission clinic initiate dose 2 tablet daily morning evening associate calcium supplement clinical examination perform time admission reveal follow pathological element influence general status ail face jaundice sclera blue pigmentation nail painful abdoman palpation weight 45 kg laboratory test perform admission reveal hypochromic anemia hemoglobin hb 109 gdl hematocrit htc 316 medium cellular volume mcv 776 fl increase level liver transaminase alanineaminotransferase alat 1589 ul aspartateaminotransferase asat 63 ul gammaglutamyltransferase ggt 128 ul conjugate hyperbilirubinemia direct bilirubin dbi 1432 mgdl hyponatremia na 132 mmoll hypopotassemia k 285 mmoll systolic arterial pressure 156 mm hg diastolic 96 mm hg blood lead level 6628 gdl urinary 4197 gl normal 50 gl value deltaaminolevulinic acid 766 mgl normal 45 mgl perform abdominal ultrasound reveal disappearance delimitation cortical medullar part kidney request consultation occupational healthcare specialist recommend continuation chelation therapy edta increase dose 4 tabletsday require neurological consultation specialist establish diagnosis behavioral disorder depressive element recommend psychotherapy base clinical laboratory finding establish diagnosis lead poisoning initiate intense iv hydration order favor lead elimination approximately 3 liter 24 hour initially decrease progressively quantity cease vomit able consume liquid associate diuretic initially furosemide vein value arterial pressure persist upper limit force introduce angiotensinconverte enzyme inhibitor remission arterial hypertension liver function administer amino acid intravenously associate liver protector mouth administer vitamin b complex order improve neurological impairment evolution slightly favorable 3 day admission patient continue present severe abdominal pain vomiting complain pain lumbar area laboratory parameter present normalization value approximately 10 day treatment 6th day admission cease chelation therapy edta repeat blood urinary lead level blood level 4557 gdl urinary 8364 gl discharge patient abdominal ultrasound reevaluation reveal pathological modification 14 day admission patient discharge complaint recommend exposure lead avoid contact working pottery process longterm outcome case depend exposure heavy metal intend repeat blood lead level 12 24 month assess renal urea creatinine urinary exam hepatic function asat alat ggt bilirubin,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
proband 19yearold woman child healthy unrelated parent family history unremarkable bear term normal pregnancy perinatal period uneventful early development refer normal 1 year age psychomotor delay evident start walk autonomously 22 month poor balance frequent fall 3 year age develop demyelinate sensorimotor neuropathy brain mri disclose supratentorial leukodystrophy childhood clinical sign remain stable 10 year walk difficulty worsen limb weakness tremor ensue neurological evaluation show dysarthria dysmetria ataxic gait hyporeflexia limb muscle waste able walk step ataxic gait mild cognitive impairment document iq 75 wiscr scale histological analysis muscle biopsy show hypoatrophy fibre clinical evolution slowly progressive followup examination 19 year age able walk anklefoot orthotic aid develop marked dorsallumbar scoliosis clinical sign stable neurophysiological study confirm worsen mixed axonal demyelinate peripheral neuropathy brain spinal cord mri show mild extension signal abnormality extensive cavitation cerebral white matter cerebellum brainstem spare spinal cord thin obvious focal lesion figure 1a plasma lactate 29 mm nv 21,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
54yearold patient admit fever diarrhea acute renal failure significant medical history medication travel recently relevant familial history day admission develop fever fluctuant rash diarrhea pain joint admission blood pressure 14070 mm hg temperature 39c physical examination show severe edema involve low upper limb ascite pleural effusion cervical axillar infracentimetric lymphadenopathy present hepatosplenomegaly confirm compute tomography ct scan bilateral arthritis ankle resolve spontaneously blood analysis reveal table table11 leukocytosis normal hemoglobin platelet level biologic sign hemolysis elevate creactive protein low albumin elevate serum creatinin mild proteinuria hematuria despite intravenous rehydration saline albumin renal function worsen patient require dialysis diagnostic investigation perform hemiplegia occur brain mri show multifocal ischemic lesion echographic rythmologic study rule cardiologic cause stroke renal biopsy perform fig1a b periodic acidschiff pas staining show endotheliosis glomerulus fig1a arrow associate mesangiolysis double contour silver stain fig1b arrow arteriolar thrombus moderate cd20 b lymphocyte infiltrate present interstitium peritubularcapillaritis immunofluorescence study deposit lymph node biopsy fig2a b show abnormal follicle hyalinization germinal center onionskin aspect mantle zone clinical presentation lymph node histology consistent hyalinevascular multicentric castleman disease mcd hiv hhv8 serology hhv8 lymph node tissue staining negative serum vascular endothelium growth factor vegf highly elevate biologic manifestation thrombotic microangiopathy tma renal biopsy brain mri consistent glomerular neurologic tma lesion apparent cause thrombotic microvascular involvement note notably evidence infection shiga toxinproducing germ adamts13 activity decrease 14 remain 5 alternative complement pathway normal plasma exchange initiate kidney histological lesion multifocal ischemic brain lesion discontinue 1 month onset disease patient condition remain stable furthermore chemotherapy include 6 course rituximab 375 mgm2 cyclophosphamide 750 mgm2 dexamethasone 40 mgday day 1 day 4 start plasma exchange chemotherapy perform immediately plasma exchange course perform 3 week clinical manifestation vascular leak syndrome regress renal function normalize serum vegf level decrease 825 pgml 1 course chemotherapy patient discharge 43 day admission neurological event occur initiate treatment thoracoabdominal ct scan perform 6 course chemotherapy show normal liver spleen size lymph node enlargement year diagnosis remission mcd persistent plasma creatinine 86 moll proteinuria,"['O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 18yearold han female admit peke union medical college hospital adrenal crisis trigger pneumonia develop recurrent respiratory infection age 5 fail respond multiple hepatitis b virus hbv vaccination reduce serum cortisol acth level discover 16 glucocorticoid replacement initiate addition hair loss start age 4 absence pubic axillary hair notice development regular menstruation history include nephrotic syndrome confirm minimal change nephropathy renal biopsy physical examination admission reveal alopecia totalis oral candidiasis hypohidrosis trachyonychia facial dental abnormality note child family symptom sign disorder identify nonconsanguineous parent initial immunologic test reveal remarkable panhypogammaglobulinemia reduce cell count b cell t cell natural killer nk cell table table11 cd4cd8 ratio expression level tcell activation marker normal range increase proportion cd8hladr subset antinuclear antibodie ana antineutrophil cytoplasmic antibody anca negative regular hydrocortisone replacement suspend 800 serum cortisol measure 093 gdl acth 500 pgml serum level anterior pituitary hormone serum urine osmolality reference range antiperoxidase antibody antithyroglobulin antibody negative positive antiprotein tyrosine phosphatase antibody fast blood glucose 59 mmoll magnetic resonance image contrast suggest normal pituitary diagnose cvid isolate acth deficiency ectodermal dysplasia symptom fever cough vomiting clear antibiotic stressdose hydrocortisone treatment intravenous immunoglobulin ivig therapy suggest deny parent followup 1 year discharge report infection event previous year stay home avoid outdoor activity glucocorticoid replacement withdraw 4 month discharge receive traditional chinese medicine lymphocyte subset test followup document increase level b cell t cell nk cell count remain normal limit assess nkcell activity flow cytometric procedure follow previously describe method1011 effector target cell ratio set 101 apoptosis target cell line 1243 reference range 15112691 observe coculture patient peripheral blood mononuclear cell pbmc indicate deficient nkcell cytotoxicity,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'B-DISEASE', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
69yearold male diabetic patient admit acute leave ventricular lv failure treat intensive decongestive therapy severe peripheral edema bilateral basal crepitation initial workup reveal normal level troponine 001 ngml cpkmb 46 ngml rule acute coronary syndrome level bnp 1230 pgml confirm diagnosis heart failure echocardiographic assessment reveal lvef 10 dilate cardiac chamber estimate pulmonary artery systolic pressure pasp 70 mm hg feature raise lv diastolic pressure angiography perform 3 day decongestive therapy reveal critical triple vessel disease left main coronary artery disease fig1 refer cabg patient frusemide infusion oral ramipril aldactone take elective opcab 1 week angiography renal function monitor regularly adjust diuretic dose feature end organ dysfunction st risk mortality 24 repeat echocardiographic assessment reveal improvement lvef 15 decrease pasp 30 mm hg decrease lv fill pressure opcab perform median sternotomy leave ita grafting leave anterior descend artery lad revascularize lad right ita rita ra composite graft prepare distal end rita revascularize diagonal artery significant improvement systolic blood pressure distal anastomosis graft heart lift lateral posterior wall vessel long skin incision open sternum widely release pericardium right displace heart gradually supplement headlow lateral tilt position liberal dose inotropic support ra sequential grafting obtuse marginal posterior lv branch posterior descend artery distal anastamose perform uneventfully patient electively ventilate 2 day echocardiography 1st pod reveal improvement lvef 20 start low dose beta blocker inotropic support wean slow uneventful recovery echocardiography 4th pod reveal improvement lvef 30 table 1 persistent pleural drainage require prolong intensive care unit stay pleural drainage subside drain remove discharge diuretics low dose beta blocker ramipril,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
70yearold male admit hospital perioperative cardiac evaluation abdominal aortic aneurysm patient undergo coronary artery bypass grafting cabg severe stenosis left main coronary artery lmca 4 year consist right internal thoracic artery rita left anterior descend artery lad saphenous vein graft svg left circumflex artery lcx continual growth abdominal aortic aneurysm year surgery indicate leave coronary angiogram show 90    stenosis lmca total occlusion graft pci perform lmca stenosis fig1 7fr sheath insert right femoral artery cls4 guide catheter boston scientific natick ma usa engage left coronary artery lca ostium guidewire sion blue asahi intecc aichi japan insert distal lad guidewire hitorque pilot 50 abbott vascular santa clara california usa insert distal lcx intravascular ultrasound ivus intrafocus wr terumo corp tokyo japan demonstrate heavy circumferential calcification lmca lesion 40    15 mm quantum maverick balloon catheter boston scientific inflate lesion lca angiogram reveal large dissection fig2 40    28 mm multilink vision stent abbott vascular immediately deploy angiographic image residual dissection disappear stent dilate 50    15 mm quantum maverick balloon catheter absence residual dissection confirm angiography stent implantation lmcalad lmcalcx kiss balloon angioplasty initiate 40    28 mm stent delivery balloon lad 30 mm    15 mm ikazuchi balloon kaneka medics tokyo japan lcx final angiographic imaging show optimal result ivus imaging lesion show completely seal stent fig3 large hematoma femoral puncture site local bleeding observe removal femoral sheath manual compression apply haemostasis hematoma appear spread day patient discharge hospital fifth day pci unexpectedly patient admit emergency room newonset chest pain dyspnoea day discharge vital sign indicate cardiogenic shock electrocardiogram show st elevation lead v1v3 echocardiography detect leave ventricular asynergy large mass outflow tract right ventricular chamber observe fig4 contrastenhance compute tomography show 40 mm hematoma compress main pulmonary artery trunk right ventricle fig5 examination patient suffer sudden cardiopulmonary arrest receive immediate cardiopulmonary resuscitation return spontaneous circulation insertion percutaneous cardiopulmonary support device patient undergo emergent surgery removal hematoma inform consent obtain patient family surgery large dark red clot pulmonary artery trunk aorta observe suspect origin epicardial hematoma blood ooze lmca stent site despite successful surgical repair patient die aortic rupture induce external cardiac massage,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O']"
patient 59yearold man diagnose pd age 49 year fluctuation recur state peak dose dyskinesias severely diminish patient quality life patient deem candidate bilateral subthalamic dbs multidisciplinary evaluation 75    positive response standardized levodopa test exclusion cognitive decline psychiatric comorbitity absence structural brain damage potentially relevant lead placement lead unanimous decision dbs placement decision proceed surgery medication consist 11125 mg levodopa 150 mg piribedil history orofacial cervical dystonia state patient alert sign psychiatric comorbidity neuropsychological testing adequate cranial nerve deficit find swallow normal gait postural stability normal minimal rigidity neck right arm coordinative motor skill rapid pro supination restrict left hand dyskinesias evident moderate impairment state medication hold 12 h patient show mild dysarthria dysphonia rest tremor right arm leg slight action tremor right hand rigidity severe neck mark right mild left motor skill hand markedly impair gait slow unaided comprised intermittent freezing mild dystonic posturing right foot sign laryngeal spasm day surgery dose dopaminergic medication administer 0700 pm bedtime dose levodopa hold facilitate intraoperative testing day operation patient underwent placement stereotactic frame local anaesthesia 0900 plan standard stn coordinate trajectorie patient place semisitting position table frame attach table patient request head slightly flex anteriorly comfort left electrode place uneventfully perform bur hole right patient complain cramp neck facial muscle difficulty breathe point pulse oximetry show good saturation reading 95    progress dystonic dysarthria 6 microelectrode recording macroelectrode test stimulation begin patient show highpitche inspiratory stridor pulse oximetry show decrease oxygen saturation 0215 pm shortly narrow complex tachycardia note minute patient unresponsive cardiac resuscitation initiate patient fiberoptically intubate removal bar stereotactic frame fiberoptic intubation laryngeal spasm confirm visually transthoracic echocardiogram obtain immediately successful resuscitation show cardiac pathology air bubble stimulation implant lead resolve symptom possible time lead subcutaneously tunnel impulse generator attach right permanent electrode place testing accord microelectrode recording 50 mg levodopa administer nasogastric tube hour subsequent postoperative period postoperative head ct scan immediately procedure normal patient transfer intensive care unit extubate 0200 pm follow day neurological deficit sign laryngeal spasm nasogastric tube discontinue preoperative medication resume cardiac workup negative impulse generator implant 7 day later patient show good symptom control pd,"['O', 'O', 'B-SEX', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
47yearold woman present hospital 1month history abdominal distention physical examination reveal huge mass low abdoman peripheral blood test show elevated level carcinoembryonic antigen cea 3352 ngml normal 5 ngml carbohydrate antigen 125 219 uml normal 45 uml normal level ca199 9 uml normal 37 uml compute tomography ct demonstrate large round mass maximum diameter 15 cm pelvic cavity presence ascite pleural effusion fig1a b colonoscopy identify elevated lesion severe stenosis sigmoid colon histopathological examination biopsy specimen tumor show moderately differentiate adenocarcinoma schedule early operation patient develop acute dyspnea general edema 2 week ct scan second ct scan examination demonstrate massive bilateral pleural effusion atelectasis ascite fig2a b thoracic drainage laparotomy emergently perform macroscopically tumor sigmoid colon invade serosa huge pelvic mass find contain right ovarian tumor small nodule peritoneal dissemination distribute great omentum perioperatively 3800 ml serous ascitic fluid drain cytodiagnosis fluid drain ascite pleural effusion reveal tumor cell bilateral oophorectomy total hysterectomy omentectomy sigmoidectomy regional node dissection perform fig3a histopathological examination resect specimen show moderately differentiate adenocarcinoma tumor ovary sigmoid colon fig3b dissect paracolic node show malignant cell immunohistochemically tumor cell ovary colon show positive expression cytokeratin 20 ck20 expression cytokeratin 7 ck7 confirm ovarian tumor metastasis primary colon cancer fig4a b postoperative course uneventful pleural effusion ascite rapidly resolve postoperatively regimen 5fluorouracil 5fu leucovorin oxaliplatin folfox administer 2 week 5 month 29 month operation patient require curative hepatic resection liver metastasis 78 month operation patient remain alive evidence disease,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE']"
76yearold woman present hospital complaint epigastralgia day prior admission laboratory datum admission reveal elevation aminotransferase alanine aminotransferase guanosine triphosphate alkaline phosphatase serum total bilirubin tumor marker carcinoembryonic antigen cea carbohydrate antigen 199 ca199 span1 neuronspecific enolase nse normal range abdominal compute tomography ct magnetic resonance cholangiopancreatography mrcp show mass enlarged gallbladder bulky hepatic lymph node surround hepatic hilum fig1a b apparent lesion upper low gastrointestinal endoscopy endoscopic ultrasoundguided fineneedle aspiration eusfna perform obtain tissue hilar lymph node immunohistochemical staining speciman identify diffuse positivity keratin cd56 synaptophysin tumor cell consistent nec endoscopic nasogallbladder drainage engbd catheter place bile cytology reveal class v malignant cell positron emission tomographycompute tomography petct examination perform evaluate primary metastatic lesion reveal accumulate lesion identify accumulation 18f fluorodeoxyglucose fdg gallbladder suvmax 78 lymph node suvmax 134 fig1c d basis finding likely diagnosis gallbladder nec confine regional hepatic hilar lymph node metastasis finally decide perform surgical resection prior chemotherapy concern complication develop mechanical obstruction hepatic hilum enlarged lymph node undergo cholecystectomy hepatic hilar lymphadenectomy extrahepatic biliary duct resection hepaticojejunostomy bulky lymph node totally resect en bloc apparent residual lesion surgically postoperative course uneventful discharge tenth day surgery macroscopically tumor 58    42 mm size locate fundus contain yellowish gallstone fig2a portion hepatic hilar lymph node 71    37 mm excise separately fig2b microscopic examination gallbladder reveal moderate differentiate tubular adenocarcinoma infiltrate mucosa muscular layer serosal surface nec component fig2c d tumor cell gallbladder slightly positive synaptophysin cd56 negative chromogranin fig2eg resection margin liver bed negative tumor cell epithelium carcinoma show intestinal metaplasia goblet cell fig4a area stain alcian blue fig4b hand hepatic hilar lymph node compose small round tumor cell hyperchromatic nucleus scant cytoplasm fig3a tumor cell large vesicular nucleus tumor cell arrange sheet cord trabecular rosette fashion intersperse focal necrosis immunohistochemically positive cd56 synaptophysin chromogranin fig3b3d mitotic count 24 10 highpower microscopic field ki67 proliferation index 7080 consistent nec surgical dissection margin hepatic lymph node microscopically cauterize tumor cell invasion extrahepatic biliary duct result thorough pathological reevaluation total segmentation negligible area adenocarcinoma detect lymph node fig3e f adenocarcinoma component intestinal metaplastic epithelium gallbladder positive cdx2 fig4a neuroendocrine component hilar lymph node negative cdx2 fig4b postoperatively patient receive cycle carboplatin area curve 5 day 1 repeat 21 day etoposide 80 mgm2 day 1 3 repeat 21 day course grade 4 neutropenia occur manage prophylactic fluoroquinolone 4 month multiple recurrence paraaortic lymph node detect pathologically demonstrate eusfna nec patient underwent secondline chemotherapy amrubicin 24 mgm2 day 1 3 repeat 21 day grade 4 neutropenia anemia develop course need receive pegylate granulocyte colonystimulate factor red blood cell transfusion die progressive disease 8 month surgery,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O']"
20yearold previously healthy bengali man present hospital anuria feature uremic encephalopathy day prior presentation experience severe upper abdominal pain vomiting treat primary care facility have case acute pancreatitis initial symptom improve gradually anuric disorient transfer hospital management presentation hospital severely agitated restless disorient tachypneic acidotic breath mild pedal edema present jugular venous pressure raise pulse 112 beatsminute blood pressure 14090 mmhg body temperature 98 f sign meningeal irritation absent plantar response bilaterally extensor fundus evaluate examination system unremarkable laboratory parameter show feature renal dysfunction serum creatinine 13 mgdl serum urea 293 mgdl raise pancreatic enzyme serum amylase 249 ul reference 100 ul serum lipase 227 ul reference 1360 ul normal liver function test serum bilirubin 09 mgdl alanine aminotransferase 38 ul aspartate aminotransferase 35 ul alkaline phosphatase 122 ul serum albumin 37 gl normal potassium 51 mmoll normal bicarbonate 19 mmoll normal triglyceride 173 mgdl serological marker include antinuclear antibodie cytoplasmic antineutrophil cytoplasmic antibodie perinuclear antineutrophil cytoplasmic antibodie c3 c4 normal limit ultrasonogram abdoman unremarkable noncontrastenhanced computed tomography ct finding suggestive acute pancreatitis fig1 kidney unremarkable patient manage have case aki acute pancreatitis urgent hemodialysis initiate receive session hemodialysis level consciousness improve complain profound visual loss assessment reveal perception light funduscopic examination show retinal whitening extensive cotton wool exudate purtscher flecken fig2 compatible purtscher retinopathy highdose parenteral methylprednisolone 1 g intravenously daily 3 day administer evaluation renal dysfunction renal biopsy histopathological finding compatible renal cortical necrosis fig3 patient deny substance abuse alcohol ingestion consume nephrotoxic drug herbal product recent past history suggest connective tissue disease available history hypotension course current illness patient finally diagnose acute pancreatitis complicate renal cortical necrosis lead aki purtscher retinopathy lead complete bilateral blindness die 16 month initial presentation result recurrent attack acute pancreatitis undergo maintenance hemodialysis renal function recover vision improve fingercounte 2 foot,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
female outpatient 50 routinely visit hospital liver cirrhosis result hepatitis b virus biliary duct stone 65 year age suffer hcc bclc early stage liver function preserved childpugh score underwent leave lateral segmentectomy hcc preoperative treatment histopathological finding reveal bridge fibrosis pseudolobule formation serum level alphafetoprotein afp protein induce vitamin k absenceii normalize primary resection figure 1 image study ln metastasis detect time primary resection hcc half year postoperatively patient afp level increase dramatically 7802 ngml lobular lesion fine enhancement detect contrastenhanced magnetic resonance image tumor measure 27 mm diameter locate caudally left kidney contrastenhance computed tomography tumor show strong enhancement arterial phase figure 2a 2b relatively low density portal phase figure 2c 2d enhancement finding appear consistent typical hcc pattern detail imaging study magnetic resonance imaging computed tomography perform case rare metastatic ln initially debatable need rule exclusion diagnose threedimensional imaging prove tumor feed main vessel inferior mesenteric artery red arrow accessory feeder superior mesenteric artery figure 3 fluorine18fluorodeoxyglucose positron emission tomography fdgpet positron emission tomographycompute tomography detect tumor figure 4 think positron emission tomographycompute tomography helpful identify metastatic tumor image finding reveal intrahepatic extrahepatic metastasis base tumor location clinical diagnosis solitary metastasis mesocolic ln hcc dissemination determine ideal therapeutic strategy solitary extrahepatic rare metastasis difficult rapid growth critical concern case tumor solitary accompany metastasis consider diagnostic therapeutic viewpoint finally choose surgical resection case disseminative nodule lymphadenopathy ascite observe surgery tumor locate mesocolon nearly wall descend colon partial resection descend colon regional mesocolon perform patient postoperative course uneventful discharge postoperative day 8 serum level tumor marker decrease immediately surgery figure 1 macroscopically mesocolic tumor solid elastic mass smooth surface figure 5a yellowish nodule encapsulate cut surface figure 5b enlarge ln contain metastatic hcc ductal structure figure 6a immunohistochemically tumor positive afp negative ck20 consistent pattern primary hcc figure 6b histopathological diagnosis metastatic hcc mesocolic ln writing report patient remain free recurrence 13 month second surgery carefully follow adjuvant therapy perform,"['B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
case 58yearold white hispanic woman history uveal melanoma right eye fig1 admit hospital jaundice abdominal pain 10 day admission laboratory test obtain complete blood count normal limit amylase 136 ul total bilirubin 637 mgdl direct fraction 530 mgdl crosssectional abdominal compute tomography ct contrast show lowattenuating lesion localize pancreatic head measure 4    3 cm thin section distal bile duct suspicious compression multidisciplinary meeting patient schedule eusfna eus show solid heteroechoic predominantly hypoechoic area welldefine lesion regular contour measure 31    26 cm localize head neck pancreas fig2 vascular lymph node invasion identify eusfna perform 22 g needle fanning technique cytology specimen fig3 cell present discohesive disperse pattern marked variation size shape include epithelioid spindleshape cell plasmacytoid round nucleus nuclear chromatin clumping irregular excessive parachromatin clearing single multiple macronucleoli abundant cytoplasm deep brownishblack granule obscure cell detail background show necrosis hemorrhage patient underwent right orbital exenteration follow duodenopancreatectomy whipple procedure complication fig4 surgical speciman show undifferentiated cell extended disposition brown pigment infiltrate pancrea serosa duodenal wall immunohistochemistry positive melana hmb45 vimentin s100 protein negative cytokeratin consistent metastatic malignant melanoma moment patient receive adjuvant chemotherapy outside oncology clinic,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
28yearold african american woman present r adam cowley shock trauma center baltimore maryland evaluation rightside paralysis leftsided paresthesia find home nightstand bed symptom begin eat local restaurant chain consume alcohol smoke cigarette dip liquid phencyclidine pcp asymptomatic night go bed complication find bed follow morning unable patient deny physical trauma fall bed history seizure sickle cell anemia fever urinary bowel incontinence pain patient history viral meningitis residual deficit year prior gastric bypass surgery cholecystectomy treat presume urinary tract infection day prior admission outside institution triage vital sign follow temperature 368c blood pressure 155100 mm hg heart rate 90 beat minute respiratory rate 16 breath minute oxygen saturation 95 room air physical exam patient alert orient person place time cranial nerve iixii grossly intact 25 strength right low extremity 35 left low extremity 45 bilaterally upper extremity sensation intact open eye spontaneously verbal response orient appropriate obey command result glasgow coma scale score 15 pupil equal round reactive light tenderness palpation cervical thoracic lumbar spine obvious external sign trauma anal sphincter tone intact multiple laboratory abnormality note admission include hyperlactemia elevate liver function test electrolyte derangement complete blood count remainder complete metabolic panel normal limit value summarize reference range table 1 toxicology screen positive pcp blood culture draw admission grow aerobic bacteria salmonella enterica serotype 412 repeat culture draw day later grow group b streptococcus aerobic nonaerobic subsequent blood culture negative stool culture metronidazole vancomycin therapy initiate empirically transition ceftriaxone learning culture result addition detailed autoimmunity workup include antinuclear antibody ana hlab27 return normal limit admission computerized tomography scan cervical thoracic lumbar spine reveal spinal fracture magnetic resonance imaging mri reveal acute intracranial abnormality enhancement central aspect c3t2 suggest spinal cord edema disc protrusion c34 c45 c56 bilateral posterior neck muscle edema lumbar puncture initially perform patient admission concern raise intracranial pressure suspect trauma hour presentation strength progressively deteriorate 15 extremity lose proprioception toe bilaterally develop absent anal sphincter tone patient admit neurotrauma intensive care unit deterioration ultimately require endotracheal intubation respiratory failure positive blood culture result lumbar puncture perform demonstrate pattern consistent atm result summarize table 2 extensive workup infectious etiology complete result summarize table 3 plasma exchange therapy initiate suspect diagnosis atm despite maximal medical therapy patient remain quadriplegic experience neurologic pain receive tracheostomy prolong respiratory failure require feed jejunostomy tube placement time report,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
21yearold patient present close emergency department 8 pm nausea numbness left limb incoordination walk dysarthria symptomatology instal progressive mode 4 hour presentation nausea initial symptom start 4 pm headache nuchal pain vomit 530 pm numbness left limb incoordination walk 7 pm dysarthria add entire clinical constellation patient medical history current medication student smoke use recreational drug drink alcohol occasionally family history thromboembolism cardiovascular problem hematologic disease evaluate neurosurgeon emergency unit brain ct scan highlight infracentimetric hypodensity thalamic nucleus left level right cerebellar hemisphere pica territory chest xray reveal widen projection area right hilum pathological finding follow evaluation send national institute neurology cerebrovascular disease consultation special treatment ambulance transportation repeat episode vomit initial physical examination 10 pm show normal vital sign blood pressure 130 80mmhg heart rate 100 beat minute normal body temperature 368c cardiopulmonary exam normal carotid bruit register neurological examination notable normal orientation patient equal reactive pupil divergent strabismu left eye horizontal nystagmus normal deglutition mild paresis left arm ataxia limb accent left extremity numbness left limbs bilateral response present deep tendon reflex babinski sign left stereotypical language patient able repeat word fragment phrase perform simple command medium complexity laboratory analysis highlight normal hemoleucogram normal blood glucose level 911 mmol l normal range 3958mmol l serum creatinine 069mmol l range 0509mmol l total serum cholesterol 52mmol l normal range    52 mmol l test thrombophilia negative present normal sinus rhythm ecg brain ct perform emergency unit mention reveal infracentimetric hypodensity level left thalamic nucleus level right cerebellar hemisphere pica territory doppler ultrasound cerebral cervical blood vessel highlight marked frena flow velocity v2 segment right vertebral artery accentuate aspect high v2 segment complete disappearance flow v3 segment carotid atheromatous lesion modification trajectory arterial caliber overall possibility dissection right vertebral artery high segment indication cerebral angio mri cerebral angio mri show area t2 flair hypersignal important restriction diffusion low adc situate right cerebellar area posteroinferior territory anterior bilateral cerebellar territory leave cerebellar peduncle right    leave thalamic nucleus subcortical occipital bilateral ischemic aspect recently constitute vertebrobasilar territory t1 fs hypersignal present entire intracranial segment right vertebral artery craniospinal junction angiographic arterial 3d tof sequence presence rapid flow right vertebral artery view c2 segment progressive pinch aspect flute beak shape distal level absence rapid flow signal lack right pica visualization mri aspect suggest subacute dissection right vertebral artery cerebral ventricular system normal dimension shape topography pericerebral fluid space basal cistern normal conclusion ischemic lesion recently constitute vertebrobasilar territory subacute dissection right vertebral artery heparin administration start immediately process hospitalization dissection aptt value keep range 5070 second prophylactic therapy stress ulcer perform 7 day debut patient transition acenocumarol longterm anticoagulation treatment acenocumarol institute heparin overlap get inr therapeutic 23 interval evolution favorable patient regain verbal fluency capacity autonomy movement ataxia remit right limb persist left extremity register lot improvement patient discharge home recommendation continue treatment acenocumarol 6 month clinical paraclinical treatment reevaluation 6 month follow possible patient return hospital 6 month,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
73yearold man transfer emergency room sudden chest pain diagnose stsegment elevation myocardial infarction stemi coronary risk factor history smoking 50 year primary percutaneous coronary intervention perform long stringshape contrast defect observe left anterior descend artery fig1a optical coherence tomography oct imaging reveal odd smoothsurfaced 50 mm long object fig1b long white object look like parasitic worm retrieve intracoronary aspiration revascularization successfully complete plaque rupture presence thrombus detect oct fig1c eleventh hospital day transthoracic echocardiography reveal new float object left atrium contrast compute tomography reveal huge 76 cm mass recognize admission right upper pulmonary lobe direct pulmonary vein invasion fig1d bronchoscopic finding negative lung tumor histopathologic examination aspirate coronary object reveal pleomorphic lung carcinoma fig2 patient diagnose stemi coronary embolization associate lung carcinoma brain mri reveal patient asymptomatic cerebral infarction right frontal lobe small parietal lobe lesion diagnose metastasis give observation diagnose right lung carcinoma stage iv ct2bn2m1b treat accord chemotherapy regimen carboplatin    paclitaxel know effective treatment advanced nonsmall cell lung cancer respond treatment show good clinical course fig3 chemotherapy total 9 cycle regimen carcinoma progression suppress year pci followedup regularly,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
76yearold japanese man experience decrease appetite nausea abdominal distension late february 2011 patient pass loose soft stool watery daily result blood test perform primary care physician pcp april june normal upper low gastrointestinal endoscopy show atrophic gastritis assess patient helicobacter pylori antibodie perform rapid urease test histopathological evaluation negative june patient receive medication mental health clinic symptom improve body weight decrease 23 kg stop medication refer department november patient suffer hypertension 30 amlodipine 5 mgday administration initiate 2005 olmesartan 2008 patient currently receive 30 mgday olmesartan deny use new medication nonsteroidal antiinflammatory drug history smoking alcohol consumption physical examination show patient height 165 cm body weight 47 kg body mass index 17 kgm2 body temperature 363 pulse rate 101min blood pressure 10181 mmhg respiratory rate 12 breathsmin saturation pulse oximetry spo2 98 patient heart murmur heart sound jugular venous distension patient bilateral pitting edema low leg present unilateral gazeevoked nystagmus mildly reduce tactile sensation thermal nociception toe dorsal region foot fingertonose test result tandem gait poor patellar achille tendon reflex disappear confabulation observe patient revise hasegawa dementia scale hdsr score 1730 cutoff point 20 hematologic finding follow white blood cell count 6200 l hemoglobin level 125 gdl mean corpuscular volume 884 platelet count 230000 l sodium level 136 meql potassium level 38 meql chlorine level 103 meql iron level 57 gdl reference value 64187 gdl ferritin level 366 ngml reference value 50200 ngml btype natriuretic peptide bnp level 1253 pgml reference value 184 pgml vitamin b1 level 8 ngml reference value 2466 ngml electrocardiogram normal chest xray show normal cardiothoracic ratio 408 pulmonary congestion pleural effusion cranial fluidattenuate inversion recoverymagnetic resonance imaging finding reveal periaqueductal hyperintensitie fig1 wernicke encephalopathy diagnose sinus tachycardia tendency hypotension note clear symptom heart failure dehydration observe infer vitamin b1 deficiency likely play role condition antihypertensive agent discontinue 10 day intravenous administration vitamin b1 patient loss appetite nausea gait disturbance disappear body weight increase 3 kg nystagmus ameliorate physical examination patient confabulation hdsr score absence deep tendon reflex improve gastrointestinal symptom ameliorate blood pressure increase 16090 mmhg pcp resume administration olmesartan late december 2011 week later patient complain recurrent decrease appetite nausea experience diarrhea bowel movement 2day period pass soft stool daily body weight decrease 47 kg come hospital 3 week resumption olmesartan treatment vital sign follow body temperature 351 pulse rate 93min blood pressure 13275 mmhg neurologic finding show worsening symptom laboratory finding follow sodium level 139 meql potassium level 29 meql chlorine level 116 meql hyperchloremia note serum sodium level minus chloride level 139116 23 meql additionally arterial blood gas finding follow ph 725 pco2 25 mmhg hco3 11 mmoll urinalysis finding follow sodium level 15 meql potassium level 13 meql chlorine level 100 meql urine anion gap 72 meql apparent increase bowel movement absence hco3 gastrointestinal tract 6 plain abdominal radiography abdominal compute tomography finding reveal continuous dilation entire intestinal tract fig2 patient diagnose intestinal pseudoobstruction discontinue olmesartan nausea body weight decrease promptly ameliorate duodenal biopsy finding discontinue olmesartan show inflammation observe discontinuation fold structure clearly ameliorate fig3,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O']"
73yearold hispanic male history stage iv chronic kidney disease threevessel coronary artery disease admit coronary artery bypass graft surgery mitral valve repair postoperative day patient develop cardiac tamponade subsequently progress cardiac arrest temporary pacing wire remove advanced cardiovascular life support emergent exploratory sternotomy perform patient transfer intensive care unit icu care patient icu admission renal failure progress require hemodialysis nasogastric tube place postoperative day establish early enteral nutrition peg tube insertion suggest give cognitive impairment poor swallowing function modify barium swallow test coagulation profile prior procedure reveal international normalize ratio 104 partial thromboplastin time 36 second complete blood count show hemoglobin 116 gram deciliter hematocrit 349 281103 platelet microliter blood urea nitrogen 55 milligramsdeciliter serum creatinine 522 milligramsdeciliter patient take aspirin 81 mg day recent cardiac surgery anticoagulant agent history coagulopathy peg tube insertion perform postoperative day intravenous anesthesia esophagogastroduodenoscopy egd accomplish difficulty reveal diffuse moderately erythematous mucosa bleed gastric antrum attempt peg tube placement rapidly expand hematoma figure 1 develop needle insertion site procedure stop patient send icu nasogastric tube single dose intravenous desmopressin 03 microgramkilogram administer suspicion uremic bleeding gastrointestinal bleeding event note assess platelet function platelet function assay pfa order desmopressin injection pfa collagenepinephrine closure time 195 second normal 174 second collagenadp closure time 76 second normal 120 second indicate platelet dysfunction aspirin uremia aspirin discontinue monitor daily complete blood count metabolic panel day later patient undergo second attempt peg tube placement pfa collagenepinephrine closure time prior procedure go 141 second possibly withhold aspirin improvement renal function egd show area flat bluish gastric submucosal bruise site previous hematoma figure 2 peg tube place successfully adjacent site course following month patient continue undergo feed peg tube adverse event,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
46yearold caucasian woman type 2 diabetes mellitus bipolar disorder present emergency department vague abdominal symptom vomit pertinent history include leave knee amputation right toe amputation complication secondary diabetic neuropathy time admission undergo care infect diabetic ulcer right foot note history capd history renal disease creatinine 123 mgdl blood urea nitrogen bun 16 mgdl blood glucose level poorly control subcutaneous insulin injection report range 400 500 mgdl home poor drug compliance blood glucose level decrease range 175 378 mgdl implementation strict insulin regiman admission noncontrast ct scan show confluent bilobar geographic region hypoattenuation subcapsular distribution liver fig1 mri liver protocol perform evaluation indeterminate finding assess possible vascular etiology area infarction possible patient inphase gradient echo image demonstrate hyperintense foci liver distribution correspond hypoattenuate region see ct opposedphase sequence loss signal area indicate presence intracellular fat water fig2 addition area hypointense remain hepatic parenchyma fat suppression mr sequence confirm presence fat establish diagnosis shs furthermore followup ct abdomen pelvis perform 3 month later show near complete resolution finding fig3 note strict glucose control decrease average blood glucose level 200 mgdl,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
36yearold male patient case 6year history diffuse cutaneous ssc fig1 receive regular followup medication therapy experience malaise poor appetite progressive shortness breath 1 month oligouria 3 day admit hospital renal failure pulmonary edema emergency department blood pressure pulse rate respiratory rate 174127 mm hg 88min 22min respectively laboratory analysis reveal follow value white blood cell count 7730l 350011000l hemoglobin 86 gdl 1216 gdl platelet count 87000l 150000400000l blood urea nitrogen 78 mgdl 621 mgdl creatinine 89 mgdl 1115 mgdl calcium 82 mgdl 88103 mgdl phosphorus 54 mgdl 2745 mgdl haptoglobin 656 mgdl 30200 mgdl lactate dehydrogenase 547 ul 106211 ul routine urinalysis reveal proteinuria score 2 200 mgdl white blood cell count 35high power field red blood cell count 2550high power field autoimmune profile indicate antinuclear antibody level 1320 speckle normal 140 test antiscl70 antidoublestrande dna antiro antila anticardiolipin antibody negative kidney echogram show decrease bilateral kidney size hydronephrosis despite chronic change visible echogram patient develop acute pulmonary edema oligouria 3 day admission accordingly clinical diagnosis acuteonchronic renal failure diagnosis src support presence renal failure microangiopathic hemolytic anemia hypertension patient start captopril therapy sustain deterioration renal function anuria lead requirement regular hemodialysis admission 3 day captopril change amlodipine patient develop severe intolerable cough think associate captopril systolic blood pressure control 140 180 mm hg approximately 3 week initiation maintenance hemodialysis patient newly develop generalized tonicclonic seizure disorder brain compute tomography ct scan reveal small lacunar infarct left basal ganglion intracranial hemorrhage large infarct seizure resolve spontaneously anticonvulsant patient finally discharge home incident schedule regular hemodialysis thrice weekly 1 week discharge patient develop suddenonset headache vomit confusion recurrence generalized tonicclonic seizure present emergency department blood pressure 183100 mm hg platelet count 149000l serum ldh 332 ul peripheral blood smear contain 23 schizocyteshpf fig2 brain ct reveal interval change lumbar puncture reveal traumatic tap cerebrospinal fluid culture negative bacteria mycobacterium virus brain magnetic resonance imaging mri show bilateral hyperintensity occipital parietal lobe fluidattenuate inversion recovery flair sequence fig3 finally patient diagnose pre resume captopril therapy dose 25 mg thrice daily difficult differentiate src ttp consider plasma exchange treatment patient mental status return normal 3 day absence plasma exchange followup mri brain 2 month later show complete resolution cerebral edema fig4 srcrelate pre confirm patient experience neurologic recovery renal function improve remain dialysis dependent,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
53yearold woman present institution progressive abdominal distention irregular vaginal bleeding week duration contrast ct abdomen pelvis reveal illdefined irregular mass low uterinecervical region figure 1 multiple peritoneal omental masse enlarge pelvic paraaortic lymph node largevolume ascite initial cbc significant hemoglobin 92 gdl leukocytosis 36 790 microliter thrombocytosis 625 000 microliter serum calcium elevate 131 mgdl bun creatinine normal limit hepatic function normal limit pelvic exam reveal fungate vaginal mass patient underwent biopsy endometrium vaginal mass reveal highgrade tumor predominantly ovalshape cell immunohistochemical staining positive vimentin cd10 cyclin d1 consistent diagnosis highgrade endometrial stromal sarcoma figure 2 tumor negative er rare cell positive pr immunohistochemical staining cytokeratin negative biphasic component entirely rule give small size biopsy specimen relative tumor patient ca125 markedly elevate 1624 uml nl 34 contrast ct chest reveal rightside pleural effusion suspicious nodule lymphadenopathy patient deem operable disease schedule debulke surgery preoperative laboratory study show serum calcium increase 192 mgdl develop evidence acute kidney injury bun rise 37 mgdl creatinine 181 mgdl physical exam note lethargic dry mucous membrane surgery cancel patient medical instability workup reveal elevated pthrp 301 pgml nl 1427 depressed pth level 3 pgml nl 1565 depressed 25oh vitamin d level 16 ngml nl 30100 consistent humoral hypercalcemia malignancy patient treat pamidronate calcitonin intravenous fluid eventually require temporary hemodialysis denosumab refractory hypercalcemia patient improve regard electrolyte abnormality give extent disease plan neoadjuvant chemotherapy follow surgery good response achieve start regimen carboplatin paclitaxel receive 3 cycle palliative radiation uterus control bleeding disease fail respond significantly chemotherapy ultimately die complication malignancy,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
67yearold woman send emergency department fever sore throat medical history include esrd regular hemodialysis 3 time week 15 year hyperuricemia gout comorbidity dyslipidemia hypertension secondary hyperparathyroidism diabete hemogram reveal white blood cell count wbc 700l 2 neutrophil 94 lymphocyte 2 monocyte hemoglobin 111 gdl platelet count 131000l impression febrile neutropenia acute pharyngitis admit hematologic ward survey management broadspectrum antibiotic piperacillin 2 g tazobactam 025 gm iv q8h administer infection sign resolve gradually admission review oral medication glipizide 5 mg tid saxagliptin 25 mg qd fenofibrate 600 mg qd aluminum hydroxide 324 mg tid folic acid 5 mg qd calcium carbonate 1000 mg tid febuxostat 40 mg qd receive epoetinbeta 2000 iu ivtiw febuxostat drug 1 year febuxostat administer 2 month admission inadequate serum uric acid control allopurinol 50 mg qd week febuxostat exposure routine laboratory test reveal wbc 6000l serum uric acid level 98 mgdl febuxostat discontinue causal relationship agranulocytosis exclude survey viral infection autoimmune disorder clinical laboratory evidence epsteinbarr virus cytomegalovirus human immunodeficiency virus infection antinuclear antibody ana antiextractable nuclear antigen antiena negative bone marrow examination hospitalization show hypocellular marrow marked decrease myeloid component evidence hematologic neoplasm chromosome analysis bone marrow normal karyotype patient deny history radiation chemical exposure stop febuxostat 17 day neutropenia improve significantly wbc 2100l neutrophil 66 granulocyte colonystimulate factor gcsf support discharge wbc differential count completely normal followup fig1 study approve institutional review board,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
46yearold woman history grave disease gd transfer emergency department suspicion dka notice polydipsia polyuria fatigue approximately month prior admission suffer 1month complaint appetite loss approximately 7 kg weight loss fatigue nausea sweat medical history include gd diagnose 42 year age manage methimazole poor compliance antithyroid drug deny family history thyroid disease diabete day admission diagnose influenza nearby hospital oseltamivir phosphate prescribe emergency department present drowsiness body temperature 370 blood pressure 9060 mmhg heart rate 200 bpm respiratory rate 32 breathsmin oxygen saturation 99 5 l nasal air glasgow coma scale gcs score 14 clinical examination reveal diffuse goiter bilateral exophthalmos lung clear auscultate abdomen soft nontender skin warm wet low extremity edema electrocardiogram show mark tachycardia atrial fibrillation chest radiograph normal laboratory datum show table 1 initial laboratory datum demonstrate mark metabolic acidosi increase plasma glucose level 472 mgdl increase hba1c level 137 increase free triiodothyronine level 6440 pgml free thyroxine level 2830 ngdl suppressed thyrotropin tsh level 0005 iuml score 55 diagnostic criterion burch    wartofsky thyroid storm diagnostic criterion japan thyroid association thyroid storm satisfied thyrotoxicosis symptom involve central nervous system tachycardia gastrointestinal symptom 4 accordingly diagnose dka thyroid storm admit medical intensive care unit monitoring treatment clinical course show figure treat intravenous insulin drip aggressive intravenous fluid therapy thyroid storm gd treat intravenous hydrocortisone 100 mg 8 hour oral potassium iodine 50 mg 6 hour oral methimazole 20 mg 6 hour history asthma landiolol hydrochloride shortacte betaadrenoceptor blocker 412 gkgmin control heart rate day 3 tachycardia resolve landiolol hydrochloride discontinue day 6 white blood cell count decrease 2800 cellsmm3 neutrophil 442 1238 cellsmm3 methimazole discontinue methimazoleinduced neutropenia suspect patient refer endocrine surgeon thyroidectomy perform day 32 discharge hospital day 37 maintain multiple daily insulin infusion levothyroxine sodium hydrate immunological investigation reveal elevated level antiglutamic acid decarboxylase gad antibody antiinsulinoma antigen 2 ia2 antibody insulin autoantibody consistent t1d intravenous glucagon stimulation test perform blood sample glucose cpeptide take baseline 6 minute plasma glucose level 139 152 mgdl baseline 6 minute respectively corresponding serum cpeptide level 08 13 ngml baseline 6 minute respectively,"['O', 'B-SEX', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
61yearold male refer emergency department general practitioner april 2010 investigation loose bowel motion episode black stool patient history insulindependent type ii diabete mellitus hypertension ischaemic heart disease previous ischaemic event obstructive sleep apnoea depression schizophrenia previous incisional hernia repair examination morbidly obese bmi 45 note mark hepatomegaly associate recent weight loss haematemesis jaundice abdominal pain patient deny previous blood transfusion usage intravenous drug drink alcohol faecal occult blood test negative patient colonoscopy 2 year prior unremarkable refer tertiary centre management ultrasound scan uss display ovoid mass mixed echogenicity arise liver measure 12    9 cm compute tomography ct scan confirm malignant appear pedunculate lesion attach segment iv fig1 subsequent magnetic resonance imaging mri confirm t2 weight image wi lesion isointense liver peripherally central branch hyperintensitie fig2a correspond hypointensitie see t1wi fig2b enhancement lesion note arterial phase fig3a portal venous phase fig3b 2 min fig3c central area nonenhancement lesion slightly hypointense delay image 10 fig3d 20 min compare surround liver laboratory investigation reveal mildly elevate gammaglutamyl transpeptidase 137 iul normal 550 iul hepatitis screen alphafetoprotein carcinoembryonic antigen cancer antigen 199 unremarkable patient undergo subsegmental resection 15 cm segment ivb mass june 2010 severe hepatic steatosis cirrhosis patient discharge postoperative day seven complication pathology resection speciman confirm sftl speciman display pale tan nodular appearance firm rubbery cut surface histological examination reveal fascicle spindle cell storiform arrangement push margin evidence extracellular collagen deposition area myxoid stroma branch vessel hyalinisation speciman display high mitotic rate 9 10 highpower field hpf necrotic haemorrhagic feature immunohistochemistry show positive staining cd34 cd99 bcl2 tumour negative ckit cd31 sma desmin cytokeratin ae1ae3 mnf116 cam 52 ema s100 margin clear nonneoplastic remainder liver display pericellular fibrosis indicative steatohepatitis patient followedup regularly 4 6 month ct scan local general practitioner liaise consultant surgeon episode readmission investigation recurrent right upper quadrant pain 2011 2013 multiple mri scan perform period reveal expect postsurgical change tumour recurrence 2016 patient present local emergency department progressively worsen right upper quadrant pain increase dyspnoea oxygen demand ct chest abdoman pelvis reveal extensive tumour recurrence adjacent previous resection site fig4 addition clinically significant rightside pleural effusion pleural mass right lung base measure 38 cm fig5 pleurocentesis perform drain 1400 ml serosanguineous fluid cytology negative malignant cell case discuss extensively multidisciplinary setting decide give patient site disease significant perioperative risk candidate radical reoperation suitable chemo radiotherapeutic therapy available patient subsequently refer palliative team management symptom discharge community alive 1 month discharge,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O']"
39yearold korean male come hospital complaining cough myalgia fever last 5 day company worker deny previous medical history current smoker drink alcohol month vital sign blood pressure 10060 mmhg heart rate 100min respiratory rate 25 breathsmin body temperature 39 c physical examination decrease breathing sound note right low lung laboratory test reveal creactive protein crp level 119 mgdl total bilirubin level 18 mgdl alanine transaminase aspartate transaminase level 250 172 iul respectively platelet count 98000mm3 white cell count 8150mm3 neutrophil 85 arterial blood gas analysis check room air ph paco2 pao2 bicarbonate oxygen saturation level 750 34 mmhg 67 mmhg 265 mmoll 95 respectively test human immunodeficiency virus negative mycoplasma chlamydia antibody negative streptococcal legionella urinary antigen negative antinuclear antineutrophilic cytoplasmic antibody negative chest xray show consolidation right mid low lung field chest compute tomography show consolidation surround ground glass opacity right middle lobe small pleural effusion right hemithorax fig1 abdominal sonography reveal abnormal finding hepatobiliary system begin administer 4 lmin oxygen nasally empirical antibiotic generation cephalosporin macrolide follow diagnosis communityacquire pneumonia second day hospital patient fever sustain complain dyspnea hypoxemia aggravate require 7 lmin oxygen simple mask consolidation pleural effusion markedly progress fig2a perform bronchoscopy thoracentesis multiplex realtime reverse transcriptase polymerase chain reaction rtpcr respiratory virus bronchoalveolar lavage fluid positive human adenovirus microbiological study negative pleural fluid lymphocytedominant exudate positive human adenovirus diagnosis adenovirus pneumonia start antiviral therapy oral ribavirin 400 mg q 12 h maintain antibiotic hospital day 4 fever subside symptom improve transaminase level crp platelet count gradually normalize fig3 followup chest xray clear fig2b discharge hospital day 13 complication,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 7yearold italian boy bear uneventful gestation normal duration age 16 month present clinically evident enlarge abdomen refer oncological examination initial test reveal anemia thrombocytopenia splenomegaly bone marrow biopsy reveal presence foam cell lead suspicion lysosomal storage disease biochemical testing reveal elevated level acid phosphatase 478 iul normal range 57 iul chitotriosidase activity 508 nmolmg protein normal range 59410 nmolmg protein reduce betaglucosidase activity 2 nmolmgprotein normal range 45180 nmolmgprotein molecular analysis show homozygous l444p mutation gba gene omim reference 606463 confirm diagnosis chronic ngd patient begin ert dosage 60 ukg 2 week age 18 month patient reach age 30 month decide combine ert srt miglustat clinical decision approve institution ethics committee informed consent obtain patient parent commence combination therapy dose miglustat adjust accord patient body surface area uptitrated 4 week follow scheme onethird target dose week 1 2 twothird target dose week 3 4 target dose 100 mg time daily 1 month 2 week start miglustat therapy patient follow specific dietary modification avoid high intake carbohydratecontaine food single meal especially food high disaccharide sucrose maltose ensure acceptable gastrointestinal tolerability experience mild episode diarrhea commence miglustat therapy decrease frequencyseverity time start ertmiglustat combination treatment observe reduction splenomegaly gradual normalization hematological value plasma angiotensinconverte enzyme activity table 1 plasma chitotriosidase evaluate time diagnosis approximately 6 month followup value show initial reduction start ert substantial sustained decrease commencement miglustat treatment fig1 patient follow accord recommend guideline gd specify complete neurological examination clinical evaluation ocular movement psychological evaluation 612 month 10 5 year combination therapy followup patient sign neurological impairment february 2016 display epileptic crisis demonstrate clinical performance cooperation show good muscular tone trophism normal reflex slight hyperreflexia leg negative romberg sign toe heel deambulation normal particular ocular evaluation reveal evidence saccadic movement velocity reduction normal visual evoke potential patient auditory brain response normal addition demonstrate cognitive impairment regularly attend school good performance age 5 year,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
64yearold female find lie 1012 hour binge drink take outlying emergency department ed subsequently transfer hospital mental status change respiratory distress hypoxia management past history rheumatoid arthritis congestive heart failure control hypertension alcoholism smoke pack day past 50 year presentation blood pressure 17680 mmhg heart rate 80 bpm respiration 24 bpm temperature 98f 367c arterial blood gas room air show ph 730 paco2 60 pao2 61 mmhg hco3 29 meql saturation 92 improve 95 oxygen high flow nonrebreather mask physical examination lethargic disorient dysarthritic neurological focalization scatter expiratory wheeze note bilaterally normal heart sound remain result physical examination routine laboratory result unremarkable exception leukocyte count 14000dl 88 neutrophil repeat vital sign consistent normal blood pressure evidence tachycardia monitor repeat abgs nonrebreather mask show ph 722 paco2 78 pao2 140 mm hg hco3 30 meql hemoglobin sao2 97 ed start iv steroid antibiotic copd exacerbation diagnostic workup undergo chest x ray infiltrate major abnormal finding ecg significant sinus tachycardia give negative finding chest x ray sinus tachycardia ecg increase aa gradient patient send spiral chest ct contrast rule pulmonary embolism ct 100150 ml air inadvertently inject right antecubital vein power contrast injector estimate technician approximation volume available imaging concurrent imaging ct show significant air right atrium right ventricular cavity figure 1 air mix contrast main pulmonary artery proximal branch division pulmonary circulation figure 2 concurrently filling defect note right low lobe artery consistent pulmonary thromboembolism figure 3 44 patient maintain hemodynamic stability trendelenburg leave lateral decubitus position durant maneuver supportive care transfer intensive care unit icu observation respiratory distress worsen place temporarily noninvasive positive pressure ventilation nippv improvement hour later intubate place mechanical ventilation intravenous dose heparin infusion initial bolus 80 unitskg follow 18 unitskghour initiate treatment concurrent thromboembolism echocardiography evidence right leave ventricular failure subsequent echocardiography 24 hour later evidence intracardiac air complete resolution air embolism 48 hour remain hemodynamically stable requirement vasoactive agent finally extubate 48 hour initial presentation later discharge home warfarin subsequent outpatient followup,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
73yearold female history coronary artery disease situs inversus recently notice left arm exercise weakness magnetic resonance angiogram computer tomography upper limb vessel show critical stenosis leftside sca calcification near orifice fig1 percutaneous revascularization right femoral artery approach severe left sca stenosis confirm fig2a supplementary video 1 online direct stenting left sca carry balloonexpansible express ld 1025 mm stent boston scientific corporation natick ma usa fig2b 8 atmosphere 13 second severe shortness breath hypotension develop stente blood pressure 8856 heart rate 90 oxygen saturation 74 emergent intubation fluid infusion inotropic agent norepinephrine give immediate angiography show vascular perforation stented segment left sca fig2c supplementary video 2 online emergency balloon inflation stent 840 mm balloon cardiovascular surgeon consult high surgical risk bypass endovascular treatment suggest decide retrograde approach left brachial artery surgical cutdown suitable graft stent cath lab modify cut iliac extension selfexpande endurant ii graft stent 1082 mm medtronic inc minneapolis mn usa originally design treat abdominal aortic aneurysm aaa suitable length 30 mm fig3 retrograde wire operatormodifie endurant ii graft stent deploy stent segment fig2d perforation seal successfully stente graft stent slow flow left common carotid artery lcca note angiography confirm near total occlusion lcca occlude sca graft stent fig2e supplementary video 3 online firm wire conquest pro asahi inc seto japan successfully advance outside graft stent lcca despite sequent balloon dilation bifurcation site flow lcca poor intravascular ultrasound confirm severe compromise lcca ostium cause graft stent fig2f balloonexpansible carotid stent express 737 mm boston scientific corporation lcca left brachiocephalic artery fig4a timi iii flow lcca restore stente fig4be supplementary video 4 online intravascular ultrasound confirm proper expansion lcca stent fig4f followup chest radiography reveal leftside hemothorax thoracocentesis drainage proper care patient discharge till patient free symptom month,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
68yearold female smoker history pulmonary embolism diabetes mellitus diagnose stage iiib t4n2m0 squamous nsclc treat definitive chemoradiotherapy cisplatin vinorelbine september 2014 october 2014 positron emission tomographycompute tomography petct scan demonstrate good response primary lesion new metastasis right adrenal gland right femur develop irradiate november 2014 month later disease progress development multiple bone subcutaneous metastasis point patient suffer severe dyspnea oxygendependent receive cycle carboplatin gemcitabine follow severe pancytopenia treatment switch nivolumab 3 mgkg q14 day january 2015 week cycle nivolumab subcutaneous lesion upper grow substantially accompany severe pain significant inflammatory reaction fig1 subcutaneous metastasis grow slightly second cycle treatment mark symptomatic improvement observe include improvement general appearance dyspnea reduction bone pain patient long require oxygen supplementation subcutaneous lesion start regress complete resolution 12th week improvement bone lesion figs1 2 patient continue nivolumab june 2015 tolerate treatment unfortunately develop bacterial aspiration pneumonia pass away june 2015,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O']"
60yearold woman patient admit hospital feb 18 2016 frequent episode hemoptysis 2 week previous decade patient frequent severe episode hemoptysis typically ensue follow upper respiratory tract infection ear nose throat examination laryngoscope fail identify apparent source bleed ct chest scan reveal abnormality recent episode occur upper respiratory tract infection 2 week ago patient cough 500 ml fresh blood episode hemoptysis alleviate antitussive therapy patient deny history smoking illicit drug use diagnostic workup reveal evidence coagulopathy admission physical examination reveal sign rhonchi reduce breath sound bronchoscopy show 1 cm lesion membranous trachea 2 cm carina tortuous blood vessel observe run submucosa trachea fig1 ct angiography perform demonstrate artery extend submucosa descend aorta fig2 diagnosis dieulafoy disease trachea entertain blood vessel consider culprit hemoptysis selective arterial embolization perform 1 week later fresh episode acute hemoptysis observe patient follow time write report study approve ethics committee shanghai jiao tong university affiliate sixth people hospital get inform write consent patient,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
65yearold woman report persistent pain 3 month symptom severe walk change position slightly relieve take painkiller patient describe pain numbness leg describe bowel bladder voiding difficulty patient report past medical history hypertension coronary heart disease cerebral infarction asthma control physical exam demonstrate kyphosis thoracic spine stand position lumbar vertebra bend forward backward straight activity limit obvious rap pain t12 level patient general medical examination unremarkable upper low extremity motor stretch reflex sensory examination xray compute tomography ct magnetic resonance imaging mri exam perform patient hospital fig1 lateral xray show t12 fracture 40 kyphotic cobb angle ct show intravertebral vacuum sign sagittal t1weighted mri show decrease signal intravertebral vacuum cleft posterior cortex breakage cord compression t12 sagittal t2weighte mri show increase signal intravertebral vacuum cleft patient diagnose kmmell disease stage iii9 operation perform general anesthesia prone position standard posterior exposure spine give pedicle screw insert target vertebrae t10 t11 l1 l2 carm guidance10 screw connect left temporary stabilize rod laminectomy perform decompress fully visualize spinal cord10 careful subperiosteal dissection carry right exposure lateral wall t12 vertebral body anterior aspect reach right pedicle articular process t12 vertebral body remove t11t12 t12l1 intervertebral disk remove temporary stabilize rod replace rod bend desire contour autologous bone graft titanium mesh place intervertebral space rod desire contour connect right adequate hemostasis ensure wound thoroughly irrigate saline drainage tube insert surgical wound close layerbylayer10 time skin incision completion wound closure last 150 minute estimate blood loss total 600 ml postoperatively patient give preventive antibiotic treatment 1 day pain treatment 3 day anticoagulant therapy 1 week drainage tube remove 3 day postoperative volume drainage 50 ml 24 hour patient allow bed custommade plastic orthosis 1 week operation plastic orthosis keep 3 month patient allow hospital 12 day operation surgical suture remove pain assessment conduct visual analogue scale vas vas preoperative 1 week operation 1 year operation 9 score 3 score 2 score respectively demonstrate significant improvement patient resume normal activity return work 3 month operation kyphotic cobb angle preoperative 1 week operation 1 year operation 40 8 17 respectively demonstrate significant improvement fig2,"['O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
18yearold man present history palpable lump presternal area find incidentally weight reduction patient relevant medical trauma history physical examination lesion find nonmovable firm mass tenderness associated skin change detect midline position sternum manubrium level visible fistulous opening discharge lesion ultrasonography detect wellcircumscribe oval anechoic mass posterior acoustic enhancement measure 33    17    31 cm locate subcutaneous fat layer sternum dependent portion mass internal wellcircumscribe heterogeneously hypoechoic eggshape lesion fig1a b show movement accord patient movement mass compress linear transducer fig2a b color doppler study show vascularity cystic mass internal hypoechoic lesion fig1c surgical excision mass perform postoperative complication grossly excise mass welldefine ovoid cystic mass graytan color section find unilocular cyst fill whitish mucous material microscopically mass line ciliated pseudostratifie columnar epithelium suggestive respiratory typemucosa fig3 nonspecific collagenous fibrosis cyst differential diagnosis subcutaneous cyst include epidermal inclusion cyst thyroglossal duct cyst branchial cleft cyst dermoid cyst histological evidence squamous epithelium keratin thyroid tissue skin appendage cystic wall present case mass diagnose bronchogenic cyst,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE']"
23yearold man history severe aplastic anemia saa undergo bone marrow transplantation hlahaploidentical mother january 2014 conditioning regimen consist busulphan cyclophosphamide antithymocyte globulin bucyatg 10 cyclosporine csa shortterm methotrexate mtx plus mycophenolate mofetil mmf prophylaxis graftversushost disease gvhd 11 standard measure adopt prevention infectious complication include fluconazole antifungal prophylaxis acyclovir prevent herpesrelated infection hemogram reveal reconstruction granulocyte anc05109l day 12 posttransplantation patient develop grade ii acute gvhd skin day 42 posttransplantation treat treatment standarddose methylprednisolone achieve complete response cr patient chronic gvhd cgvhd skin gradually progress day 100 posttransplantation treat prednisolone csa day 120 posttransplantation complain cough antibiotic administer blood analysis reveal follow wbc 234109l anc 172109l hemoglobin 85 gl platelet 72109l chest compute tomography ct scan test pathogen routine culturing include blood test betad glucan gtest galactomannan gmtest negative patient cough respond antibiotic empirically initiate treatment voriconazole 6 mgkg12h day follow 4 mgkg12h liver toxicity occur voriconazole treatment antifungal regimen change micafungin 100 mgd persistent cough improve hoarseness develop week treatment    ulcer observe throat laryngoscopy fig1a patient develop severe dyspnea following week antiinfection topical treatment apply fiberoptic bronchoscopy reveal irregular nodular material white moss nearly obstruct bronchus chest ct imaging negative fig1b c histopathological examination biopsy specimen reveal aspergillus species fig1d patient diagnose pseudomembranous aspergillus tracheobronchitis type itba base result bronchoscopy pathological examination 12 antibiotic micafungin treatment cease liposomal amphotericin b liposomal amb administer daily target dose 3 mgkg patient serum creatinine level rise 604 moll 168 moll 7 day liposomal amb treatment progressive renal dysfunction antifungal regimen switch combination posaconazole 400 mg12 h caspofungin 50 mg daily 70 mg dose combination therapy continue 2 week previous nodule throat completely disappear bronchoscopy fig2a repeat chest ct scan show progression fig2b symptom dyspnea gradually progress fiberoptic bronchoscopy perform remove obstructive material patient airway week week symptom relieve final chest ct scan show negative result discontinuation antifungal therapy test negative aspergillus posaconazole administer secondary prophylactic treatment patient discharge hospital patient follow remain free recurrence invasive fungal infection,"['O', 'B-SEX', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
73yearold man diagnose type 2 diabetes mellitus 35 year age severe diabetic neuropathy diabeticesrd complain respiratory distress sudden chest pain day treatment visit emergency room physical examination reveal body temperature 354c heart rate 90 beatsmin regular rhythm blood pressure 13077 mmhg physical examination reveal coarse crackle bilateral lung auscultation laboratory datum show wbc count 8800l shift left neutrophil 82 hb 102 gdl blood urea nitrogen bun 822 mgdl creatinine cre 650 mgdl hba1c 59 creatine kinase ck 189 iul creactive protein crp 851 mgdl braintype natriuretic peptide bnp 1274 pgml chest radiograph reveal perihilar consolidation air bronchogram fig1 electrocardiogram reveal stsegment elevation poor rwave progression lead v1v3 echocardiography reveal apical ventricular asynergy patient diagnose acute myocardial infarction congestive heart failure coronary angiography perform reveal severe angiostenosis septal branch pci perform patient require continuous maintenance dialysis follow day patient go cardiorespiratory arrest cardiopulmonary resuscitation perform follow mechanical ventilation day 8 ventilator assistance discontinue patient produce increase volume sputum begin appear purulent pseudomonas aeruginosa identify sputum culture tazobactampiperacillin tazpipc 45 g q12h administer despite therapy patient respiratory condition worsen chest compute tomography ct scan day 15 reveal bilateral perihilar opacity pleural effusion atelectasisfig2 suspect development complication microbial substitution pneumomycosis perform sputum culturing serum fungal antigen test administration tazpipc change meropenem 05 gday day 16 patient serum test positive cryptococcus antigen day 21 cryptococcal body identify set blood culture liposomal amphotericin b lamb 3 mgkgday administer day 23 cryptococcal body identify sputum cerebrospinal fluid bilateral pleural effusion fig3 patient diagnose disseminate cryptococcosis day 25 brain ct reveal absence intracranial hypertension brain abscess patient infect human immunodeficiency virus hiv administration lamb 3 mgkgday continue day 31 chest ct reveal solitary nodule left lingular segment time suspect pulmonary cryptococcus lesion fig4a day sputum blood bilateral pleural effusion cerebrospinal fluid culture test negative day 52 chest ct reveal lung nodule right pulmonary apical region nodule gradually decrease size day 79 fig4b c lamb consider effective creactive protein level remain elevate bilateral pleural effusion continuously increase patient lose consciousness decrease vital capacity increase bilateral pleural effusion diagnose co2 narcosis patient general condition deteriorate day 87 ventricular fibrillation occur patient die autopsy perform later date cryptococcus isolate identify classify cryptococcus neoformans var grubii serotype genetic analysis,"['O', 'B-SEX', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
82yearold male admit outside hospital emergency room abdominal pain faint previous history auricular fibrillation treatment dicumarinic anticoagulant previous episode abdominal pain diagnose spontaneous mesenchimal haematoma treat non operatively deny kind trauma hematemesis melena physical examination patient stable suffer intense pain right low abdoman defense blood test show haemoglobin level 10 gdl coagulation alter expect ct scan show massive hemoperitoneum figure 1 know mesenteric hematoma figure 2 assume diagnosis expansive mesenteric hematoma plus ongoing bleed laparotomy perform exploration 3 liter fresh old blood clot find 90 cm ileocecal valve torsionate perforate meckel diverticulum intradiverticular bleeding find figure 3 diverticular resection perform postoperatory uneventful patient discharge home 9th postoperative day,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
present case pancreatic tumor history trauma panceratitis 47yearold tunisian man history crohns disease admit university hospital 2015 fluid chronic diarrhea 4 stool day daytime ooddebr associate vomit abdominal pain fever weight loss encrypt date 6 month laboratory test normal nonspecific elevation serum pancreatic enzyme patient undergo abdominal ultrasound compute tomography ct reveal aspect ileitis ileal loop extend 300 mm distended ileal loop upstream cystic image tail pancrea clean wall uncalcified hypodense content fluid density endoluminal bourgeon pancreatic duct dilatation measure 28 x 22 mm figure 1 size head normal enlarged lymph node figure 2 aspect bilateral sacroiliitis bilateral coxarthrosis mri aspect ileitis ileal loop cystic nature pancreatic lesion parietal enhancement caudal portion pancrea slight dilation wirsung gallbladder contain multiple gallstone biliary sludge tumor marker normalon hand colonoscopy terminal ileum appear swollen inflame frequent ulceration biopsy biopsy take subacute ulcerative ileitis compatible crohns disease esophagogastroduodenoscopy normal patient operate laparoscopy caudal pancreatectomy cholecystectomy 15 cm cystic tumor tail pancrea resect send pathological examination postoperative course uneventful patient discharge home 7 day good general condition symptom glucose intolerance normal diet administration microscopic examination reveal differentiate cystic neuro endocrine tumor tail pancreas grade accord classification 2010 mitosis 210cfg ki672    associate neuroendocrine hyperplasia lesion islet langerhan surgical limit healthy ptnm pt2 ectopic spleen chronic cholecystitis patient come outpatient consultation hospital feel severe complaint correct periodic finding normal glucose metabolism,"['O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
54yearold asian man iga nephropathy underwent livingdonor kidney transplantation 14 year previously medical condition stable 14 year develop multifocal salmonpink skin discoloration swelling spontaneous pain left knee leg symptom gradually expand right forearm outside right thigh admit hospital evaluation fever 39 c multifocal cellulitis fig1 month admission develop chronic diarrhea serum creatinine level stabilize 17 mgdl maintenance immunosuppressive therapy comprise tacrolimus 3 mgday mycophenolate mofetil 1500 mgday prednisone 4 mg day tacrolimus trough concentration 63 ngml patient dog breeder 12 year admission white blood cell count 12400l creactive protein level 39 mgdl patient initially treat ampicillinsulbactam 9 gday intravenously day initiation therapy afebrile day later automate blood culture bactec fx bectondickinson company spark md usa show positivity gramnegative spiral bacilli colony obtain patient blood culture analyze malditof ms biotyper ver 30 bruker corporation germany identification score 2064 20 indicate accurate identification h cinaedi fig2 additional evaluation patient blood specifically h cinaedi mean gyrase subunit b gyrbtargete pcr assay forward primer agggattccacaaagtgagc reverse primer tcttgtcctgtgcgttcatc amplify region gyrb gene yield positive result perform gyrbtargete pcr single colony isolate blood culture distilled water dna dnasefree water negative control prevent contamination gyrbtargete pcr fig3 addition perform 16 rrna gene sequence strain result    99 consistent exist sequence fig4 give result diagnose patient h cinaedi bacteremia cellulitis examine genomic heat shock protein hsp 60 sequence blood culture isolate result identification cluster b h cinaedi blood culture obtain 11 day positive h cinaedi culture obtain 15 day negative patient cellulitis gradually resolve patient continue antibiotic treatment total 6 week ampicillinsulbactam drip 2 week oral levofloxacin 4 week recurrence 6 month therapy stool culture negative take treatment apply enteric bacteria elimination case,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
37yearold african american female past medical history significant stage 1 sarcoidosis present facility chief complaint shortness breath year prior present bilateral uveitis lupus pernio lp right ear subsequently diagnose sarcoidosis successfully treat condition sarcoidosis remain quiescent year ago outside institution discover laryngeal involvement treat prednisone 60 mg daily month eventually taper 10 mg daily sarcoidosis remain wellcontrolled maintenance dose prednisone month prior time selfdiscontinue prednisone favor homeopathic treatment nopalea cactus juice unsubstantially claim antiinflammatory property 4 subsequently develop dyspnea exertion progressing dyspnea rest time voice increasingly hoarse experience frequent episode difficulty swallow emergency department physical examination concern respiratory distress present inspiratory stridor hoarseness chronicappeare indurate lesion right ear give sign upper airway disease impend respiratory failure emergent bedside laryngoscopy perform reveal obstruct airway epiglottis retroflex glottis significant edema arytenoid aryepiglottic fold immediately treat highdose intravenous dexamethasone take emergently operating room secure airway concern complete upper airway obstruction confirm direct visualization larynx intubate surgical airway take biopsy lingual surface epiglottis 4 cuff shiley tracheostomy place respiratory status immediately stabilize extubate transfer medical intensive care unit tracheostomy exchange 4 cuffless shiley postoperative day 5 time transition intravenous dexamethasone prednisone 60 mg daily biopsy ultimately reveal nonnecrotizing epithelioid granuloma consistent sarcoidosis figure 1 prescribe highdose prednisone month receive education selftracheostomy care discharge home subsequent onemonth threemonth followup visit deny respiratory issue repeat laryngoscopie show significant improvement edema arytenoid aryepiglottic fold epiglottis continue obscure glottis despite therapy highdose prednisone methotrexate initiate prednisone taper 10 mg daily regimen fail prednisone dosage increase 20 mg daily reduce edema decline surgical treatment continue medical management immunosuppressive therapy facilitate eventual decannulation,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
62yearold female present outpatient department wuhan central hospital tongji medical college september 2015with complaint recurrent infection umbilical region report abdominal pain similar burn sensation accompany discharge faecal matter symptom sign wax wane last 5year attention pique fact patient family describe patient individual cry easily patient history diarrhoea constipation abdominal disturbance surgical treatment mention prior medical history acoordinate physical examination reveal normal vital sign external fistula locate umbilical region redness surround skin morphological examination indicate fistula secretion mainly consist small intestinal juice abdominal wall soft tenderness bowel sound regular escherichia coli enterococcus faecali detect fistula secretion culture finding laboratory examination normal ct scan abdoman reveal intestinal wall adhere abdominal wall navel region bowel obstruction detect fig1 presumptive diagnosis ecf reach diagnosis mainly base digital radiography fistulous tract conduct iopamidol370 contrast agent procedure perform local anaesthesia reveal distal ileum approximately 40 cm ileocaecal junction entrap fig2 patient agree surgery clear preoperative conversation understand operative risk factor sign inform consent bowel preparation patient receive exploratory laparotomy abdominal cavity completely expose loop terminal ileum approximately 40 cm proximal ileocaecal junction find entrap internal hernia ring finding consistent preoperative contrast image defect abdominal wall 10 cm extremely small portion bowel wall stuck retrieve cavity fig3 nonetheless defect result perforation loop fig4 sidetoside ileoileal anastomosis complete utilize 75 mm linear stapler remove affected ileum segment internal hernia ring close plication suture instead mesh repair patient small defect infection risk abdominal cavity thoroughly clean saline solution rubber drainage tube place pelvis scar tissue remove improve wound healing subsequently relaxation suture available close abdomen layer final diagnosis richter hernia present spontaneous ecf reach patient discharge 2 week surgery complication hernia recurrence observe 10 month followup,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
3monthold infant uae geneticallyconfirmed diagnosis jarcholevin syndrome dependent mechanical ventilation birth admit centre implantation veptrs receive intubated patient mechanically ventilate volumecontrolled mode 030045 fraction inspire oxygen fio2 peak inspiratory pressure pip 2345 cm h2o positive endexpiratory pressure peep 7 cm h2o backup respiratory rate rr 34 chest xray thorax perform admission figure 1a month surgery figure 1b show improvement bilateral posterior atelectasis base lung owe difficulty progress weaning process mechanical ventilation veptrs implant expand thorax bronchoscopy perform show bronchomalacia predominantly upper lobar bronchi prolong mechanical ventilation expect tracheostomy previously perform initial ct scan figure 2a followup ct scan figure 2b month surgery show resolution posteriorbasal atelectasis coincide decrease fio2 021 postoperatively patient servoi ventilator volumecontrolled mode need variable pip 25 45 cm h2o peep value 711 cm h2o attempt wean patient ventilator following month unable activate inspiratory flow trigger require significant sedoanalgesia adapt ventilator repeat episode desaturation occasion bradycardia associate bronchial collapse continue asynchrony require bolus sedation addition exist medication initially receive fentanyl midazolam continuous infusion pump progressive increase dose continuous cisatracurium muscular relaxant adapt mechanical ventilation figure 3 clinical stabilisation achieve muscular relaxant withdraw progressive decrease sedation initiate change drug regimen period patient develop ocular flutter attribute pharmacological cause neurological alteration rule normal eeg ophthalmoscopy metabolic workup cranial mri 5 month age nava mode start improve patient adaptation ventilator use neural trigger nava catheter additionally cost 200 catheter accord manufacturer change 5 day require 7 month catheter change 15 day observe deterioration edi signal accord literature jarcholevin syndrome appear mental retardation life expectancy pretty long ethically consider patient opportunity overcome thoracic insufficiency technically possible tachypnoea initially observe rr 55 sign increase work breathing rr eventually return normal age 40 day synchrony achieve ventilator allow progressive decrease sedoanalgesia receive completely withdraw 10 day need extra bolus sedation reduce zero concurrently reduction sedation ocular flutter disappear show significant progress psychomotor development setting nava level 1 cm h2ov peep 11 cm h2o edi trigger 05 v patient tidal volume vt 67 mlkg figure 3 10 day nava mode require type sedation sporadic episode bronchial collapse resolve quick increase peep 20 cm h2o manual ventilation selfinflate bag stabilise nava mode pip oscillate 15 45 cm h2o nava level 04 edi peak 15 100 v posterior pulmonary ct scan perform 2 month surgery 1 month start nava prior thoracic expansion show significant reduction posterobasal atelectase previously observe figure 2b turn 1 year old attempt different device trilogy 100 philip astral 150 resme patient finally tolerate mechanical ventilation home ventilator monnal t50 air liquide volume assistedcontrolle mode follow setting vt 80 ml 9 mlkg peep 10 cm h2o flow trigger 05 lmin pip 30 cm h2o tolerate decrease peep 9 cm h2o short disconnection ventilator currently patient 19 month old able walk neurodevelopment normal,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
40yearold woman visit department obstetric gynecology hospital complaint sudden dyspnea effort previously diagnose endometriosis prescribe combination oral contraceptive pill drospirenoneethinylestradiol betadex trade yaz bayer leverkusen germany follow kumamoto earthquake subsequent aftershock april 2016 spend 7 night vehicle notice sudden dyspnea effort walk outside car 8th morning earthquake walk personal reason daytime spend night small car leg hang position notice swelling pain left low extremity serum ddimer level 132 gml deep vein thrombosis dvt suspect home doctor contrastenhance compute tomography ctscan reveal contrast deficit bilateral pulmonary artery fig2a left low extremity posterior tibial soleus gastrocnemius vein fig2b right ventricular function intact estimate pulmonary artery pressure298 mmhg cardiac ultrasound plasma brain natriuretic peptide highsense troponin t concentration level 972 pgml 00061 ngml respectively diagnose pte admit department admission blood pressure 12980 mmhg heart rate 72 beat minute degree oxygen saturation sao2 arterial blood gas 977 body mass index 244 kgm2 electrocardiography cardiac ultrasound indicate heart failure investigation factor relate thrombus formation include protein c protein s antithrombin antiphospholipid antibody reveal factor normal discontinuation oral contraceptive administration rivaroxaban 30 mg daily direct oral anticoagulant trade xarelto bayer initiate accord result einsteinpe trial 3 7 day followup contrastenhance ct scan reveal reduction thrombosis fig3 patient follow rivaroxaban patient give consent publication study,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
patient 48yearold man previously hospitalize hemoptysis 42 year age time chest radiograph chest compute tomography ct reveal diffuse groundglass opacity ggo bilateral lung field fig12 bronchoscopic examination reveal accumulation large amount blood trachea bronchi fig3 patient bronchoalveolar lavage fluid balf bloody contain numerous hemosiderinladen macrophage culture test balf reveal finding electrocardiogram transthoracic echocardiogram reveal abnormality questionnaire complete time reveal patient hemorrhagic episode family history bleed disease exception young brother diagnose hepatitis c furthermore receive drug potential cause dah follow abovementione examination dah sort vasculitis suspect treatment highdose intravenous methylprednisolone 1000 mg daily 3 day follow prednisolone 25 mg daily initiate relieve symptom chest ct show resolution ggo patient prednisolone dose taper eventually discontinue twoandahalf year discharge hospital patient readmitte hospital recurrence hemoptysis 46 year age abovedescribe therapy initiate lead improvement condition prednisolone dose taper 60 mg daily maintenance dose 5 mg daily 48 year age readmitte hospital recurrence hemoptysis point steroidinduce diabetes mellitus treat glimepiride 3 mg daily admission weight 75 kg height 167 cm vital sign follow blood pressure 178102 mmhg pulse rate 109 beatsmin pulse oximetry 97 room air body temperature 368c chest auscultation reveal fine crackle right lung field skin rash subcutaneous bleeding joint swelling present chest radiograph ct show presence diffuse ggo bilateral lung field mild anemia observe hemoglobin 113 gdl hemoglobin level 146 gdl prior hemoptysis episode activate partial thromboplastin time aptt prolong 535 second normal range 251407 second laboratory test show patient blood glucose hemoglobin a1c level 299 mgdl 82 respectively steroidinduce diabetes mellitus autoantibody collagen disease negative table diagnose condition recurrence dah administer highdose intravenous methylprednisolone 3 day follow prednisolone 60 mg daily condition improve observe previous episode detailed inquiry patient medical history reveal elementary school student hospitalize receive blood transfusion twice follow abnormally heavy bleeding tooth extraction specific congenital bleeding disorder diagnose time reveal young brother diagnose hemophilia b adolescence consider possibility hemophilia blood coagulation factor examine reveal factor ix activity 3 patient subsequently diagnose moderate hemophilia b time diagnosis patient dah resolve corticosteroid therapy decide continue treat patient prednisolone coagulation factor ix replacement therapy recurrence dah hemorrhagic symptom observe 3 year tapering discontinuation prednisolone,"['O', 'O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
34yearold japanese woman diagnosis mctd presence raynauds phenomenon pancytopenia elevate plasma creatinine kinase antibodie u1ribonucleoprotein 2005 receive 10 mg prednisolone daily pulmonary arterial systolic pressure estimate echocardiography slightly elevate 48 mmhg 2006 feel progressive shortness breath physical effort 2011 pulmonary arterial hypertension diagnose 74 mmhg mean pulmonary arterial pressure mpap evaluate right heart catheterization rhc 2012 cyclophosphamidebase immunosuppressive therapy propose refuse possible early menopausal symptom treatment 250 mgday bosentan 120 gday beraprost initiate january 2014 dyspnea deteriorate functional class iv admit hospital physical examination show low systemic blood pressure 8961 mmhg tachycardia 104min low blood oxygen level percutaneous oxygen saturation spo2 95 jugular venous distension severe systemic edema coarse crackle loud pulmonic valve closure sound detect unable undergo 6minute walk test severe dyspnea laboratory examination show elevated plasma brain natriuretic peptide bnp level 9294 pgml hypoxemia pao2 625 mmhg paco2 271 mmhg presence antibody u1ribonucleoprotein 979 uml antinuclear antibodie 1640 speckled pattern chest xray show enlarged pulmonary artery cardiomegaly figure electrocardiogram show p wave elevation v1v2 lead rhc demonstrate elevate mpap 65 mmhg normal pulmonary arterial wedge pressure 12 mmhg high pulmonary vascular resistance 1547 dyneseccm5 decrease cardiac output cardiac index 169 lminm2 ventilationperfusion scan show sign pulmonary thromboembolism sign chronic obstructive pulmonary disease interstitial lung disease find compute tomography dyspnea consider mctdassociate pah refractory bosentan beraprost therapy addition supportive therapy oxygen supplementation diuretic 40 mgday furosemide initiation 60 mgday sildenafil gradual increment dose beraprost choose additional treatment dyspnea remain unchanged plasma bnp level increase ivcy 750 mgm2 4 week initiate dose prednisolone increase 60 mg daily dyspnea ameliorate able undergo 6minute walk test 260 m minimum spo2 95    plasma bnp level decrease initiation ivcy figure month admission followup rhc reveal improved mpap 65 53 mmhg pulmonary vascular resistance 1547 1116 dyneseccm5 cardiac index 169 183 lminm2 table remain stable obtain improvement 18 month admission table consider parenteral prostanoid lung transplantation subsequent treatment,"['O', 'O', 'B-SEX', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
22yearold tibetan man significant past medical history diagnose pulmonary tuberculosis ptb routine medical examination receive antitb therapy include isoniazid inh 300 mgd rmp 450 mgd ethambutol emb 750 mgd pyrazinamide pza 1500 mgd 1 week continuous therapy admit tibet people hospital nasal hemorrhage platelet plt count 04    109l normal range 100300    109l epistaxis cure symptomatic treatment day later develop hematochezia hematuria purpura require transfusion freshfrozen plasma platelet local hospital day later november 18 2015 transfer west china hospital ineffective treatment physical examination present pallor mild jaundice sclera purpura tachycardia heart rate 132min weak breath sound base left lung laboratory result admission indicate dic prothrombin time 178 second normal range 96128 second international normalize ratio 153 normal range 088115 fibrinogen 113 gl normal range 2040 gl ddimer 2345 mgl normal range 055 mgl fibrin degradation product 604 mgl normal range5 mgl plt 2    109l normal range 100300    109l abnormal datum follow white blood cell wbc 4838    109l normal range 3595 hemoglobin 65 gl normal range 130175 gl total bilirubin 308 umoll normal range 50280 umoll direct bilirubin 166 umoll normal range    88 umoll aspartate aminotransferase 75 ul normal range 40 ul alanine aminotransferase 293 ul normal range 50 ul lactate dehydrogenase 380 ul normal range 110220 ul serum urea nitrogen 1301 mmoll normal range 32779 mmoll creactive protein 1670 mgl normal range 5 mgl complement 3 041 gl normal range 07851520 gl complement 4 00797 gl normal range 01450360 gl routine urine test show blood cell 330 cellul leukocyte 250 cellul protein 2 gl urobilinogen 70 umoll routine stool test show red blood cell 4hp white blood cell 1hp occult blood test    tspot result positive realtime polymerase chain reaction analysis mycobacterium tb sputum positive acid fast stain test sputum smear negative chest compute tomography ct admission november 18 2015 fig1 show infiltrate upper lobe left lung leave pleural effusion pericardial effusion accompany enlargement mediastinal lymph nodes abdominal ultrasound show small fluid adjacent liver spleen serologic marker negative acute chronic viral hepatitis hiv direct coomb test autoimmune hepatitis peripheral blood film culture negative bone marrow smear medulloculture negative antituberculosis drug discontinue immediately admission fast initiate infusion freshfrozen plasma platelet pack red blood cell intravenous immune globulin recombinant human thrombopoietin omeprazole polyene phosphatidylcholine nutrition supportive treatment day fast november 23 2015 patient start therapy consist emb moxifloxacin amikacin active hemorrhage day admission november 26 2015 platelet count rise gradually inh 200 mgd intravenously guttae administer 24 day admission december 11 2015 liver function test platelet count return normal main laboratory feature summarize table 1 month later december 17 2015 review chest ct fig1 indicate infiltration hydrothorax pericardial effusion absorb 4 week admission patient recover leave hospital inh 300 mgd emb 750 mgd levofloxacin 500 mgd streptomycin 750000 ud intramuscular injection recurrence dic hemorrhage 8 month followup unfortunately patient refuse followup chest ct discharge table 2 show timeline case,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
34yearold hispanic male significant past medical history present hospital month history cough productive whitish sputum presentation deny fever chill night sweat chest pain hemoptysis pain recent travel sick contact report approximately 1520 pound weight loss month deny smoking socially drank alcohol unprotected sexual intercourse multiple partner past admission temperature 979f heart rate 85 beat minute respiratory rate 16 breath minute blood pressure 10766 mm hg oxygen saturation 100 room air examination show oral thrush decrease breath sound crackle right low lung base cutaneous lesion report rest clinical examination unremarkable complete blood count cbc show hemoglobin 97 gdl wbcs 23109l platelet 164109l creatinine 062 mgdl blood urea nitrogen 10 mgdl radiograph chest show extensive right leave perihilar opacity right compute tomography ct scan chest show right side large perihilar mass figure 1 multiple thoracic lumbar vertebrae rib sternal tiny lytic lesion consistent bony metastasis figure 2 blood sputum culture negative tuberculosis rule consecutive negative sputum smear acid fast bacilli negative quantiferon gold test test positive human immunodeficiency virus hiv cd4 count come 7 cellsul start prophylaxis bactrim 80160 mg daily azithromycin 1200 mg weekly opportunistic infection bronchoscopy biopsy perform unreveale undergo video assist mediastinoscopy biopsy right hilar mass pathology show spindle cell positive cd34 bcl2 vimentin hhv8 diffuse positivity cd31 diagnostic ks start treatment haart form emtricitabine tenofovir disoproxil fumarate 200300 mg dolutegravir 50 mg patient actively involve decision management option favor haart isolated regimen additional chemotherapy condition show continue clinical improvement repeat ct scan chest month show profound regression disease disappearance lesion figure 3,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O']"
58yearold white american male present emergency department ed acute onset confusion disorientation inability walk steadily dehydration associate generalized weakness polyuria polydipsia previous week diagnose cml year early hematological response multiple chemotherapy regimen time treatment allopurinol await allogenic bone marrow transplant vital sign admission ed include heart rate 104 bpm blood pressure 12268 mm hg temperature 997f 376c remarkable finding physical examination altered mental status dehydration laboratory evaluation hemoglobin 133 gdl white blood cell count 183109l neutrophil 796 lymphocyte 72 monocyte 83 platelet count 910109l serum level calcium 186 mgdl phosphate 46 mgdl sodium 135 meql potassium 27 mgdl albumin 40 gdl creatinine 22 mgdl total bilirubin 09 mgdl alkaline phosphatase 125 iul aspartate aminotransferase 41 iul alanine aminotransferase 71 iul spep negative m spike hormone vitamin level pth 85 pgl 1565 pgl phtrp 14 pgl 2 pgl 25oh vitamin d 304 ngml 2050 ngml 125 oh vitamin d3 337 ngml 1864 ngml chest ct scan show diffuse lytic lesion bone destruction visualize thoracic skeleton concern diffuse bone marrow involvement clinical history biochemical finding lead diagnosis cmlassociate hypercalcemia context blast phase treatment aggressive hydration 09 saline calcitonin 400 unit subcutaneous administer additionally zoledronic acid 33 mg intravenous adjust renal insufficiency give day treatment normalization symptom serum calcium level achieve discharge hospital patient continue palliative treatment ponatinib radiotherapy acceptable serum calcium level maintain zoledronic acid 4 mg week despite therapy cancer progress pass away approximately month initial admission hypercalcemia,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
31yearold man develop diabete insipidu urine volume 10 20 l 24 hour 2003 year later complain fatigue anorexia jaundice pruritus symptomatic occipital mass laboratory test show abnormal liver enzyme table 1 patient negative hepatitis virus show fig1 abdominal mri show multiple lowdensity lesion liver t1weighte image obvious expansion intrahepatic bile duct t2weighte image magnetic resonance cholangiopancreatography reveal multifocal intrahepatic bile duct stricture dilatation common hepatic duct normal highly suggestive sc neurohypophyseal area mri show thicken hypothalamic nucleus lowdensity signal 49    56 mm size hypothalamicpituitary area multisystem highrisk organ lch confirm occipital mass biopsie local hospital patient give ursodeoxycholic acid 150 mg 3 time day begin receive course coep chemotherapy cyclophosphamide 1000 mg vincristine 2 mg epirubicin 90 mg prednisone 90 mg 2009 5th day 1st coep chemotherapy patient appear severe liver function injury obvious increase serum bilirubin table 1 refuse chemotherapy year later patient develop liver decompensation bleed esophageal varix ascite splenomegaly refer lt model end stage liver disease score 17 undergo successful orthotopic lt november 2011 center donor come voluntary deceased citizen organ donation china liver histopathology lt reveal micronodular cirrhosis sc positive immunostaine cd1a s100 suggestive lch involve liver fig2 postoperatively man continue immunosuppresse tacrolimus mycofenolate mofetil patient currently normal liver function evidence recurrence lch 4 half year followup,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O']"
december 28 2014 70yearold man complain abdominal pain dizziness nausea refer hebei general hospital hebei china gastroscopy show irregular hemorrhagic ulcerative lesion extend gastric body less curvature pyloric stenosis stomach gastric biopsy reveal adenocarcinoma january 7 2015 palliative gastrectomy plus rouxeny near esophagojejunostomy perform diffuse enlarge paraaortic anterior superior pancreatic lymph node lymph node common hepatic artery resect postoperative pathology demonstrate moderately differentiate gastric adenocarcinoma fig1a immunohistochemistry show follow human epidermal growth factor receptor 2 her2    vascular endothelial growth factor vegf    cd31    cd105    fig1be triple positive tp    glutathione stransferase    gst    topoisomerase enzyme ii    topoii    p53    ki67 70 diagnosis stage iv gastric adenocarcinoma multiple lymphnode metastasis t4n2m1 patient administer 1 cycle chemotherapy oxaliplatin s1 treatment terminate patient tolerate associate gastrointestinal disturbance february 2 2015 adjuvant radiotherapy administer radiotherapy positronemission tomography compute tomography petct show extensive distant metastasis leave supraclavicular mediastinal lymph node lymph node abdominal cavity patient eastern cooperative oncology group ecog performance status 2 body mass index bmi 19 consider risk malnutrition oral apatinib 850 mg day combine follow radiotherapy prescribe informed consent obtain patient prior treatment attempt improve tolerance treatment palliative intensity modulate radiation therapy imrt patient receive dose 64 gy 30 fraction mediastinum dose 52 gy 26 fraction abdominal metastatic lesion n    5 left supraclavicular lymph node treat apatinib figs2 3ac petct scan perform 2 week radiotherapy show 80 reduction maximum standardized uptake value suvmax 2deoxy218ffluorodglucose fdg fdg uptake high left supraclavicular lymph node compare metastatic region treat concurrent apatinib radiation therapy accord response evaluation criterion solid tumor recist clinical effect partial response fig2 patient receive radiotherapy 66 gy 28 fraction left supraclavicular lymph node residual metastasis tumor marker biochemical analysis evaluate 2 month month therapy chest abdominal ct scan indicate stable disease anemia gastrointestinal symptom improve ecog performance status 0 bmi 22 hematologic toxicity hypertension renal dysfunction proteinuria handfoot syndrome observe apatinib therapy september 2015 followup examination show increase carbohydrate antigen 125 ferritin gastroscopy abdominal ct reveal abnormality november 2015 patient difficulty swallow experience intermittent hematochezia apatinib terminate gastrointestinal bleeding gastroscopy reveal anastomotic stenosis gastric cancer intragastric hemorrhage fig3df patient family refuse chemoradiotherapy symptomatic treatment hemostatic drug good supportive care prescribe 1 week therapy hemorrhaging resolve month later patient experience intermittent hematochezia december 20 2015 petct demonstrate extensive metastasis patient family request good supportive care april 16 2016 patient die pulmonary infection,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE']"
44yearold man diagnose lcnec thymus bone metastasis different hospital 3 year previously serum level acth cortisol elevate brain magnetic resonance imaging reveal pituitary gland normal immunohistochemical staining thymic tumor tissue reveal partial antiacth antibody positivity tumor determined ectopically produce acth patient underwent chemotherapy cisplatin irinotecan continuation chemotherapy problematic lack tolerance treatment hypertension diabete cause ectopic acth syndrome initiate treatment zoledronic acid bone metastasis patient refer endocrine center hospital 3 month sensation weakness worsening hyperglycemia physical examination reveal hypertension subcutaneous mass palpable anterior chest redness swelling left low leg fever respiratory symptom hypoxemia abnormal chest sound oxygen saturation pulse oximeter room air 97 respiratory rate 13 breath minute laboratory finding white blood cell neutrophil count blood sugar triglyceride lowdensity lipoprotein cholesterol level find elevate patient potassium level decrease 28 meql patient lactate dehydrogenase 468 iul betad glucan 3708 pgml acth 3541 pgml cortisol 491 gdl level elevate patient serum negative aspergillus candida cryptococcus antigen cytomegalovirus pp65 antigenemia test yield negative result datum suggest increase production acth tumor progression disease promote elevation patient serum level acth cortisol compute tomography ct reveal progression disease thymic metastatic bone lesion multiple groundglass opacity lung fig1 2 patient underwent bronchoalveolar lavage bal right b5 segment 150 ml saline 627 bal fluid recover cell count bal fluid 061105 ml cell differentiation bal fluid 170 macrophage 810 lymphocyte 20 neutrophil cd 48 ratio 057 gram ziehlneelsen grocott staining negative polymerase chain reaction reveal patient bal fluid positive pneumocystis jirovecii pcp diagnose base result patient treat sulfamethoxazoletrimethoprim 12 gday 3 week anticortisol therapy metyrapone initiate time small dose slowly correct hypercortisolemia intensive insulin therapy potassium supplementation initiate cefazolin administer treat cellulitis left low leg patient pcp fully improve exacerbation respiratory status continue administer sulfamethoxazoletrimethoprim prophylactic dose metyrapone dosage gradually increase 250 mgday blood cortisol value observe decline slowly fig3 order prevent hypocortisolemia patient temporarily treat hydrocortisone improvement left low leg cellulitis pcp hyperglycemia patient underwent laminectomy radiation therapy spinal cord compression cause metastatic spinal tumor octreotide therapy initiate discharge 68th day hospitalization,"['O', 'B-SEX', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
68yearold man refer internal medicine department razi hospital rasht city north iran hypogastric region discomfort especially right low quadrant month pain colicky form episode day episode last 45 minute pain radiate alleviate rest association pain defecation eating report furthermore patient complain 23 kg weight loss month follow anorexia symptom nausea vomiting fever shake chill demonstrate admit center week refer hospital evaluation patient undergo surgery prostatectomy seven year presentation center history endoscopy year early dyspepsia find helicobacter pylori positive time eradicate treatment course history hiv diabete smoking alcohol consumption record vital sign normal time admission physical examination abdoman soft distention bowel sound normoactive tenderness right low quadrant abdoman rebound state note peripheral blood analysis show table 1 stool examination urine analysis evaluation electrolyte normal abdominal ct scan show welldemarcated homogenous solitary mass cecum distention ileum ileum wall thicken figure 1 colonoscopy reveal large mass like lesion cecum figure 2 procedure biopsy take cecum lamina propria infiltrate number pmnc admix eosinophil figure 3 immunohistochemical evaluation positive vimentin cd68 ckit cd117 negative cd34 smooth muscle actin sma alk focally positive report cyclin d1 desmin pancytokeratin figure 4when colonoscopy perform evidence invasive obstruction lead suspicion malignant tumor pathological confirmation imt patient refer surgery order remove mass surgery approximately 40 ml ascite find abdomen mass see cecum ileocolic intussusception patient undergo right hemicolectomy endtoend anastomosis ileocolic enlarge lymph node observe patient discharge seven day surgery complication followup,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
51yearold g1p1 caucasian female lifelong neurogenic bladder secondary spina bifida occulta refer symptom constipation fi average bristol type 12 stool 5 day require frequent manual disimpaction additionally report twice weekly episode urgent fecal seepage require use daily continence pad symptom improve addition psyllium bisacodyl suppositorie defecography suggest atrophy puborectalis poor squeeze eas muscle atrophy anorectal manometry arm show normal resting pressure augmentation squeeze pressure consistent weak eas figure 1 bear fix perineal descent note inability widen posterior anorectal angle poor evacuation contrast strain consistent dd push arm similarly demonstrate type iv dd classify inability generate adequate propulsive force absent incomplete relaxation anal sphincter 8 figure 2 reflex sensory testing indicate intact rectoanal inhibitory reflex rectal hypersensitivity patient fail management home conventional biofeedback therapy follow successful trial temporary sns improvement fi symptom 75 patient permanent sns place year later patient report sustain improvement constipation fi symptom,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
52yearold man 30year history smoking present abnormal nodule measure 08    15 cm left upper lung lobe image chest compute tomography ct scanning march 2012 community hospital previously additional relevant abnormal symptom physical examination suggest significant abnormality laboratory finding normal range carcinoembryonic antigen cea level 3025 ngml normal range 05 ngml find serum subsequently positron emission tomography petct scan show lung lesion standardized uptake value 794 highly suspect malignant tumor fig1 subsequently undergo leave upper lung lobectomy lymph node dissection postoperative pathological examination reveal adenocarcinoma adc fig2a immunohistochemistry ihc stain result positive ck7 ttf1 p63 napsina negative ck 56 syn cga ki67 2030 clinical stage classify ia2 pt1bn0m0 tumor early stage patient receive adjuvant treatment continue monitor regular hospital visit 3 month patient condition stable onset left chest pain april 2015 patient transfer hospital tertiary care hospital treatment physical examination suggest significant tender point left chest wall laboratory finding show single parameter outside normal range cytokeratin19 fragment antigen 211 cyfra211 level 1745 ngml serum normal range    033 ngml ct petct scan highlight involvement left pleura show bilateral lung lesion fig3a e point clinical stage upgrade ivb ctguide left pleura puncture pathological ihc analysis show positive staining p63 p40 ck 7 ck 56 ttf1 napsina staining absent support diagnosis squamous cell carcinoma scc fig2b molecular evaluation confirm l858r mutation exon 21 t790 m mutation exon 20 fig4b c consider pathology scc distinct compare originally resect nsclc speciman retrospectively reassess surgery speciman verify primary diagnosis morphologic ihc result complete agreement initial diagnosis l858r mutation identify newly add molecular evaluation fig4a relieve acute pain left pleura quickly possible palliative threedimensional conformal radiotherapy 3dcrt chest lesion deliver total dose 42 gy14 fraction f daily 5fweek fig5 volume radiation dose 5 gy v5 value left right total lung 20 0 78 respectively volume radiation dose 20 gy v20 value 10 0 5 respectively mean lung dose mld 5 gy consider mst pathology scc patient receive gp chemotherapy cisplatin 75 mgm2 d1 gemcitabine 1250 mgm2 d1 d8 21 day cycle 4 cycle patient achieve partial remission pr 2 cycle follow stable disease sd 4 cycle fig3b3b f c g accord response evaluation criterion solid tumor recist 11 gefitinib 150 mg qd maintenance treatment november 2015 onward treatment ibandronate sodium give monthly skeletalrelate event patient currently surveillance sd fig3d h ps score 0,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
57yearold male admit hospital 5 month history massive rectal bleeding rectorrhagia past history passage fresh blood mix stool 55 year complain rectal bleeding age 2 go hospital numerous time symptom multiple intervention disease cure completely hospital visit past patient forget date diagnose treat hemorrhoid symptom relieve recur thirty year ago diagnose rectal hemangioma manage cryotherapy hospital relieve symptom year recur consult hospital shortterm symptomatic relief proper treatment cause 5 month severity rectal bleeding increase go local hospital intervention control bleeding symptomatic treatment intravenous fluid blood transfusion finally refer hospital evaluation intermediate rectal bleeding fresh blood present admission patient complain dizziness stand shortness breath palpitation walk short distance history similar illness family general examination patient appear pale heart rate blood pressure normal limit rest lose 5 kg body weight 5 month rectal examination fresh blood see anal region soft mass feel digital rectal examination proctoscopy anal cavity rectum see fill fresh blood active site bleed polyp ulcer detect laboratory examination red blood cell count 309    1012l normal 432572    1012l hemoglobin 86 gl normal 135175 gl parameter normal limit enhance ct show isodense 35 hu homogenous bowel wall thicken contrastenhance ct venous phase enhance heterogeneously multiple calcification see thicken bowel wall perirectal area lesion see extend distal sigmoid rectum fig1 multiple hypodense lesion see spleen fig2 initial management anemia patient underwent abdominal laparotomy follow surgical excision surgery 25 cm long lesion find extend distal sigmoid rectum rectum sigmoid colon excise sigmoidanus anastomosis postsurgical histopathological examination excise speciman show submucosal multiple thinwalle vessel vary size interpose stroma vessel luman consist blood cell consistent blood vessel consist clear fluid consistent lymph vessel immunohistochemistry speciman show endothelial cell positive cd 31 cd 34 cell positive d240 negative d240 fig3 basis histopathological report immunohistochemistry hemolymphangioma diagnose surgery follow complication intestinal infection manage patient discharge hospital 23rd day surgery complication recurrence notice 6 month followup study approve affiliated hospital sun yatsen university institutional review board write consent case report obtain patient,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
report case 68yearold female past medical history present upper gastrointestinal bleeding pain leave upper abdoman physical examination find splenomegaly sign portosystemic collateral formation include abdominal wall dilate vein rectal haemorrhoid biological abnormality note hypersplenism anaemia thrombocytopenia patient undergo upper gastrointestinal endoscopy show stage iii oesophageal varix portal hypertensive gastropathy red sign ultrasonography reveal fusiform dilatation portal bifurcation measure 40 mm diameter dilate branch sign portal thrombosis detect figure 1 portal doppler study show normal hepatopetal flow sign portal hypertension find include splenomegaly repermeation umbilical vein splenorenal collateral circulation complementary angioct allow well assessment portal system contain thin calcification aneurysmal wall main portal trunk figure 2 figure 3 figure 4 sign portal hypertension note oesophageal gastric varix parietal collateral circulation associate ultrasonography finding liver cirrhosis confirm transcient elastometry biopsy,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O']"
64yearold man admit department gastroenterology affiliated hospital qingdao university medical college qingdao china epigastric pain physical examination reveal palpable mass lymphadenopathy organomegaly endoscopy submucosal lesion identify gastric antrum duodenal bulb fig1 endoscopic ultrasonography eus olympus eus eume2 miniprobe sonography demonstrate lesion 05 cm homogeneously hypoechoic neoplasm originate submucous layer fig2 initial diagnosis digestive neuroendocrine tumor compute tomography reveal enlarged lymph node multiple region mediastinal retroperitoneal mesenteric inguinal intracavitary nodule duodenum reach definitive diagnosis patient underwent repeat eus biopsy perform endoscopy 2    1 cm columnar uplift terminal ileum multiple submucosal lesion rectum identify fig3 eus reveal lesion terminal ileum size 16    12 cm lesion rectum size 06    10 cm homogeneously hypoechoic originate muscularis mucosa layer pathological examination biopsie specimen lesion rectum show diffuse lymphomatous proliferation dense infiltration monomorphic small cleaved cell irregularly shape nuclei fig4 immunohistochemical analysis cell positive cyclin d1 cd20 cd21 sox11 bcl2 negative cd3 cd10 compatible diagnosis mcl ki67 staining reveal proliferative index 30 base finding diagnosis ann arbor stage iv mcl confirm patient refer combination chemotherapy rituximab cyclophosphamide doxorubicin vincristine prednisone rchop regimen patient remission clinically,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O']"
78yearold previously healthy male heavy smoker present emergency department generalized jaundice sclera skin ascite hepatic coma relative declare know urinary bladder carcinoma diagnose routine control perform 3 month medical paper prove diagnosis show mention 2month history progressive jaundice somnolence temporary loss consciousness weight loss clinical sign mention previously viral hepatitis drug excess report family history cancer declare present admission abdominal ct scan show mark hepatomegaly multiple small nodule 210 mm diameter suppose hepatic metastasis bladder carcinoma thoracic xray show bilateral bronchopneumonia abnormal opacity patient die hepatic encephalopathy 7 hour admission prior autopsy sign informed consent relative obtain case publication case report ethical committee approval necessary autopsy macroscopic examination show huge liver 65 kg widely distribute white nodule vary size fig1 urinary bladder modify 30    30    50 mm prostate nodule infiltrative aspect observe fig2 bilateral bronchopneumonia confirm central tumor mass 10 mm white nodule identify encase small bronchus middle lobe right lung peripheral nodule fig3 moderate edema brain lesion identify organ modification tissue fix 10 neutral formalin embed paraffin iliac crest bone graft microscopic examination prostate show 33 gleason grade 2 occult adenocarcinoma fig2 cluster sheet small round cell see liver parenchyma fig1 lymph node hepatic hilum examination lung parenchyma show peribronchial sclc multiple tumor embolus vein lymphatic vessel multiple coinshape tumor nodule 1 2 mm diameter pleura fig3 small round tumor cell see bone marrow iliac crest bone fig3 brain metastasis detect base macro microscopic feature clinical picture final diagnosis peribronchial coinlike peripheral sclc massive angiolymphatic invasion metastasis lymph node liver bone associate encephalopathy synchronous occult adenocarcinoma prostate,"['O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
18yearold college student refer university clinic have low hemoglobin hg 47 gdl completely till month present easy fatigability postural dizziness palpitation dyspnea give history 30 kg weight loss past 6 month physical examination look pale jaundice cyanose vital sign normal limit elevated heart rate 98min cardiovascular respiratory abdominal examination unremarkable primary investigation hospital reveal low hemoglobin level 51 gdl low iron 10 ugdl positive occult blood test provisional diagnosis microcytic hypochromic anemia workup bone marrow aspirate trephine biopsy reveal normocellular marrow depict normal trilineage hematopoiesis upper gi endoscopy show erosive antral gastritis patchy ulcerative inflammation abdominal ultrasound show slightly enlarged liver rounded echogenic lesion anterior wall right lobe suggestive hemangioma spleen slightly enlarge normal echogenicity focal lesion compute tomography ct scan abdomen pelvis show fairly large define soft tissue mass locate anterior upper pelvis engulf jejunal loop cause bowel wall thicken patient undergo exploratory laparotomy excision jejunal mass macroscopic examination reveal 11    8    2 cm annular mass locate jejunal wall ulcerate mucosa extend serosal surface microscopic examination reveal tumor situate muscularis propria extend mucosa serosa neoplastic cell arrange predominantly pseudoalveolar pattern fig1ab polygonal shape variable eosinophilic clear cytoplasm fig1c nucleus oval vesicular chromatin inconspicuous nucleolus scatter osteoclastlike multinucleate giant cell identify fig1bc frequent mitotic figure necrosis note lymph node involve tumor immunohistochemically neoplastic cell strongly diffusely positive s100 protein fig1d positive vimentin melanocytic marker hmb45 melan neuroendocrine marker chromogranin synaptophysin cd56 smooth muscle actin desmin cd34 cd117 cytokeratin lca negative neoplastic cell fluorescein situ hybridization fish analysis ewsr1 break apart probe paraffinembedde tumor show evidence 22q12 rearrangement 197 205 96 interphase nucleus score native state ewsr1 break apart probe see adjacent fuse overlap redgreen yellow signal ewsr1 gene rearrangement present red green separate signal fig1e patient receive chemotherapy radiotherapy clinical follow patient remain disease free 3 year present local recurrence treatment plan surgical resection patient seek medical advice different institution die disease year later,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
84yearold woman present local clinic dyspnea exertion leave pain persist month admit hospital leave pleural effusion chest xray suffer hypertension dyslipidemia history pleural tuberculosis chronic pyothorax smoking history dust exposure examination vital sign oxygen saturation normal spo2 96 ambient air chest examination reveal mass left pain decrease breathing sound left lowerlung field rest examination finding normal laboratory test reveal elevated level c reactive protein lactate dehydrogenase ldh soluble interleukin2 receptor sil2r table 1 chest xray fig1 show leave pleural effusion mediastinal shift hospital day intercostal drainage tube insert drainage chest compute tomography ct fig2 reveal irregular pleural mass invade left chest wall rib destruction pleural effusion mass adjacent posterior mediastinum lateral mass thick invade chest wall diagnose mass chest wall tumor pleural fluid serous purulent fluid analysis show exudative 81 white blood cell lymphocyte fluid culture negative cytology evidence malignancy table 1 ctguided needle biopsy perform histopathology result support diagnosis diffuse large bcell lymphoma dlbcl positive cd10 cd20 negative cd3 cd5 fig3 18fluorodeoxyglucose positron emission tomographycompute tomography fdgpetct reveal high fdg uptake left chest wall mass uptake fig4a b diagnose primary malignant lymphoma originate chest wall reconfirm medical history tuberculous pleurisy pyothorax performance status ps 3 pain fatigue owe bad ps age difficult perform operation administer combination chemotherapy rituximab lowdose oral etoposide 50 mgday d114 q28 administer pleural effusion disappear week pain disappear ps improve 1 month chest ct perform month later show complete response fig4c d continue oral chemotherapy maintain good ps year diagnosis,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
82yearold woman transfer hospital dyspnea massive hemoptysis patient history bronchial asthma wellcontrolle bronchodilator medication history tuberculosis nontuberculous mycobacterial infection smoke physical examination reveal diffuse bilateral crackle suffer severe hypoxemia ph 7362 pco2 351 mmhg po2 610 mmhg hco3 201 mmhg 55 mmhg spo2 905 10 l o2min reservoir mask tracheal intubation 100 ml brightred blood aspirate chest radiograph show bilateral infiltrate fig1 chest ct demonstrate multiple consolidation ground glass opacity focal bronchiectasis right segment 4 s4 fig2 spaceoccupye lesion day admission respiratory condition improve active hemorrhaging tracheal tube extubate small bloody sputum cough determine origin bleed undergo contrastenhance ct show bronchiectasis right s4 regression infiltration cta reveal abnormal vascular anastomosis right inferior phrenic artery right pulmonary artery focal bronchiectasis right middle lobe fig3 lead suspect possible source massive hemoptysis perform embolization superselecte right inferior phrenic artery 22fr microcatheter fig4 angiogram right bronchial artery show obvious active bleeding week embolization successfully discharge free recurrent hemoptysis year,"['O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
65yearold man 45year history cigarette smoking visit hospital diagnosis abnormal chest shadow xray remarkable medical history prescribe anticoagulant antiplatelet agent compute tomography ct scan reveal huge mass left upper lobe maximum size 110 cm diameter subsequently expand left hilum mediastinum intrapulmonary metastasis locate left low lobe pleural effusion left multiple liver tumor range 05 47 cm diameter fig1 note liver metastasis locate subcapsularly liver surface irregularly distort laboratory finding follow white blood cell count 11900mm3 hemoglobin 148 gdl platelet count 214000mm3 aspartate transaminase 31 iul alanine transaminase 19 iul lactate dehydrogenase ldh 749 iul coagulation abnormality find subsequent histological examination tumor speciman obtain bronchoscopy confirm diagnosis small cell carcinoma consider clinical diagnosis performance status age patient decide regimen antitumor chemotherapy consist cisplatin 60 mgm2 body surface area day 1 etoposide 100 mgm2 body surface area day 13 day 2 week initial ct scan start chemotherapy session day 3 initiate chemotherapy complain abdominal discomfort vital sign show tachycardia 120 beat minute hypotension 8555 mmhg hematological examination show severe anemia hemoglobin 67 gdl dramatically drop 148 gdl 10 day attempt identify bleeding site gastrointestinal endoscopy avail ct scan reveal rapid enlargement liver tumor left lobe contain partial highdensity area plain scan novel finding ascite show high density usual suggest ruptured liver metastasis associate hemorrhagic ascite fig2 subsequent contrastenhance ct image negative extravasation undergo angiography left right hepatic artery observe obscure tumor vessel left hepatic lobe extravasation fig3a suspect hypovascularity metastatic tumor inactive bleeding time benefit therapeutic embolization hepatic artery uncertain base finding angiography perform transcatheter arterial embolization tae left main hepatic artery gelform particle prevent future rebleeding postembolization angiography reveal slow blood flow left hepatic artery peripheral vessel weakly visualize fig3b embolization concomitant supportive therapy include rbc transfusion 6 u total clinical course patient stabilize blood pressure remain 12070 mmhg tachycardia disappear anemia improve transfusion progress liver dysfunction appear month embolization relatively good health restart antitumor chemotherapy continue firstline regiman course good partial response gain chemotherapy lung liver lesion,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
33yearold moroccan man 5month history recur sinusitis present temperature myalgia cough hemoptysis thoracic physical examination reveal reduce vesicular murmur chest xray show bilateral diffuse alveolar infiltrate laboratory analysis show elevation acutephase protein crp 26 mgdl creatinine 12 mgdl nonnephrotic proteinuria microscopic glomerular hematuria antibiotic therapy community acquire atypical pneumoniae levofloxacin 500 mg daily iv establish 3rd day admission patient develop respiratory failure unresponsive noninvasive ventilation intubate white lung consolidation ground glass area compute tomography scan fig1 diffuse airway bleed fiberoptic bronchoscopy mild normocytic anemia 9 gdl ancapr3 positivity 189 uml consistent diagnosis gpa despite maximal ventilatory support gas exchange improve ph 733 pao2 71 mm hg paco2 51 mm hg hco3 25 mmoll sao2 94 require extracorporeal membrane oxygenation ecmo treatment highdose methylprednisolone 1 g daily 3 day 1 mgkg daily cyclophosphamide 12 gpulse 2 week 1st 3 pulse follow infusion 3 week 2 pulse plasma exchange pe accord european vasculitis study group recommendations4 immediately start respiratory improvement allow ecmo orotracheal tube withdrawal subsequent discharge intensive care unit 9 day beginning treatment ancapr3 level normalize 3 uml month later 5th bolus cyclophosphamide prednisone 03 mgkgday patient complain arthromyalgia testicular pain edema cough shortness breath laboratory datum show worsen renal function mild anemia hypoxemia pao2 61 mm hg epididymitis confirm ultrasound rapidly progressive renal failure estimate glomerular filtration rate 35 mlmin renal biopsy perform show prominent intracapillary extracapillary proliferation formation fibrocellular crescent focal capillary necrosis fig2 lung compute tomographyscan fiberoptic bronchoscopy confirm alveolar hemorrhage relapse treatment highdose methylprednisolone 1 g daily 3 consecutive day rituximab 375 mgm2 weekly 4 week start rapid resolution urologic pulmonary involvement delayed partial improvement renal function 1year followup patient alive treatment azathioprine 150 mg daily prednisone 15 mg daily renal function markedly improve estimate glomerular filtration rate 94 mlmin gasexchange ph 742 pao2 86 mm hg paco2 36 mm hg hco3 23 mmoll sao2 95 patient sign institutional inform consent form time admission hospitalization approval ethic committee necessary routine health care,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
41yearold caucasian woman undergo primary double lung transplantation cystic fibrosis 2006 medical history unremarkable patient know history pulmonary tuberculosis tuberculosis contact december 2015 undergo retransplantation chronic lung allograft dysfunction month precede retransplantation 4 sputum specimen remain negative acidfast bacilli specific m tuberculosis culture realtime polymerase chain reaction pcr testing postoperative day 42 deterioration respiratory status prompt chestcomputerize tomography ct scan reveal subcentimeter bilateral nodule primarily locate apical posterior lobe bilateral pleural effusion fig1 day bronchoalveolar lavage bal yield positive realtime pcr rifampicinsusceptible m tuberculosis confirm culture postoperative day 62 tuberculin skin test tst interferon release assay igra test perform bal perform postoperative period yield pathogen perform day 60 cultured pseudomonas aeruginosa adjunctive antibiotic therapy imipenemcilastatin 3 gd histological examination lung biopsy perform 6 week retransplantation reveal caseate granuloma necrosis acidfast bacilli identify rifampicinsusceptible m tuberculosis realtime pcr postoperative day 65 patient status worsen severe hypoxemia shock unresponsive high dose cathecolamine multiorgan failure patient die postoperative day 70 despite treatment combine isoniazid rifampicin ethambutol pyrazinamide retrospective realtime pcr testing explanted lung bal perform postoperative day 1 7 21 remain negative organ donor die posttraumatic intracerebral hemorrhage 47yearold man history lung disease risk factor tuberculosis chronic alcohol use smoking tst result available hospitalization lung ctscan show sign active previous tuberculosis tst igra test result available routine culture pertransplantation right lung biopsy yield candida albican retrospective m tuberculosis realtime pcr yield negative result left right donorlung biopsy kidney donor transplant 2 recipient month transplantation kidney recipient develop sign symptom suggestive active tuberculosis,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
16yearold female suffer abdominal pain right upper quadrant last 10 day shortly ahead medical consultation 4 ascarislike worm vomit individually length 10 cm previous onset ascariasis lowgrade fever 384c occur apparent jaundice diarrhea anemia physical examination reveal tenderness right upper quadrant total leukocyte count 112 gl consist 52 eosinophil serum urine amylase 386 928 ul respectively term liver functionality level total bilirubin rise 232 ml hepatic enzyme similarly elevate alanine aminotransferase 163 ul aspartate aminotransferase 96 ul abdominal ultrasound describe enlargement gallbladder upper segment common bile duct 15 cm diameter intrahepatic bile duct 13 cm diameter furthermore intrahepatic bile duct discover fill echogenic band substance base evidence clinically diagnose biliary ascariasis concomitant manifestation biliary duct infection laparoscopic exploration enlarged gallbladder common bile duct visually confirm massive storage worm biliary tract subsequently 1 cm incision common bile duct order facilitate extraction pathogenic worm place specimen bag laparoscopically fig1 contain worm virtually clear laparoscope chodedochoscopy employ seek hidden worm inside biliary system fig2 finish removal ascaride biliary duct incision suture ttube place situ fig3 eventually standard laparoscopic cholecystectomy perform follow removal speciman bag drainage tube placement fig4 total worm inside common bile duct sum 100 fig5 postoperatively treat oral antihelminthic drug 3 day ttube rinse saline day 3 day 6 worm additionally wash patient experience smooth postoperative recovery finally discharge hospital complication,"['O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
41yearold man history alcoholism 10 year sober 3 year recurrent alcoholic pancreatitis known liver disease present episode hematemesis abdominal pain 2 day esophagogastroduodenoscopy egd perform 3 year early abdominal pain reveal esophageal varix gastric varix portal hypertensive gastropathy gi lesion physical examination reveal blood pressure    10060 mm hg pulse    60 beatsmin jaundice stigmata chronic liver disease soft abdoman mild epigastric tenderness rebound tenderness abdominal bruit pulsatile abdominal mass rectal examination reveal gross melena laboratory test reveal hemoglobin    125 gdl platelet    301000ml inr international normalize ratio    10 blood urea nitrogen    20 mgdl creatinine    11 mgdl serum aspartate aminotransferase    21 iul alanine aminotransferase    16 iul total bilirubin    06 mgdl alkaline phosphatase    64 iul albumin    44 gmdl lipase    32 udl hemoglobin decline acutely 93 gdl abdominopelvic computerized tomography ct intravenous contrast reveal 5 cm wide irregular pancreaticperipancreatic mass compress less curvature stomach sv fig1a b normal portal vein normal liver parenchyma sv compression pathophysiologically significant indicate proximal sv dilatation egd reveal proximal stomach fine reticular palewhite polygonal mucosal network snakeskin pattern characteristic portal hypertensive gastropathy actively ooze extensive coffeeground blood clot stomach small gastric cardial fundal varix stigmata recent hemorrhage srh esophageal varix fig2 extrinsic mass produce large round bulge extend luman proximal gastric body less curvature fig2 magnetic resonance cholangiopancreatography mrcp reveal 5 cm wide enhance vascular mass likely arise lga locate gastric less curvature distal pancreatic body compress stomach compress middle sv result large collateral vein drain sv superior mesenteric vein fig3a b abdominal ultrasound doppler study demonstrate large turbulent arterial flow vascular mass suggest large pa fig4 visceral arteriogram show 53    22cmwide pa supply lga branch fig5a embolize occlude microcoil fig5b week later patient stable hemoglobin level gi bleed abdominopelvic ct angiography demonstrate pa markedly decrease diameter contain numerous microcoil blood flow fig1c,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
75yearold man refer hospital evaluation dysphagia 9 month associate symptom nausea vomiting deny hematemesis hematochezia lethargy dyspnea active smoker consume alcohol 30 year physical examination reveal peripheral lymphadenopathy thyromegaly ascite mass abdomen laboratory datum normal hbsag negative hiv negative syphilis negative test serum antibody helicobacter pylori negative chest compute tomography ct notable huge wellcircumscribed homogeneous cylindrical mesenchymal neoplasm measure 1555940 cm low middle esophagus mild contrast enhancement fig1a ct reveal abnormality lung heart rib mediastinum endoscopic examination show submucosal lesion esophagus start 20 cm incisor tooth extend cardia fig1b endoscopic ultrasonography eus reveal hypoechoic lesion clear boundary locate 4th layer mass appear benign tumor preoperatively diagnose esophageal leiomyoma base chest ct endoscopic examination eus findings endoscopic mucosal resection endoscopic submucosal resection possible large size surgical resection plan inform write consent take patient underwent thoracoscopicassiste resection mass gastroesophageal anastomosis thoracic duct ligation jejunostomy postoperative course uneventful grossly spindle shape lump measure 14    35    25 cm observe resect esophagus grow esophageal luman block luman lump locate submucosa cover intact mucosa erosion ulcer hemorrhage cut surface homogenously white grayishwhite color histological examination hematoxylin eosin stain reveal tumor cover intact squamous epithelium arise submucosal layer expand muscular layer tumor compose nodule vary size separate collagen fiber numerous cytoplasmrich cell observe collagenous septation invasive growth pattern fig2ac nodule mainly compose small midsized centrocytelike monocytelike cell arrange diffuse pattern atypical lymphocyte possess clear boundary pale cytoplasm irregular nucleus occasional nucleolus fig2d mitosis rare lymphoepithelial lesion recognize lesion immunohistochemical staining epithelium diffusely positive cytokeratin fig3a tumor cell diffusely positive cluster differentiation cd20 pair box 5 fig3b bcell lymphoma bcl2 fig3d small deposit tumor cell distribute mainly collagen fiber positive multiple myeloma oncogene 1 cd138 cd43 tumor cell positive cd30 small lymphocyte positive cd3 cd5 follicular dendritic cell positive cd21 cd23 fig3c cell negative cyclind1 cd10 bcl6 b lymphocyte specific activation oct bind protein 1 follicular dendritic cell arrange nodule tumor cell relatively evenly distribute pattern suggestive follicular colonization see malt lymphoma case gene rearragement clonality analysis immunoglobulin heavy chain gene kappa light chain gene lambda light chain gene perform identiclonetm ighigkigl gene clonality assay invivoscribe technology monoclonal gene rearrangement 1 band appear 150 175 base pair bp heavy chain gene 2 discrete band 225 250 bp kappa light chain gene 1 band 125 150 bp lambda light chain gene fig4 addition epsteinbarr virus observe lymphoma situ hybridization eb virusencode small rna fig3e f base clinical datum pathological immunohistochemical gene rearragement analysis final diagnosis primary esophageal malt lymphoma surgical resection additional therapy form chemotherapy radiotherapy administer 8 month followup evidence recurrence metastasis find ct patient asymptomatic ethical approval study obtain medical ethic committee affiliated hospital military medical university write inform consent obtain patient publication case report accompany image,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
47yearold female patient present progressively worsen pain chest wall bilateral low extremity muscle weakness family history bone disease fracture physical examination unremarkable exclude bone muscular abnormality bone scintigraphy technetium99 m methylenediphosphate show increase uptake shoulder multiple rib thoracic lumbar spine bilateral sacroiliac joint leave ilium leave foot fig1 plain radiograph reveal osteoporosis change thoracic lumbar spine compression change spine consistent finding magnetic resonance imaging compute tomography ct fig1 decrease bone mass present lumbar spine tscore 34 femoral neck tscore 31 hip tscore 35 main laboratory datum show table 1 demonstrate hypophosphatemia hypokalemia hypouricemia elevated level alp ctelopeptide chloride decrease carbon dioxide combine power urinalysis reveal high ph value increase level potassium decrease level specific gravity chlorine phosphate persistent glycosuria proteinuria repeatedly find despite normal hba1c plasma glucose level laboratory test result include thyroid function test serum parathyroid hormone 25hydroxyvitamin d protein electrophoresis normal range addition serum tumor marker negative limited technique determine level serum fibroblast growth factor 23 clinical diagnosis ho fluorodeoxyglucose positron emission tomographycompute tomography 18ffdg petct technetium99 m octreotide 99mtcoct scintigraphy perform confirm occult causative tumor exist result 2 test negative mild uptake seventh rib find petct identify evidence neoplastic lesion potentially responsible ho fig2 immunological examination show elevated level serum igg igm iga positive antinuclear antibody antissa antibody rheumatic factor subsequently schirmer test abnormal lip biopsy support diagnosis ss fig3 eventually patient diagnose ho secondary ss treat alkalinization citrate 4 gday potassium citrate 3 gday 2 week steroid prednisone 20 mgday 1 month 10 mgday 4 month neutral phosphate 10 gday 5 month calcium supplement 600 mgday 5 month activate vitamin d 05 gday 5 month far recover uneventfully relieve pain increase serum phosphorus level case report approve ethics committee west china hospital sichuan university chengdu china write inform consent obtain,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
69yearold man aware onset exertional dyspnea july 2010 history smoke 40 year 20 cigarette day parent 1 brother lung cancer past medical history unremarkable occupational exposure exertional dyspnea admit people hospital shunde district echocardiography compute tomography pulmonary angiography ctpa echocardiography indicate severe pah pulmonary arterial pressure pap 104 mmhg right heart enlarge right ventricle diameter 57 mm ctpa show pah thrombus upper lobe artery right lung region lung affect pe consider small induce severe pah addition connective tissue disease drug use history chemotherapy hiv test    diagnose ipah combine pe treat warfarin 25 mg day target international normalize ratio inr 15 25 slidenafil target pah therapy 20 mg twice day patient dyspnea relieve slightly use medication 1 month reteste pap echocardiography decrease 72 mmhg symptom sign fail improve take medication 6 month march 2011 go kyorin university affiliated hospital japan treatment right heart catheterization reveal pap 723447 mmhg pulmonary capillary wedge pressure pcwp 17510 mmhg cardiac output 43 lmin cardiac ejection index 236 lminm2 pulmonary vascular resistance 73 wood unit reteste ctpa show thrombus upper lobe artery right lung disappear diagnose have ipah treat sildenafil 20 mg 3 time day sorafenib 400 mg day target pah therapy oral warfarin anticoagulation therapy 25375 mg day daily dose adjust inr 2 3 disappointingly dyspnea relieve pap test echocardiography 95 mmhg september 2011 visit shanghai pulmonary hospital china relief dyspnea arterial blood gas analysis show pao2 63 mmhg oxygen saturation 93 lung function test reveal mild obstructive dysfunction pulmonary ventilation fev1fvc 6206 fev1 prediction 809 severe reduction diffuse capacity lung carbon monoxide dlco 42 6minute walk test 385 m chest highresolution compute tomography hrct fig1a b show smooth thickening interlobular septum diffuse centrilobular nodule enlargement mediastinal lymph nod right heart catheterization reveal pap 833453 mmhg pcwp 14611 mmhg acute vasodilator testing negative coronary angiography ctpa normal pulmonary ventilationperfusion vq lung scan show match ventilation perfusion defect bronchoalveolar lavage show elevated percentage 65 hemosiderinladen macrophage golde score 80 normal range 020 diagnose have ipah suspect actually have pvod continuously treat target pah therapy ask continue anticoagulation treatment stop warfarin anticoagulation treatment 2014 fail recall exact date feel cumbersome frequently test inr blood coagulation monitoring furthermore discontinue warfarin therapy fail monitor ddimer prevent pe recurrence dyspnea relatively stable develop fatal episode pulmonary edema therapy january 2015 rush hospital dyspnea suddenly exacerbate ctpa show thrombus right main pulmonary artery fig1c rivaroxaban administer anticoagulation treatment medication relieve dyspnea ill walk instead bind wheelchair half year severe pah suspect pvod combine lifethreatening pe mandate lung transplantation survival month later undergo bilateral sequential allogenic lung transplantation assist venoarterial extracorporeal membrane oxygenation vaecmo sign write consent july 29 2015 histology explanted lung speciman show pulmonary vein occlusion fig1df pulmonary embolism right pulmonary artery confirm have pvod combine pe instead ipah live dyspnea 1 year lung transplantation echocardiography show normalization pap enlarge right ventricle heart study approve ethic committee people hospital zhongshan city write inform consent obtain patient,"['O', 'B-SEX', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
58yearold cotton farmer present west china hospital sichuan university 1month history recurrent fever 38 40 c productive cough dyspnea prior admission diagnose pneumonia treat latamoxef ofloxacin vancomycin voriconazole local hospital remission symptom observe hepatitis b virus carrier 10 packyear smoke history history diabetes mellitus tuberculosis use glucocorticoid past inform admission blood pressure 14595 mm hg heart rate 120 minute respiratory rate 30 minute temperature 393 c physical examination reveal diminish breath sound rale hear evaluation system unremarkable moderate edema low limb arterial blood gas analysis show ph 7361 pco2 535 mm hg po2 628 mm hg laboratory datum table table11 reveal leukocytosis 49500mm3 974 neutrophil elevated procalcitonin 516 ngml chest compute tomography presence nodule mass patchy consolidation bilateral pleural effusion note fig1a soon alert sputum smear presence filamentous grampositive weakly acidfast bead bacilli possible diagnosis nocardia infection fig1b c trimethoprimsulfamethoxazole 3 pill 6 hour noninvasive ventilation promptly administer sputum culture show growth numerous bacteria precisely determined n otitidiscaviarum method mass spectroscopy day 6 admission fig1d antibiotic modify amikacin imipenem addition trimethoprimsulfamethoxazole accordance sensitivity test patient improve expect eventually die severe respiratory insufficiency 13th hospital day,"['O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O']"
n march 2015 62yearold woman admit hospital complain progressive visual disturbance begin 4 year ago treat cataract local hospital relief see contrary symptom aggravate half year ago headache leave eye pain tearing increase secretion compute tomography ct scan brain local hospital show sellar region lesion 2 year early patient underwent resection melanoma left heel t2n0m0 ki67 35 stage ii follow resection recur melanoma nearby primary site 15 month later t3n3m0 stage iii lymphadenectomy family history melanoma physical examination patient bilateral temporal hemianopsia right finger counting 1 m left finger counting 05 m enlarge lymph node palpable right groin ophthalmologic examination patient right vision 04 leave vision 008 intraocular pressure 15 mm hg bilaterally optometry find right eye 600ds025dc65 left eye 625ds050dc20 patient maculopathy eye optic atrophy left eye light reflex eye movement eye normal ct scan brain parenchyma orbital chest unremarkable ct scan ultrasound examination abdoman show hepatic portal retroperitoneal lymphadenectasis enlarge leave lobe liver substantial placeholder lesion ultrasound examination bilateral inguinal lymph node discover multiple low echo light group large 31 mm diameter hilu echo asymmetrical thickening skin ct scan sellar region reveal crumby mass protrude sphenoid sinus obscure boundary bone destruction average ct value mass 46 hu sellar region magnetic resonance imaging mri reveal round mass 30 mm diameter enlarged sellae fig1a b mass show isointense t1weighte image t1wi t2weighte image t2wi homogeneous enhancement gadoliniumdtpa injection dural tail sign see small foci inside tumor show hyperintense signal t1wi hypointense signal t2wi enhancement see mass penetrate meninge surround left internal carotid artery blur left optic nerve pituitary stalk short right displacement laboratory finding reveal increase level prolactin 11908 gl normal range 5993004 gl cortisol 67710 nmoll normal range 1186061800 nmoll decrease level free thyroxine ft4 604 pmoll normal range 12002200 pmoll free triiodothyronine ft3 209 pmoll normal range 350650 pmoll patient diagnose giant prolactinoma patient underwent transnasal transsphenoidal surgery remove tumor relieve compression optic nerve intraoperatively see tumor invade fill left interval sphenoid sinus bone sellar floor leave parasellar destroy absorb little normal pituitary tissue see right tumor sellar turcica tumor reddish black extremely rich blood supply close adhesion surround structure texture center tumor soft tough rim intraoperative frozensection examination find melanin granule consider malignant melanoma meningioma tumor cell compose eosinophilic stain epithelial cell cell nucleus round reniform hippocrepiform evident nucleolus nuclear fission see tumor show evidence necrosis fig2 tumor immunopositive focally melanomaspecific marker s100 hmb45 vimentin immunopositive neuroendocrine tumor marker cga syn fig3 ki67 index 3 5 high metastatic melanoma adenomatous component take melanoma history suspect lymph node hepatic metastasis consideration patient diagnosise mmpa surgery significant relief see visual field headache level prolactin cortisol ft4 return normal hormone replacement therapy focal liver lesion lymphadenectasis cause discomfort patient refuse surgical intervention treatment discharge hospital immediately disease free 2 month surgery patient successively find new melanoma metastatic site skin low left leg knee upper left leg left groin right groin right leg followup late january 2016 patient walk live depress late followup late january 2017 patient alive bad symptom sensory deficit leg hyperalgesia hand mouth impaired intelligence live disease careful nursing daughter,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O']"
2013 50yearold man patient visit hospital complaining local bone pain left leg august 14 2013 patient undergo left distal femoral tumor en bloc resection reconstruction modular femoral prosthetic system pathology diagnosis confirm osteoblastic osteosarcoma fig2 cycle neoadjuvant chemotherapy 4 cycle adjuvant chemotherapy map regiman highdose methotrexate cisplatin doxorubicin administer january 2015 mass find left upper crus area tumor recurrence confirm biopsy january 23 2015 upper femur amputation carry patient refuse hip joint replacement wound heal patient go normal life help artificial limb refuse receive chemotherapy concern chemotherapy toxicity nausea vomiting leucopenia deadlimb headache half year amputation patient get occasional cough chest tightness thin chest compute tomography ct perform july 15 2015 ct result reveal multiple pulmonary nodule table 1 consider possibility metastasis patient reject chemotherapy immunophenotype suggestive cd31 cd34 tumor cell fig3 furthermore cell show strong positive staining vegfr2 fig3 apatinib administer dose 500 mg daily half month later symptom disappear progressive wound necrosis appear debridement surgery finally conduct enlarged lymph node near iliac vessel resect february 24 2016 figfig44 result pathological examination reveal inflammatory hyperplasia lymph node apatinib administration stop 3 week wound healing period thin chest ct perform 7 11 month follow apatinib administration 7month followup time point 2 5 measurable 9 17 nonmeasurable lesion disappear 1 new measurable nodule 6 new nonmeasurable lesion observe table 1 fig5 consider pd accord response evaluation criterion solid tumor recist 11 standard 11month followup time point total 9 lesion disappear include 1 measurable nodule 2 nonmeasurable lesion present apatinib treatment 6 nonmeasureable lesion present 7 month apatinib treatment new lesion raise target lesion measurement accord recist 11 standard narrowly consider pr toxicity patient experience include mild handfoot syndrome slight high blood pressure control appropriate treatment severe toxicity treatmentrelate adverse event observe patient continue use apatinib maintenance therapy major toxic effect go normal life drive automatic car,"['O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
61yearold chinese woman complain dizziness 3 week admit hospital bifrontal mass find radiologically dizziness patient present sign symptom commonly associate neurological disease headache vomit sensory disturbance alter consciousness seizure 20year history hypertension properly control angiotensinconverte enzyme inhibitor patient healthy special circumstance identify personal family history patient find normal neurological examination plain contrastenhance magnetic resonance imaging mri head show spaceoccupye lesion bifrontal lobe mainly right cling sagittal sinus cerebral falx 57    50    50 cm duralbase mass grow sagittal midline reveal isointensity t1weighte image slight hyperintensity t2weighte image homogenously enhance characteristic duraltail sign fig1 diagnosis parasagittalparafalcine meningioma craniotomic meningioma resection choose treatment blood cell examination coagulation function liver renal function test urinalysis chest xray electrocardiogram normal albumin 36 gl total bilirubin tbil 122 moll direct bilirubin dbil 41 moll alanine transaminase alt 17 ul international normalize ratio inr coagulation value 102 patient advanced age history hypertension perform echocardiograph blood gas analysis test creatine kinase level pulmonary function result reveal surgical contraindication write consent obtain patient milligram vpa twice day initiate 3 day operation patient tolerate administration craniotomy perform radical tumor resection simpson ii tumor pink solid moderate blood supply texture medium thirty minute end surgery 800 mg vpa administer intravenous infusion operation patient regain consciousness 30 minute score 15 glasgow coma scale gc hour later transport ward patient undergo ugh vomitus approximately 50 ml compose coffeecolore blood exclude possible etiology endotracheal intubation damage diagnose patient experience acute erosivehemorrhagic gastritis reaction craniotomy injury patient give omeprazole inhibit gastric acid secretion hematemesis cease patient administer vpa 1200 mg intravenously 2 postoperative day stomach intestine functional recovery vpa dosage change 500 mg oral administration twice day brain mri perform postoperative day 3 reveal tumor radically remove operative field clean fig2a b subsequent paraffin histological examination confirm diagnosis meningioma 3 postoperative day 4 patient suddenly find deep coma pupil dilate 30 mm round light reflex sensitive neurological examination unremarkable vital sign stable mental state gradually change deep coma gcs    8 believe cause intracranial lesion computerized tomography ct scan brain immediately perform fail reveal abnormality severe brain swell intracranial hemorrhage cerebral infarction fig2c possible cerebral infarction exclude 24 hour glucocorticoid mannitol vasodilator patient routine laboratory result blood cell liver renal function relatively normal range albumin 33 gl tbil 133 moll dbil 45 moll alt 12 ul inr coagulation value 101 history ugh check blood ammonia level perform fecal occult blood test blood gas analysis blood ammonia elevate 1816 moll normal range 1132 moll fecal occult blood test positive consider history elevated blood ammonia diagnose ughinduced hepatic encephalopathy oral administration vpa change intravenous administration prevent seizure lactulose vitamin b larginine administer clysis vinegar perform patient fast patient blood ammonia level fluctuate 14482077 moll remain unconscious follow 3 day unremarkable progress patient mental state blood ammonia level hold multidisciplinary conference discuss diagnosis treatment initially consider hemodialysis peritoneal dialysis multidisciplinary discussion suspect diagnosis vhe finally blood vpa level normal range decide stop vpa administration perform dialysis administer levetiracetam instead vpa patient blood vpa ammonia level routinely monitor patient mental state begin improve 24 hour vpa discontinuation achieve complete consciousness 48 hour gcs    15 ammonia level blood decrease dramatically return normal 4 day fig3 postoperative day 15 8 day discontinuation vpa patient discharge complication followup interview postoperative month 5 witness consciousness nonrecurrence primary tumor fig2d patient gcs score 15 report enjoy satisfying quality postoperative life,"['O', 'O', 'B-SEX', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
60yearold man present retroperitoneal metastatic lymph node magnetic resonance mr image history right liver resection 2010 pulmonary wedge resection 2012 transarterial chemoembolization twice 2014 postoperative pathology suggest mixed liver cancer poorly differentiate lung cancer liver metastasis examination tumor close duodenum pancrea stomach hepatic portal vein patient unresectable masse hypertension 10 year chronic hbvrelate cirrhosis 30 year treat lamivudine 100 mg qd adefovir dipivoxil 10 mg qd 6 year keep constant body temperature 37 c blood pressure 14896 mm hg pulse 77 beat minute patient obvious sense abdominal pain abdominal distention nausea vomit test tumor marker level result normal show carcinoembryonic antigen 37 ngml alpha fetoprotein 173 ngml carbohydrate antigen 199 level 61 uml study procedure approve ethic committee affiliated hospital zhejiang university efficacy local ablation estimate choi criterion appraise variation tumor size lesion density compute tomography ct image complete response disappearance lesion new lesion partial response pr decrease size 10 decrease tumor density 15 ct new lesion stable disease fit complete response pr progressive disease progressive disease increase tumor size 10 fit pr tumor density ct new lesions19 preoperative mr imaging scan show mass 28    35 cm size close duodenum pancrea blood vessel fig1a substance phase mr image indicate mildly high signal intensity tumor intermediate low signal intensity solid component wall fig1b initial ablation retroperitoneal mild hyperechoic area axial image fig1c study inpatient underwent percutaneous transhepatic biopsy ablation avoid nearby blood vessel procedure perform 40 minute local anesthesia mild sedation ultrasonography realtimely guide inserting 2 ndyag laser fiber echolaser x4 esaote italy 03 mm diameter 21gauge chiba needle lesion fig1d heat run blood flow20 ablation valid area 12 15 mm power 5 w 5 6 minute subsequently immediate ultrasonography show lesion cover hyperechoic zone figfig1e f day contrastenhance ultrasound ceus reveal abnormal residual proximal pancreatic head fig2a 5day followup contrastenhance ct image low mass low signal intensity upper tumor reveal intermediate high signal intensity residual substance phase fig2b c surprizingly 1week followup ceus image show enlarged retroperitoneal lymph node locate near pancreatic head fusion residuary small nodule fig2d patient undergo 2nd ablation 2 laser fiber show lesion welldefine hyperechoic zone fig2e f 2nd day postoperative ceus image show remanent fig2 g correspond mr image show left tumor fig2h 3rd laser ablation perform fig2j2j 3 day later ceus find minor lesion locate separation gap 2 needle fig3a subsequently patient 4th ablation separation gap hyperechoic overlay fig3bd 3 day later base 4 treatment enhance ct image retroperitoneal mass suggest complete necrosis fig3eg3eg follow 1 month substance phase mr reveal lowintensity signal tumor necrosis resolution problem fig3h 5 month 4 ablation ct show tumor pr little enhanced recurrence yellow arrow locate left low edge original lesion fig4a b laboratory test tumor marker level carcinoembryonic antigen alpha fetoprotein carbohydrate antigen 199 indicate 36 ngml 267 ngml 81 uml respectively obvious effect discover case procedure,"['O', 'B-SEX', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
61yearold male patient history chronic obstructive pulmonary disease regular bronchodilator treatment 2014 suffer severe productive cough mucus sputum month unintentional body weight loss 6 kg 6 month sputum analysis chest imaging examination 2014 diagnose squamous cell carcinoma right upper lobe lung ct3n2m0 stage iiia receive neoadjuvant chemoradiotherapy etoposide 70 mg 45 mgm2    cisplatin 79 mg 50 mgm2 4500 cgy 25 fraction june july 2014 october 2014 surgical intervention arrange tumor locate right hilum invade main bronchus major vessel videoassiste thoracoscopic surgery right intrapericardial pneumonectomy perform postoperatively pathological exam reveal squamous cell carcinoma t3n0m0 stage iib postoperative course smooth suffer severe cough right chest pain month later laboratory exam reveal leukocytosis white blood cell    21860 l elevate creactive protein 2394 mgdl chest xray show cavitary lesion compute tomography show pleural effusion fluid collection mottled gas appearance dependent portion right hemithorax fig1a accord patient history result laboratory exam image finding postpneumonectomy empyema diagnose bronchopleural fistula highly suspect admission chest tube drainage insert bronchoscopic tissue glue sealing perform persistent air leakage present decide repair bronchial stump flap coverage patient receive neoadjuvant chemoradiotherapy month ago flap harvest chest area appropriate pedicle artery injure irradiation discuss plastic surgeon decide repair bronchial stump tram flap intraoperatively patient place supine right exploratory thoracotomy perform bronchial stump locate superior epigastric vascular artery right rectus abdominis muscle identify location tram flap mark skin fig2a tram flap harvest right rectus abdominis fig2b deepithelialize fig2c subcutaneous tunnel tram flap move right thoracic space tension kink pedicle fig2d tram flap fix posterior chest wall cover bronchial stump fig2e tissue glue apply bronchial stump bronchoscope donor site flap close mesh repair postoperative course smooth air leak diminish gradually patient discharge stable condition free air leak follow 12 month fig1b patient provide write informed consent publication report accompany image,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
63yearold male patient smoking drinking history admit june 11 2014 major complaint gradually aggravate dysphagia fatigue suspicion obstructive disease upper digestive tract athlete retire good physical status admission family social history indicate abnormal thorough physical examination skin oral mucosa eye genital area fail identify superficial lesion additionally laboratory test include hepatic function renal function serum tumor marker carcinoembryonic antigen cytokeratin 19 fragment squamous cell carcinoma neuronspecific enolase carbohydrate antigen 125 normal range endoscopic radiological examination carry accurate diagnosis endoscopic examination reveal slightly pigment irregular mass locate low esophagus measure 50 cm    30 cm size fine needle biopsy lesion reveal esophageal melanoma confirm histopathology chest abdomen compute tomography ct enhance cranial magnetic resonance image mri bone emission compute tomography ect show enlarge mediastinal nd celiac lymph node fig1a obvious involvement supraclavicular lymph node concurrently ct show isolated irregular pulmonary tumor fig1b positron emission tomography carry cover health insurance patient patient clinically stage ct3nxm1 accord 7th edition american joint committee cancer tnm staging system esophageal cancer ctguide percutaneous pulmonary biopsy avoid aim diminish risk tumor dissemination singlestage resection esophageal pulmonary lesion assume reasonable multidisciplinary consultation approve ethical committee xuzhou central hospital prognosis patient probably extremely poor target antibody afford financial reason inform consent simultaneous ivorlewis esophagectomy right upper lobectomy perform successfully general anesthesia doubleluman endotracheal intubation follow systemic dissection lymph node locate mediastinum abdomen accordance principle oncological surgery operation time 290 minute obvious bleeding surgery postoperative pathological staining speciman reveal pleomorphic cell abundant melanin granule fig1c immunohistochemical test demonstrate positive expression human melanoma black 45 hmb45 microtubuleassociate protein tau 1 mapt1 melan s100 negative expression desmin synaptophysin epithelial membrane antigen ema consistent melanoma resection margin dissect lymph node pathologically tumornegative addition molecular study patient indicate mutation vraf murine sarcoma viral oncogene homolog b1 braf v600e base finding diagnosis advanced pmme tentatively establish stage iv pt3n0m1 insufficient evidence distinguish synchronous primary pulmonary melanoma metastasis patient postoperative recovery mainly uneventful patient discharge 14 day surgery subsequently 4 cycle adjuvant conventional chemotherapy interval 3 week complete control moderate toxic effect include thrombocytopenia leukopenia nausea vomiting diarrhea detailed chemotherapy regimen follow paclitaxel liposome injection day 1 day 8 135 mg square meter body surface area nanjing luye sike pharmaceutical co ltd jiangsu china tegafur injection day 2 4 1000 mg square meter bodysurface area shandong qilu pharmaceutical co ltd jinan china plus cisplatinum day 2 3 75 mg square meter bodysurface area shandong qilu pharmaceutical co ltd jinan china patient suffer moderate leukopenia myelosuppression second cycle tpf chemotherapy recover quickly administration granulocyte colonystimulate factor gcsf concurrently recombinant human interferon alpha2b harbin pharmaceutical group biological engineering co ltd harbin china administrate hypodermic injection 6000 unit 3 day fig2 last 1 year patient follow continuously surgery chest abdomen ct cranial mri bone ect thorough physical examination carry 3 month encouragingly patient survive locoregional recurrence remote metastasis followup half year fig3,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'I-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O']"
34yearold woman 1 week postpartum present dermatology clinic intensely pruritic generalize rash day delivery child patient develop itchy rash abdomen discharge instruct follow dermatology department rash resolve leave hospital report eruption progressively spread buttock leg itching bad patient prenatal course uneventful gain 13 kg pregnancy prepregnancy weight 72 kg healthy male neonate deliver caesarean section 38 week gestation complication patient medical history unremarkable currently take medication report known drug allergy physical examination patient afebrile blood pressure normal examination skin reveal erythematous papule urticarial plaque involve abdominal stria periumbilical spare similar lesion note leg buttock fig1a face palm sol uninvolved vesicle pustule note base characteristic clinical presentation disease course diagnose puppp inform safety profile potential benefit medication remain reluctant use medication lactation despite severe symptom awb injection consider treatment venous blood 10 ml draw patient follow intramuscular injection 5 ml blood buttock seven day later subjective objective improvement symptom notice receive 1 session awb injection fig1b followup 12 day subjective symptom improve leave postinflammatory hyperpigmentation fig1c complication infection abscess formation hematoma observe injection site,"['O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'O', 'O']"
proband ii2 fig2 45year old woman present university hospital age 35 refer pregnancy congenital deafness experienced syncope age 3 diagnose epilepsy treat antiepilepsy medication subsequently experience instance syncope age 13 syncope event suspect have jln congenital deafness prolong qt interval syncope diagnose arrhythmic episode aware tachycardia epilepsy subarachnoid hemorrhage age 29 present hospital take betablocker history asthma take mexiletine addition phenytoin qtc find prolong 584 ms presentation administration atenolol initiate deliver baby iii1 fig2 caesarean operation hospital age 35 37 deliver second baby iii2 fig2 caesarean operation hospital despite administration betablocker qtc remain prolong 600 msec age 37 780 msec 44 figs2 3a unexpected treatment betablocker lqts1 expect overtly reduce qtc 18 continue experience occasional syncope finally undergo implantable cardioverter defibrillator icd operation 38 year age subsequently stable clinical condition proband suspect jln infant measure qtc 500 m great 1 month birth beta blocker initiate child remain stable condition age 10 8 figs2 3b c qtc son iii1 fig2 measure 500 ms month birth qtc sister iii2 530 ms birth father i1 mother i2 proband cousin history sudden unexplained syncope death child adult immediate family member despite prolong qtc child clinical evaluation consultation proband family member perform chiba university hospital clinical phenotype deduce clinical history physical examination ecg blood sample collect proband family member follow genetic counseling write inform consent obtain prior sample collection genomic dna isolate peripheral blood lymphocyte accord establish protocol laboratory 19 entire code exon include intronic boundary gene kcnq1 ncbi ref nm000218 lqt causative gene kcnh2 scn5a kcne1 kcne2 kcnj2 scn4b kcnj5 amplify polymerase chain reaction pcr accord establish protocol laboratory briefly 30100 ng genomic dna subject pcr amplification dna polymerase primestar gxl dna polymerase takara bio inc kusatsu japan primer set amplicon subject conventional sequence sanger sequencer apply biosystem 37303130 dna analyzer thermo fisher scientific waltham ma usa sequence datum process gene code sequencher software takara bio inc map human genome sequence build grch37hg19 genetic analysis perform screen code exon exonintron boundary kcnq1 gene ncbi ref nm0002182 np0002092 concurrent screening lqt causative gene kcnh2 scn5a kcne1 kcne2 kcnj2 scn4b kcnj5 detect novel homozygous nonsense variant nm0002182c115 g    t pglu39x exon 1a kcnq1 gene proband homozygous common variant nm0002182c1343c    g ppro448arg additional file 1 table s1 genetic screening mother i2 child iii1 iii2 reveal heterozygous nonsense variant fig2 husband ii3 screen find heterozygous common variant nm0002182c1343c    g ppro448arg proband child firstcousin marriage conclude homozygous nonsense variant proband cause jlns1 proband negative pathogenic variant lqt causative gene include kcne1 gene additional file 1 table s1,"['O', 'O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'B-SYMPTOMS', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O']"
4 half year old male child present hospital abdominal swelling child occasionally feel stomach ache relieve reason child show obvious tenderness rebound bear premature baby 32nd week mother pregnancy medical history include inguinal hernia 2 side receive operation left inguinal hernia family genetic history find physical examination child show abdoman obviously bulge mass touch umbilicus 3 finger positive sign result laboratory test normal include alphafetoprotein afp level childpugh score 5 abdominal ultrasonography show uneven lesion liver diagnosis hb consider enhancement compute tomography ct scanning show large mass left upper abdoman leave lobe liver irregular edge size mass 123    102    72 cm fig1 uneven nodular shadow edge obvious mass enhance calcification expand bile duct observe left branch portal press distant show unclear abnormal observe right branch accord medical history diagnosis hb consider recommend biopsy patient cause bleeding tumor diffusion operation necessary patient underwent dvss surgery sufficient preparation exploration show extrahepatic 12    10 cm mass left lobe liver fig2 operation sample split edge tumor clear envelope tremelloid mesenchyme see section fig2c pathological examination show sample grey red 14    13    7 cm size color section grey red grey white mhl diagnose fig3 immunohistochemistry result fig4 follow mesenchymal cd34    d240    s100    sma    cd7    epithelium ck19    afp    hcg    9 day recovery patient return home complication followup examination include blood routine liver renal function coagulation routine ultrasound scan 30 day abnormality adverse unanticipated event present,"['O', 'O', 'O', 'O', 'B-SEX', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'B-SYMPTOMS', 'I-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-DISEASE', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'O', 'B-SYMPTOMS', 'O', 'O', 'O', 'O']"
